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Abstract 
The past decade has seen a marked decline in malaria transmission and substantial progress 
towards malaria control in parts of Africa. A key tool in malaria control is the insecticide treated 
net (ITN). However, malaria remains a public health emergency in sub-Saharan Africa with 
children under five years of age bearing the greatest burden of the disease. In this thesis, I 
examine three sets of questions that are relevant to the changing epidemiology of malaria. 
a) I investigated trends in malaria cases in Kilifi County on the Kenyan Coast over 
geographical area and over time, age, and the effectiveness of ITN use in the community. 
I observed a decline in the proportion of admitted children who had malaria parasites 
detected by microscopy from 1998 to 2009 as previously observed in some countries of 
sub-Saharan African. However, there was a steady and marked increase in the proportion 
of children with malaria parasites after 2009 accompanied by a shift in burden of disease 
from younger age groups to older age groups. Community ITN use was highly effective 
in reducing the risk of malaria. As transmission fell, geographical heterogeneity became 
more marked. 
b) I undertook an analysis of data shared from 19 studies conducted between 1996 and 2015 
in 7 countries of sub-Saharan Africa to examine whether micro-geographical 
heterogeneity was generalizable. Hotspots were identified in all datasets, and were more 
marked at lower transmission intensity. Given the predictability with which hotspots 
occur as transmission intensity falls, malaria control programmes should have a low 
threshold for responding to apparent clustering of cases.  
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c) I then considered whether rapid diagnostic tests (RDTs) or PCR would alter detection of 
hotspots. Using cross-sectional studies of asymptomatic parasitaemia, I describe 
hotspots of malaria transmission in three sites on the Kenyan Coast using data from 8581 
study participants. Microscopy and RDT missed a larger proportion of infections in low 
transmission settings. PCR hotspots completely overlapped with microscopy hotspots at 
a moderate transmission, but not at two low transmission setting. From this work, I 
recommend that malaria control programmes consider PCR testing for targeted control 
when transmission intensity is low. 
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Chapter One 
1 Literature review 
1.1  The malaria parasite 
Malaria is a highly infectious disease caused by parasites of the genus Plasmodium and is 
transmitted to humans through bites from infected female mosquitoes of the genus Anopheles. 
Six parasitic species of Plasmodium cause human malaria; P. falciparum, P. vivax, P. malariae, 
P. ovale (split into two species: P.o. curtisi and P.o. wallikeri), (Carter and Mendis 2002, Singh 
et al. 2004, Sutherland et al. 2010) and P. knowlesi (Cox-Singh et al. 2008, White 2008, 
Sabbatani et al. 2010). 
P. falciparum and P. vivax are the most commonly researched parasite species because of their 
wide geographical coverage, high morbidity and mortality. P. falciparum is highly pathogenic, 
associated with the highest number of deaths and accounts for >95% of malaria infections in 
sub-Saharan Africa. This malaria parasite is characterized by cyclic patterns of fever and chills 
that in some instances leads to severe forms of malaria (i.e. severe malaria anaemia common in 
children and cerebral malaria common in older children) that are associated with high case 
fatality. Outside Africa, P. vivax accounts for the highest burden of malaria (>50% of all malaria 
(Mendis et al. 2001)), but it is less common (<10% of all malaria cases) in sub-Saharan Africa 
partly due to the absence of the Duffy bood-group-antigen (Howes et al. 2011, Gething et al. 
2012) that the parasite requires to invade red blood cells (Miller et al. 1976). However, emerging 
evidence show that P. vivax can infect and cause disease in some Duffy negative individual 
(Menard et al. 2010, Mendes et al. 2011) suggesting a possible interaction with other biological 
processes or a possibility of other receptors aiding cell invasion. 
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Infections with P. vivax are characterized by relapses arising from persistent liver stages of the 
parasite, and lower parasite densities compared to P. falciparum. Whilst P. ovale and P. 
malariae have historically been perceived to be less prevalent, recent reports show that they 
could be more prevalent in sub-Saharan Africa than previously predicted and are often 
undetected by light microscopy (Doderer-Lang et al. 2014). Nevertheless, disease due to these 
species are relatively mild and easily treated by commonly used anti-malaria drugs (Mueller et 
al. 2007). In terms of survival, P. ovale and P. vivax are best adapted to long-term survival in 
the human host due to their latent erythrocytic forms. Recent evidence shows that P. falciparum 
(Ashley and White 2014) and P. malariae (Collins and Jeffery 2007)  can also persist 
asymptomatically for decades.  
P. knowlesi is mainly found among South-Asian primates (long tailed and pig-tailed macaques), 
and infects humans more frequently than previously thought. Morphologically, P. knowlesi 
resembles P. malariae making it difficult to distinguish by microscopy, and is potentially life-
threatening given its short blood stage cycle (24 hour cycles) accompanied by high parasitaemia 
and fever (Singh et al. 2004, Cox-Singh et al. 2008). Research into the epidemiology of P. 
knowlesi malaria increased recently when it was observed that the species could infect humans. 
Human infection with P. knowlesi appears to have resulted from continued human encroachment 
into non-human primate habitats, who are the natural hosts. P. knowlesi is likely to pose a 
challenge during elimination stages of malaria as humans continue to encroach on primate 
habitats in South East Asia. 
However, P. knowlesi transmission has not been reported in Africa, and this may partly be 
associated with the absence of the reservoir host (long tailed and pig-tailed macaques) (Moyes 
et al. 2014), and the high prevalence of the Duffy negative genotypes among the African 
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population (Miller et al. 1975). Although there is a possibility that human to human transmission 
may occur in areas with high density P. knowlesi zoonosis, there is currently no evidence to 
firmly establish that such transmission takes place (Ramasamy 2014). 
This thesis hereafter focuses on the epidemiology of P. falciparum in sub-Saharan Africa except 
chapter five that examines the prevalence and geographical distribution of other malaria species 
on the Kenyan coast. 
1.2 Life cycle  
P. falciparum, the most lethal form of malaria, has a sophisticated life cycle making it difficult 
to control. The parasite undergoes several developmental stages in both the mosquito and the 
human hosts (Figure 1.1).  
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Figure 1.1: P. falciparum malaria lifecycle showing the asexual phase in the human host and 
the sexual stage in the female Anopheles mosquitoes. 
(Wirth 2002) 
The cycle begins when a female infected Anopheline mosquito injects sporozoites into the 
human host when feeding from a blood meal. The sporozoites are then transported to the liver 
via the bloodstream and invade the hepatocytes. Within the hepatocyte, the sporozoites undergo 
proliferation and differentiation culminating in the liberation of merozoites. Several rounds of 
asexual multiplication give rise to tens of thousands of haploid merozoites over a period of 6–
16 days. Merozoites are then released into the bloodstream and invade erythrocytes. Once the 
erythrocytes have been invaded, merozoites undergo a process of growth and asexual 
multiplication to produce daughter merozoites over a period of 48 hours through ring stages 
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(trophozoite) to form schizonts which consist of many mature newly formed merozoites. 
Infected red blood cells (RBC) then lyse and liberate the merozoites which immediately invade 
new erythrocytes to begin a new erythrocytic cycle. This blood stage infection is responsible for 
the clinical symptoms of malaria, especially fever. Not all the ring trophozoites mature into 
schizonts. A small proportion undergo morphological changes and sexual differentiation to 
become male and female gametocytes. The gametocytes mature after about 10 days and are 
ready to be taken up by a blood meal seeking mosquito for the vector phase. 
Following an infected blood meal, the anopheline mosquito ingests both male and female 
immature gametes circulating in an infected human’s bloodstream. Under suitable 
environmental conditions (i.e. temperature), the male and female microgametes differentiates 
into macrogametes and fuse to form a zygote which undergoes a series of differentiation and 
growth stages that result in the production of infective sporozoites in the salivary glands of the 
mosquito, thus completing the cycle (Beier 1998, Garcia et al. 2006).  
1.3 Malaria disease burden 
The global burden of malaria has markedly declined over the past 15 years (Figure 1.2) in 
association with improving access to first-line anti malaria treatment and vector control (Murray 
et al. 2012, WHO 2012c, Noor et al. 2014, Bhatt et al. 2015a). During this period, malaria 
related mortality declined by ~60% globally. On the global scale, the World Health Organization 
(WHO) estimates ~262 (95% confidence interval[CI] 205-316) million cases, with ~839,000 
(95%CI 653,000 – 1.1 million) malaria related mortality in 2000 (WHO 2015b); and ~214 
(95%CI 149-303) million cases, with ~ 438,000 (95%CI 236,000 – 635,000) malaria related 
mortality in 2015 (WHO 2015b). 
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Figure 1.2: Changes in infection prevalence in Africa 2000-2015. 
Panel a, shows PfPR2-10 for the year 2000 predicted at 5×5 km resolution and panel b, shows 
PfPR2-10 for the year 2015 predicted at 5×5 km resolution (Bhatt et al. 2015a).   
Most deaths occurred in sub-Saharan Africa (90%) followed by South-East Asia (7%) and 
Eastern Mediterranean region (2%) (WHO 2015b). The high burden of malaria in Africa has 
largely been attributed to the existence of an effective vector species that include; Anopheles 
(An.) arabiensis, An. funestus and An. gambiae (Figure 1.3) (Sinka et al. 2012). An. gambiae, 
the most important vector in Africa, preferentially feeds on humans hence transmitting malaria 
from an infectious human host to susceptible individuals. This species has a documented long 
lifespan that consequently increases the likelihood of transmitting the parasite (Beier 1998). The 
humid, temperate and stable weather conditions in Africa enable the vector to thrive and the 
parasites to complete its lifecycle. In addition, social and economic factors (poverty) play an 
important role  in sustaining malaria transmission in Africa (Greenwood and Mutabingwa 
2002).  
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Figure 1.3: A global map of dominant malaria vector species (Sinka et al. 2012). 
Besides the WHO, there are other groups that have characterized malaria transmission intensity, 
mortality attributable to malaria and effect of malaria control intervention in sub-Saharan Africa 
(Gething et al. 2011, Murray et al. 2012, Noor et al. 2014, Bhatt et al. 2015a, Gething et al. 
2016). Overall, there is a consensus on the marked spatial and temporal heterogeneity of malaria 
transmission intensity in Africa. However, the magnitude of reported estimates varies 
considerably requiring careful interpretation (Nkumama et al. 2017). For instance, Bhatt et al 
predict that nearly all sub-Saharan African counties experienced marked decline in pfPR2-10 
transmission intensity (Bhatt et al. 2015a). This is consistent with some studies in individual 
countries (for instance Kenya (O'Meara et al. 2008, Snow et al. 2015), Tanzania (Mmbando et 
al. 2010) and the Gambia (Ceesay et al. 2008)) but studies conducted in Burkina Faso and 
Uganda show little evidence of declining transmission and in some instances, depict an 
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increasing trend (Okiro et al. 2011, WHO 2015b). The inconsistencies in the global estimates of 
morbidity and mortality arise from the inherent challenges in the sparsity of data collection and 
modelling assumptions commonly undertaken. Model-based geostatistical methods rely on 
borrowing information to estimate areas where data are unavailable (Noor et al. 2014). This 
concept is anchored on Waldo Tobler’s first law of geography that states “Everything is related 
to everything else, but near things are more related than distant ones”(Tobler 1970). However, 
heterogeneity of transmission is seen at a range of scales (Bejon et al. 2014) and therefore 
assessing the true burden of malaria in Africa is hampered by a lack of data that results from 
incomplete or limited medical records on malaria cases, limited laboratory testing given that 
most malaria cases and deaths occur outside health-care facilities and are thus inaccessible for 
recording (Snow et al. 1999, Greenwood and Mutabingwa 2002, WHO 2012c).  
Health monitoring and evaluation of malaria attributable deaths, within Africa, frequently relies 
on verbal autopsy (VA) to derive cause of death (Murray et al. 2012, Gething et al. 2016). VA 
tools and procedures are not standardized, and vary substantially among sites (Soleman et al. 
2006) and their accuracy is notably lower than medical certification of causes of death (Murray 
et al. 2014). 
In addition to the measurable global morbidity and mortality associated with malaria, there is 
evidence that malaria is associated with reduced birthweight, premature births, still births, 
cognitive impairment and social economic effects. Infants born premature or with low 
birthweight are more susceptible to infectious diseases and are at an increased risk of death 
compared to term babies with normal birthweight (Katz et al. 2013, Bousema et al. 2014, Chen 
et al. 2016, Lawn et al. 2016).  
23 | P a g e  
 
1.4 Malaria pathophysiology and immunity 
When a susceptible individual is inoculated with malaria parasites, a sequence of manifestations 
follows as shown in figure 1.4 below. However, progression depends on: 1) anti-disease 
immunity, 2) host factors, 3) efficacy and timing of antimalaria drugs, and coinfection. 
 
Figure 1.4: Malaria pathophysiology 
 
1.4.1 Clinical malaria 
The typical clinical symptoms of malaria are cycles of fever and chills and occur among semi-
immune or non-immune individuals. In malaria-endemic areas, clinical malaria is a rare feature 
during infancy (Murungi et al. 2017). This is because passively acquired maternal IgG 
antibodies are thought to confer protection against malaria during the first few months of life 
(Edozien et al. , Murungi et al. 2017). However, maternal immunity against malaria is short 
lived (~6 months) subsequently predisposing children to infection later in life (Murungi et al. 
2017).  
Severe malaria manifests in three overlapping syndromes: 1) severe malaria anaemia, 2) 
impaired consciousness and 3) respiratory distress (Figure 1.5) (Marsh et al. 1995).  
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Figure 1.5: Prevalence, overlap, and mortality for major clinical subgroups of severe 
malaria. 
Total numbers are given in parentheses, and mortality is given as a percentage (Marsh et al. 
1995). 
In high transmission areas, severe malaria anaemia is predominant and affects mainly younger 
children, while in low transmission areas cerebral malaria is more common in older children 
and is associated with high case fatality (Snow et al. 1994). Children in malaria endemic zones 
acquire immunity to clinical malaria rapidly following repeated infections, and hence, there is 
an inverse relationship between transmission intensity and age of susceptibility to clinical 
malaria (Snow et al. 1997, Okiro et al. 2009). However, anti-parasite immunity develops slowly 
and is incompletely acquired even among adults living in endemic areas. Some have argued that 
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immunity may suppress infection but is never sterilizing (Doolan et al. 2009). Furthermore, 
there is evidence to show that immigrant adults, from endemic areas, living in malaria free 
regions lose their protective immunity and become susceptible again (Marsh and Kinyanjui 
2006). In addition, malaria coinfection with some diseases may alter the development of 
immunity and enhance development of malarial symptoms. For instance, coinfection with HIV-
1 has been associated with increased rate of malarial fevers (French et al. 2001), higher 
parasitaemia, more complications and a higher case fatality rate (Hendriksen et al. 2012). 
Similarly, Mendelian randomization studies using Sickle Cell trait as an instrumental variable 
have shown that malaria increases susceptibility to non-typhoidal salmonella infection (Scott et 
al. 2011), confirming prior epidemiological observations (Mabey et al. 1987, Mackenzie et al. 
2010).  The mechanism appears to be related to haemazoin production by the parasite interacting 
with host immunity (Cunnington et al. 2012).   
1.4.2 Asymptomatic parasitaemia 
Asymptomatic parasitaemia is defined as the presence of parasitaemia in the absence of fever 
or other acute symptoms (Lindblade et al. 2013). Continued exposure to malaria parasites in 
endemic areas often results in the development of anti-disease immunity (Marsh and Kinyanjui 
2006). However, this kind of immunity does not protect against re-infection but controls 
parasitaemia to levels where the infection cannot cause disease. Whilst individuals with clinical 
malaria develop symptoms and typically seek medication, individuals with asymptomatic 
parasitaemia do not and hence maintain a reservoir for onward transmission in the community 
(Bousema et al. 2014, Chen et al. 2016).  
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1.5 Malaria diagnostic tools 
Presumptive diagnosis of febrile cases as malaria was common in sub-Saharan Africa when 
diagnostic tools were not widely available (Nankabirwa et al. 2009). However, many infectious 
diseases cause fever leading to a substantial proportion of febrile cases presenting to under-
resourced health facilities or retail outlets being treated presumptively for malaria in the absence 
of diagnostic testing (Amexo et al. 2004, Nankabirwa et al. 2009). In addition to misuse of anti-
malarials, over-diagnosis also diverts attention from other causes of severe illness and may lead 
to adverse clinical outcomes (Reyburn et al. 2004).  
WHO recommends that malaria case management be based on parasitological diagnosis (WHO 
2012b). Rapid diagnostic tests (RDTs) and microscopy are the primary diagnostic tools for 
confirmation of suspected clinical malaria in most resource limited settings (WHO 2013a). 
Clinical malaria is usually accompanied by fever and readily detectable parasitaemia. On the 
other hand, nucleic acid amplification-based diagnostic tools are recommended for the detection 
of asymptomatic parasitaemia in areas of low transmission intensity where submicroscopic 
infections are more common (Okell et al. 2009, Okell et al. 2012, WHO 2013a).  
Light microscopy examination of stained blood smears remains the gold standard for laboratory 
diagnosis of malaria. Although microscopy is relatively inexpensive compared to molecular 
diagnostics, it is not accessible and affordable in smaller health facilities in Africa. Microscopy 
can be highly sensitive and specific when conducted by well-trained laboratory personnel in 
high transmission settings, but suffers from detection limits, particularly in low transmission 
settings where clinical illness may be associated with lower parasitaemias (Okell et al. 2012). 
Moreover, there are challenges with quality assurance and standardization across sites or across 
independent laboratories. The advent of RDTs has greatly expanded diagnostic coverage due to 
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their simplicity, cost effectiveness and availability when compared to microscopy and molecular 
based diagnostics. RDTs are currently widely used in endemic areas and have been shown to be 
highly sensitive and specific compared to light microscopy (Hendriksen et al. 2011). RDTs 
measure the presence of P. falciparum histidine-rich protein 2 (HRP2) and/or lactate 
dehydrogenase (LDH) (Moody 2002) with important limitations. That is, HRP2 antigen can 
circulate in blood for weeks after treatment leading to false positives, and some parasites do not 
express the HRP2 protein rendering the tool less sensitive (Cheng et al. 2014). LDH on the other 
hand, persists less than HRP2 leading to fewer false positives (Hopkins et al. 2007, Murray et 
al. 2008, Houze et al. 2009). These caveats aside, HRP2 based RDTs have well documented 
lower detection limits in the range of 100 to 200 parasites per microliter (WHO 2012b). In 
addition, poor transport and storage of RDTs with sustained exposure to high temperature can 
potentially  affects their diagnostic performance (Cheng et al. 2014).  
Recent advances in molecular techniques have led to increased sensitivity in the detection of 
malaria parasites. A set of PCR techniques for malaria diagnosis are currently available and 
include single step, nested, multiplex and quantitative PCR. Although these techniques are 
highly sensitive, they are expensive and requires highly trained personnel to operate, and are 
thus primarily used for research purposes. Other nucleic acid amplification technology currently 
in use include the loop-mediated isothermal amplification (LAMP) and nucleic acid sequence-
based amplification (NASBA) that do not need thermocyclers to operate (Erdman and Kain 
2008). These techniques are faster, relatively cheap and easy to operate compared to PCR but 
with equal sensitivity and can potentially be used in rural settings outside the research 
environment.  
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1.6 Effective case management 
Early diagnosis and prompt effective treatment is one of the key strategies for malaria control. 
Uncomplicated P. falciparum malaria is defined as confirmed parasitaemia (by microscopy or 
RDT) and fever but without signs of severe illness or vital organ dysfunction. WHO 
recommends a three days regimen of artemisinin-based combination therapies (ACT) for 
treatment of uncomplicated malaria in both children and adults except pregnant women in 
their first trimester (WHO 2015a). Both artesunate plus amodiaquine (ASAQ) and artemether-
lumefantrine (AL) and Atovaquone-proguanil (AP), have been shown to be efficacious in the 
treatment of uncomplicated malaria (Martensson et al. 2005). In low transmission settings, 
efforts to reduce transmissibility of treated P. falciparum infections to mosquitoes may be 
boosted by an additional single dose of primaquine in combination with ACT (WHO 2015a). 
Although there are concerns regarding resistance in South East Asia (Ashley et al. 2014), ACT 
for treatment of uncomplicated malaria remains highly effective in Africa, but coverage is 
substantially heterogeneous and remains unacceptably low in some areas. Approximately 
80.3% of children with uncomplicated malaria did not have access to ACT in 2015 (Bennett et 
al. 2017). 
Adults and children with severe malaria (defined as confirmed parasitaemia by microscopy or 
RDT with one or more of the following: impaired consciousness, prostration, multiple 
convulsions, acidosis, jaundice, hypoglycaemia, severe malarial anaemia, renal impairment, 
among other signs) should be treated with intravenous or intramuscular artesunate for at least 
24 hours of parenteral therapy followed by 3 days of ACT once oral therapy can be tolerated 
(WHO 2015a). Artesunate is superior to quinine in averting mortality due to severe malaria 
(Dondorp et al. 2005, Dondorp et al. 2010). 
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1.7 Malaria control activities 
1.7.1 Historical malaria control activities.  
The history of malaria control is well documented in literature and dates to the 20th century. 
Early malaria control methods mainly relied on vector control through insecticide residual 
spraying with dichlorodiphenyltrichloroethane (DDT) and drug administration using 
chloroquine (Killeen et al. 2002). Laviciding has been credited in controlling malaria in the 
northeast coast of Brazil where the accidental introduction of An. gambiae was reversed by its 
elimination from an area of approximately 54 000 km2 (Soper and Wilson 1943). Similar claims 
were made in the Nile Valley of Egypt (1942-1945) where An. gambiae had moved northwards 
from Sudan and this was reversed by larviciding (Shousha 1948). Though the Brazil campaign 
against malaria is arguably the most effective in history, its replication in sub-Saharan Africa is 
doubtful given the ecological differences between Brazil and sub-Saharan Africa. Furthermore, 
the ability of An. gambiae to exploit diverse breeding environments makes the implementation 
of laviciding programs difficult (Minakawa et al. 2005). WHO recommends the use of larval 
control in settings where mosquito breeding sites are few, fixed and easily identifiable (WHO 
2012c). The Global malaria eradication campaign launched in 1955 with the support from the 
WHO and the World Bank (Cohen et al. 2010) mainly relied on chloroquine for treatment of 
blood stream infection to reduce clinical illness and the reservoir of human infection and indoor 
residual spraying (IRS) with the insecticide DDT under the eaves of houses to interrupt 
transmission by killing the anopheline vectors (Pambana 1963, Najera et al. 2011). This 
campaign was adversely impacted by the evolution of resistance to both DDT and chloroquine. 
While the aim of this campaign was to eradicate malaria, the Garki project (Molineaux 1980) 
launched in the early 1970s, aimed at studying the feasibility of mass drug administration and/or 
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the use of DDT to interrupt transmission. The results revealed that indoor residual spraying with 
DDT was effective at reducing the ability of the vectors to transmit malaria though was not 
enough to interrupt transmission in the Sudan savannah of northern Nigeria (Molineaux 1980). 
1.7.2 Contemporary malaria control activities.  
Recent decades have seen a substantial increase in the resources channeled towards malaria 
research and control (Roberts and Enserink 2007) with the aim of reducing malaria related 
morbidity and mortality and eventual elimination. These resources have been made available by 
private foundations (such as the Malaria Foundation, Gates Foundation, Medicines for Malaria 
Venture, the Wellcome Trust and the Burroughs-Wellcome Fund) (McCoy et al. 2009), 
international programs and agencies (including the Global Fund, Roll-Back Malaria, the World 
Bank and the World Health Organization) and national programs such as the Medical Research 
Council in the UK, the National Institute of Health (NIH), the Centers for Disease Control and 
Prevention (CDC) and the President’s Malaria Initiative (PMI) in the US (Ceesay et al. 2012). 
Global financing for malaria control programmes increased from an estimated US$ 960 million 
in 2005 to US$ 2.5 billion in 2014 (Figure 1.6). Of the total invested in 2014, international 
funding accounted for 78% (WHO 2015b).  
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Figure 1.6: Investments in malaria control activities by funding source, 2005–2014. 
AMFm, Affordable Medicine Facility-malaria; Global Fund, Global Fund to Fight AIDS, 
Tuberculosis and Malaria; NMCP, national malaria control programme; UK, United Kingdom; 
USA, United States of America (WHO 2015b). 
The malaria control mechanisms to which these resources have been directed include: (i) 
Injectable artesunate and Artemsinin-combination therapies (ACTs) for the treatment of persons 
with severe and symptomatic uncomplicated malaria infections respectively, (ii) interruption of 
human-vector contact through Insecticide-treated bed Nets (ITNs) to reduce the frequency of 
malaria transmission from the anopheline vector to humans, (iii) Intermittent Preventive 
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Treatment with pyrimentamine + sulfadoxine (Fansidar) during pregnancy (IPTp) and infancy 
(IPTi), and (iv) insecticide residual spraying (IRS) with DDT (WHO 2012c). 
Multicenter trials and observational studies have shown that the use of insecticide-treated nets 
(ITNs) or curtains are effective in reducing childhood malaria-related morbidity and mortality 
(Alonso et al. 1991, Alonso et al. 1993, Cheng et al. 1995, D'Alessandro et al. 1995, Binka et 
al. 1996, Nevill et al. 1996, Fegan et al. 2007). For instance, during the first year of the Gambian 
National Bednet Program the reduction in all-cause mortality among children 1 - 9 years old 
was reported as ~25% (D'Alessandro et al. 1995). Similarly, all course mortality on the Kenya 
coast declined by ~33%  while hospital admissions for severe malaria declined by ~44% 
following ITN use (Nevill et al. 1996). ITN use not only provides personal protection against 
malaria (Howard et al. 2000, Lengeler 2000) but also provide communitywide protection by 
killing infectious mosquitoes that could otherwise cause infections (Hawley et al. 2003). 
However there have been concerns of pyrethroid insecticide resistance in the recent past (Ceesay 
et al. 2010).  
IRS targeting endophilic vectors, involves careful controlled spraying of insecticides along the 
inside walls of a home/house. In 2006, WHO recommended the scale-up of IRS using DDT 
(WHO 2006a, Kolaczinski et al. 2007). Although DDT may be highly effective in reducing 
malaria prevalence than pyrethroids and other insecticides (Kim et al. 2012), it has been 
associated with environmental pollution (Roberts et al. 2000). In addition, although reviews 
report that DDT is safe (Curtis 2002, Beard 2006), toxicity data from animal studies suggest 
likely long-term negative health effects upon exposure to DDT (Ben et al. 2001). There are 11 
other chemicals currently recommended by WHO for use in IRS, including malathion, 
bendiocarb, lambda-cyhalothrin, and alphacypermethrin (WHO 2006a).  
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Between the year 2000 and 2015; ITNs, ACTs and IRS accounted for an estimated 68%, 19% 
and 13% reductions in the prevalence of malaria respectively (Figure 1.7) (Bhatt et al. 2015b). 
 
Figure 1.7: Changing endemicity and effect of interventions 2000–2015. 
Panel a shows the predicted time series of population-weighted mean PfPR2-10 across endemic 
Africa. The red line shows the actual prediction and the black line a ‘counterfactual’ prediction 
in a scenario without coverage by ITNs, ACTs, or IRS. The coloured regions indicate the relative 
contribution of each intervention in reducing PfPR2-10 throughout the period. Panel b shows the 
predicted cumulative number of clinical cases averted by interventions at the end of each year, 
with the specific contribution of each intervention distinguished (Bhatt et al. 2015b). 
IPTp-SP is recommended for all pregnant women in malaria endemic countries starting as early 
as possible after 1st trimester of pregnancy and given at least one month apart until child birth 
to improve pregnancy outcomes (Kayentao et al. 2013, WHO 2013c). IPTp-SP has been shown 
to reduce the frequency of placental malaria and its consequence for the newborn (Schultz et al. 
1994). Although IPTi administered at the time of routine infant immunization was shown to 
substantially reduce the incidence of malaria and anaemia (Manzi et al. 2009, Willey et al. 2011), 
it has not been adopted as policy for malaria control in East Africa partly due to the shifting 
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burden of malaria to older children as transmission intensity declines, and partly due to limited 
resources. 
Seasonal malaria chemoprevention (SMC), previously referred to as Intermittent Preventive 
Treatment in children (IPTc), targeting children less than five years of age has been investigated 
and recommended as a measure to control the burden of malaria in the Sahel and sub-Sahelian 
areas of Africa that is characterized by markedly seasonal malaria transmission (Greenwood 
2006). SMC involves intermittent administration of full treatment course of amodiaquine plus 
sulfadoxine/ pyrimethamine (AQ+SP) given to children at monthly intervals, beginning at the 
start of the transmission season, to a maximum of four doses during the malaria transmission 
season. The objective is to maintain therapeutic antimalarial drug concentrations in the blood 
throughout the period of greatest malarial risk to prevent infection. This intervention has been 
shown to be effective (prevents ~75% of all malaria including severe malaria episodes among 
treated children), cost-effective, safe, and feasible for the prevention of malaria among children 
less than 5 years of age in areas with highly seasonal malaria transmission (Aponte et al. 2009, 
Wilson 2011).  
Other control methods used in the past few decades include; improved access to treatment by 
training mothers on proper malaria treatment procedure - this method has been associated with 
substantial decline in mortality among Ethiopian children (Kidane and Morrow 2000), improved 
compliance with the treatment through packaging (Yeboah-Antwi et al. 2001) and training 
shopkeepers on the importance of selling a full course of treatment (Marsh et al. 1999).  
The possibility of an effective malaria vaccines is being explored (WHO 2006b). Despite 
decades of intense research and vaccine development effort, there is no commercially available 
malaria vaccine. Trials targeting the various stages of parasite development have been on the 
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increase with the hope of identifying a vaccine candidate that can lead to an effective vaccine 
against malaria. None of the vaccines examined in field trials have attained the vaccine efficacy 
target of 80% set by the world health organization malaria vaccine technology roadmap (WHO 
2006b). RTS,S/AS01 is the most advanced malaria vaccine candidate that has undergone phase 
3 evaluation across several sites in Africa. For the 48 months of follow-up, immunization with 
a fourth dose RTS,S/AS01 vaccine was associated with 36.3% efficacy against clinical malaria 
among children vaccinated at an older age (5 to 17 months of age) and 25.9% among infants 
aged between 5 to 12 weeks of age  (RTS 2015). The seven-year follow-up data on a three-dose 
regimen show a rebound suggesting that waning immunity due to vaccination predisposes 
vaccinated children to more clinical malaria (Olotu et al. 2016). In 2017, The WHO’s Strategic 
Advisory Group of Experts on Immunization and the Malaria Policy Advisory Committee 
jointly recommended pilot projects to understand how to best implement the malaria vaccine to 
children in malaria endemic areas (WHO 2017). Kenya, Malawi and Ghana will deploy the 
vaccine in selected moderate to high malaria transmission settings (WHO 2017). The objectives 
will be to: a) Evaluate the feasibility of deploying the 4-dose regimen of the RTS,S malaria 
vaccine through the routine immunization programme, b) consolidate the safety profile of the 
vaccine when routinely deployed, and c) estimate the impact of the routine delivery of the 
vaccine on all-cause mortality in children aged 5-48 months (WHO 2017). Given the short term 
protective effect conferred by the vaccine, the effect will likely be higher in moderate to high 
transmission settings where children experience multiple episodes of clinical disease per year. 
Other malaria vaccine candidates are being assessed at various stages of development in addition 
to other sophisticated malaria control methods that include the development of genetically 
modified mosquitoes (De Freece et al. 2014). 
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1.8 Challenges to malaria control programmes 
Some of the challenges associated with malaria control include: 1) inequitable distribution of 
malaria control interventions (Noor et al. 2007), 2) drug resistance as observed in chloroquine, 
sulphadoxine/ pyrimethamine (Fryauff et al. 1998) and now emerging resistance to artemisinin 
derivatives, 3) pyrethroid insecticides resistance (Chandre et al. 1999), 4) war and civil 
disturbance leading to increased malaria transmission among refugee populations (Pitt et al. 
1998), 5) environmental changes such as farming practices, construction of dams among others 
(Ghebreyesus et al. 1999), 6) climate change that may have contributed to the spread of malaria 
to areas that were previously free of malaria due to global warming and floods (Lindblade et al. 
1999), 7) travel from endemic areas leading to imported cases of malaria (Martens and Hall 
2000) and 8) the population increase leading to more people living in endemic areas of the world 
(Greenwood and Mutabingwa 2002, Noor et al. 2014).  
1.8.1 ITN distribution Systems efficiency 
Despite huge international investment on ITNs, the processes of delivering and distributing them 
to where they are most needed are inefficient (Bhatt et al. 2015b) and inequitable (Zegers de 
Beyl et al. 2016). This challenge is further compounded by limited information on the number 
of ITNs owned and used per household within each country. It is estimated that in 2013, only 
43% of people at risk of malaria slept under a net in sub-Saharan Africa. During this period 
~21% of new ITNs were allocated to households that already had enough and this inefficient 
allocation is predicted to have worsened overtime (Bhatt et al. 2015b). Furthermore, nets are 
much more rapidly lost from households than previously thought. Therefore, systems need to 
respond to emerging coverage gaps due to continuous nets loss from households resulting from 
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damage, repurposing, or movement away from target areas and over-allocation (Bhatt et al. 
2015b). 
Gains in ITN coverage have been impressive, currently at ~60% in sub-Saharan Africa, but there 
remains an enormous challenge towards achieving universal access. Taking measures aimed at 
more efficient targeting ITNs to households that need them could improve coverage levels to 
95% of the total population in need of ITNs (Bhatt et al. 2015b). In summary, the rate of net 
loss and the degree of over-allocation of new ITNs play a major role in determining how delivery 
will translate into household coverage levels. 
1.8.2 Factors influencing ITN use 
Key tentative findings from self-reported barriers to mosquito net use within households in sub-
Saharan Africa include discomfort primarily due to heat and perceived low mosquito density 
(Pulford et al. 2011). Indoor climate is uncomfortable in the hot-humid zone (von Seidlein and 
Knudsen 2016), furthermore, bednets have been shown to reduce airflow by about 60% (von 
Seidlein et al. 2012a). Therefore, to achieve and maintain high coverage on ITN use, houses 
should be well ventilated to allow unrestricted airflow. Community engagement and 
sensitization to integrate housing characteristics that improve ventilation while minimizing 
vector entry are recommended (von Seidlein and Knudsen 2016). Although this effort may take 
time to implement, it may ultimately expand ITN uptake and consequently improve coverage. 
1.8.3 Insecticide resistance  
The emergence and spread of insecticide resistance to all four classes of public health 
insecticides (pyrethroids, organochlorines, organophosphates, and carbamates) threatens the 
effectiveness of ITNs and indoor residual house spraying. Due to low mammalian toxicity, high 
speed of action, and high insecticidal activity, pyrethroids are the only insecticide class 
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recommended by the WHO for use in ITNs (WHO 2012a). Several malaria endemic countries 
using pyrethroid-based vector control (either impregnated into LLINs or sprayed onto walls) 
have reported declined effectiveness due to pyrethroid resistance. Nevertheless, in a systematic 
review and meta-analysis, pyrethroid impregnated ITNs were found to be more effective than 
untreated nets (UTNs) regardless of resistance (Strode et al. 2014). Further evidence shows that 
although resistant mosquitoes may not be killed upon exposure to the insecticide, their average 
life span is considerably decreased (Viana et al. 2016). Continued monitoring of effectiveness 
with standardized procedures is recommended to guide malaria control programmes (Strode et 
al. 2014). 
1.8.4 Anti-malarial drug resistance 
The prospects for malaria elimination are further threatened by the emergency of artemisinin 
resistance in P. falciparum parasites (Ashley et al. 2014, WHO 2016). WHO defines artemisinin 
resistance as delayed parasite clearance and the presence of PfKelch13 (K13) mutations. As of 
March 2017, artemisinin resistance had been confirmed in 5 countries of the Greater Mekong 
Subregion (WHO 2016). Fortunately, majority of the patients in the region still recover 
following treatment with ACTs (Ashley et al. 2014, WHO 2016). No evidence of wide spread 
artemisinin resistance has been reported, however, the spread or independent emergence of 
artemisinin resistance in other parts of the world would be disastrous for the global malaria 
control programmes given that no alternative antimalaria medicines are available at present with 
the same level of efficacy and tolerability as ACTs (WHO 2016). In Africa, non-synonymous 
K13 mutations are still rare and highly diverse, and do not appear to be linked to resistance 
(Figure 1.8) (Ashley et al. 2014). Resistance to artemisinin products may have resulted from a 
combination of factors that include: poor treatment practices, poor adherence of the complete 
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course of treatment, widespread availability of oral artemisinin-based monotherapies and 
substandard generic drugs in the market. 
 
Figure 1.8: Location of study sites and proportions of patients with artemisinin resistance. 
Artemisinin resistance was defined by a parasite clearance half-life longer than 5 hours, with 
some Plasmodium falciparum isolates having kelch13 polymorphisms (at or beyond amino acid 
position 441) (Ashley et al. 2014). 
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1.9 Malaria case detection methods 
Active case detection (ACD) involves detecting malaria infections by community health 
workers at the community or household level. Active case detection can be done for clinical 
malaria or for the acquisition of infection. The former involves regular fever screening of a 
longitudinal cohort followed by parasitological examination of all febrile patients for 
symptomatic malaria. The latter would involve giving anti-malarials to clear parasitaemia at 
baseline, followed by regular parasitological examination of the full cohort without prior fever 
screening (Sturrock et al. 2013). Passive case detection (PCD) on the other hand, entails 
screening febrile patients presenting to health care facilities for malaria parasites. PCD detect 
symptomatic malaria cases but also include other febrile illness with coincident malaria 
infection (Sturrock et al. 2013). This method misses asymptomatic parasitaemia cases present 
in the community who typically do not seek medical care. The sensitivity of detection for both 
ACD and PCD is limited to the diagnostic tool used (Okell et al. 2009, Okell et al. 2012). 
1.10 Interventions targeting asymptomatic reservoir  
Two common interventions targeting asymptomatic parasitaemia exist; 1) mass drug 
administration (MDA) and 2) mass screen and treat (MSAT).  
The most inclusive way to clear the asymptomatic reservoir of malaria infections is through 
mass drug administration (MDA) (Okell et al. 2011). MDA involves administering a full dose 
of anti-malaria chemotherapy to the population with no prior screening. Although this method 
is logistically demanding, its application ensures that submicroscopic infections are also 
targeted and is effective in low transmission settings (Bousema et al. 2012b, Sturrock et al. 
2013, Newby et al. 2015).  
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To achieve high local coverage, mass screening and treatment (MSAT) strategies are used. Anti-
malarial drugs that target both asexual parasites and gametocytes are recommended in addition 
to vector control. Giving antimalarial drugs specifically based on positive test results may be 
preferable to presumptive treatment (MDA) since such a strategy limits excess drug use that 
may drive antimalarial resistance. However, the insufficient sensitivity of existing field 
diagnostics commonly used to identify asymptomatic infections makes MDA justifiable. 
Furthermore, studies have shown that MSAT has limited effect in reducing transmission (Cook 
et al. 2015). 
1.11 Measuring transmission intensity 
With renewed interest in malaria elimination, detailed understanding of malaria transmission 
intensity in space and time is critical. Measuring malaria transmission intensity is a key element 
of monitoring changes in transmission and assessing the impact of anti-malaria interventions. 
Cost effective and accurate measurement of transmission intensity is required to provide helpful 
insights on when and where the greatest risks occur and thus guide the development and 
implementation of appropriate control strategies (Smith et al. 2005). In sub-Saharan Africa, 
malaria transmission intensity varies substantially, a feature associated with the vectorial 
capacity of the local mosquitoes, human acquired immunity and the malaria control 
interventions in place (Smith et al. 2010). Several ways of measuring transmission intensity are 
described in the literature. The commonly used metrics discussed here are: (1) Parasite rate in 
humans, (2) malaria positive fraction (MPF) or slide positive rate (SPR), (3) entomological 
inoculation rate, (4) force of infection and molecular force of infection, (5) multipliscity of 
infection, (6) seroconversion rate, (7) vectorial capacity and the basic reproduction number, and 
(8) net infectiousness of humans to mosquitoes. 
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1.11.1 Parasite prevalence in humans (PR)  
PR is defined as the proportion of individuals that are parasitaemic at a given point in time 
(Tusting et al. 2014). Although consistently referred to parasite rate in the literature to date, here 
I refer it to parasite prevalence and not parasite rate per se. PR is estimated in cross-sectional 
surveys using RDTs, microscopy or PCR (Wu et al. 2015). This metric may not be definitive 
when applied to asymptomatic individuals since parasite densities fluctuate above and below 
threshold of detection over the course of infection (O'Meara et al. 2007). Similarly, detection 
thresholds vary with method used (i.e. RDT, light microscopy or PCR) (Bejon et al. 2006, 
O'Meara et al. 2007). The suitability of using PR for quantifying transmission intensity has been 
criticized in literature since it is not a direct measure of transmission intensity and becomes 
saturated at high transmission intensities (Smith et al. 2005, O'Meara et al. 2007) due to 
heterogeneous biting, multiple infection and acquired immunity. The measure should also be 
age corrected for standardization across sites (Smith et al. 2007a). 
1.11.2 Malaria positive fraction (MPF)  
MPF is also referred to Slide positive rate (SPR) in the literature, and is defined as the 
proportion of children presenting with fever to a healthcare facility who test positive for malaria 
parasitaemia by either light microscopy or RDT. I will use MPF as my preferred term over SPR 
since the measure is a fraction and not a rate per se (Bejon et al. 2014). MPF is measured through 
passive or active case detection methods especially at health facilities where routine screening 
is done using RDTs and/or microscopy (Tusting et al. 2014) or through surveys in the 
community (Hawley et al. 2003). Though the accuracy of MPF is not well established, it has 
previously been used to characterize transmission intensity in Sub-Saharan Africa (Ceesay et 
al. 2010) and used to explain variations in incidence of malaria (Bi et al. 2012). MPF is useful 
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as a rapid indicator of trends and is thus recommended by the WHO when measuring changes 
in transmission intensity (WHO 2010). In addition, MPF has been shown to have a positive 
association with malaria incidence in some studies (Bi et al. 2012). When data are collected 
through active case detection the incidence rates can be computed with minimal biases. 
However, when data are collected through passive case detection, incidence rates are prone to 
biases due to, for instance, accessibility to hospital (Tusting et al. 2014). For this reason, MPF 
is preferred as it is less prone to bias due to distance from hospital (Bejon et al. 2014). That is, 
access to hospital equally affects the slide positive and slide negative children residing in the 
same locality hence normalizing the effect of access to care (Bejon et al. 2014). 
1.11.3 Entomological inoculation rate (EIR) 
 EIR is a metric that estimates the number of bites per person per unit time (mostly in years) and 
is therefore a measure of exposure to infectious mosquitoes (Ceesay et al. 2010, Kilama et al. 
2014, Tusting et al. 2014). It is estimated by catching mosquitoes and then dissecting them to 
estimate the sporozoite rate (Birley and Charlewood 1987). Human biting rates (Ma) are 
estimated by catching and counting the number of mosquitoes that attempt to feed on a human 
while sporozoite rate (SR) is found by examining those mosquitoes for the presence of 
sporozoites (Smith et al. 2005, Kilama et al. 2014). Standard methods proposed for measuring 
Ma include human landing catches, pyrethroid spray catches, exit traps and CDC light traps 
(WHO 2013b, Kilama et al. 2014). This metric has several limitations; 1) most EIR studies 
provide little or no explanation on the rationale behind the choice of locations, houses, or trap 
placements, information on the human collectors, time of day, or frequency of mosquito 
collections. 2) EIRs are often poorly reproducible in practice, very laborious to collect and 
results vary within methods (Kelly-Hope and McKenzie 2009). EIR values tend to be higher 
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than values of force of infection (FOI), because not all infectious mosquito bites result in an 
infection (Churcher et al. 2017). Additionally, sporozoite rates, and by extension EIRs, are 
affected by seasonal variations and lack sensitivity at low transmission settings (Kelly-Hope and 
McKenzie 2009). 
1.11.4 Force of infection (FOI) and molecular force of infection (mFOI) 
FOI is defined as the number of infections per person per unit time, and the mFOI is the number 
of new parasite clones acquired per unit time (Mueller et al. 2012). FOI can be measured through 
cohort studies (which may be naturally uninfected, artificially created cohorts) or repeated cross-
sectional surveys (Smith et al. 2010). The limitation resulting from previously acquired 
infections can also be mitigated by either assessing infant conversion rates which requires 
monitoring many infants over long period, or by using the mFOI (Mueller et al. 2012). This 
metric (mFOI) allows the measurement of transmission intensity without the need to clear 
previous infections in longitudinal studies (Mueller et al. 2012). Both FOI and mFOI suffer from 
accuracy that is as a result of parasite fluctuation within infected persons, especially when they 
fluctuate below the detection limit of the commonly used diagnostic tools (Koepfli et al. 2011). 
The estimates of mFOI is also affected by seasonality, age and some malaria control methods 
(Mueller et al. 2012). Compared to FOI, mFOI has greater sensitivity and specificity and has a 
relatively high precision and accuracy in low transmission areas, and continues to show 
variation when FOI has saturated (Tusting et al. 2014). 
1.11.5 Multiplicity of infection (MOI) 
MOI is the number of concurrent parasite clones per P. falciparum-positive host (Tusting et al. 
2014). MOI is determined by genotyping parasites using polymorphic markers such as the 
merozoite surface protein-1 (MSP-1) (Atroosh et al. 2011) or merozoite surface protein-2 (MSP-
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2) (Mueller et al. 2012) amongst others (Tusting et al. 2014). The capacity of MOI to accurately 
reflect transmission intensity may depend on both the diversity of the parasite clones and the 
frequency of sampling (Koepfli et al. 2011). It has been demonstrated that in areas where 
parasite populations are less diverse, transmission intensity may be underestimated as parasite 
clones may not be distinguishable by molecular markers (Mueller et al. 2012). However, higher 
numbers of P. falciparum concurrent infections (mean = 5) have been detected in highly 
endemic areas of sub-Saharan Africa (Beck et al. 1997) while low MOI ranging between 1.5 to 
1.7 detected in Papua New Guinea, an area that is relatively a low transmission zone (Koepfli et 
al. 2011). 
1.11.6 Seroconversion rate (SCR)  
Anti-malarial antibodies are biological markers of previous infection that can explain spatial-
temporal trends in transmission intensity (Drakeley et al. 2005, Bousema et al. 2010b). Since 
antibodies are raised by the host in response to infection, serology is thought to be a good 
indicator of exposure to malaria. Serological tools are potentially more sensitive and robust than 
parasite prevalence or EIR given that antibodies last longer than patent parasitaemia and longer 
than the lifespan of infective mosquitoes. In the past, serological tools have been used to 
examine the impact of interventions that reduce malaria exposure (Cornille-Brogger et al. 
1978). Some commonly targeted malaria antigens used in serological studies include a) 
circumsporozoite protein (CSP), b) merozoite surface protein-119 (MSP-119) and c) apical 
membrane antigen-1 (AMA-1). CSP responses are not rapidly acquired, and are therefore not 
suitable for estimating transmission intensity in low transmission settings. MSP-119 is 
moderately immunogenic and can be used to estimate changes in transmission intensity over a 
range of transmission intensities. AMA-1 on the other hand is highly immunogenic and can 
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elicit long-lived immune responses that can lead to saturation at moderate transmission 
intensities (Drakeley et al. 2005). Serological measures of malaria infection have been proposed 
for diagnosis and determination of community level transmission in the pre-elimination and 
elimination phases of malaria control (malERA 2011). Seroconversion to malaria is the 
development of detectable anti malaria antibodies against the parasite antigen in the blood 
(Drakeley et al. 2005). The incidence of seroconversion can be calculated by fitting a reverse 
catalytic model to age-specific malarial seroprevalence data (Drakeley et al. 2005). SCR 
estimates analogous to force of infection can also be computed (Drakeley et al. 2005, Corran et 
al. 2007). A further advantage of using SCR as a measure of transmission intensity is its ability 
to account for malaria exposure over time, hence allowing temporal patterns in transmission 
intensity to be studied (Corran et al. 2007). This metric has recently gained popularity as a tool 
for monitoring variations in malaria transmission intensity in Africa (Corran et al. 2007, Stewart 
et al. 2009), Asia (Lim et al. 2005) and the Pacific (Cook et al. 2010) where studies have shown 
close correlation between independent metrics of malaria transmission intensity and SCR. 
Although this metric has been associated with high precision and accuracy, SCR may not be 
sensitive to short-term changes in transmission given that antibodies can persist for years after 
the exposure period (Corran et al. 2007), however, this weakness can be mitigated by assessing 
seroconversion among children under five years of age (Ceesay et al. 2010). 
1.11.7 Vectorial capacity (C) and the basic reproduction number (Ro) 
 C is defined as the expected number of infectious bites that could eventually arise from all the 
mosquitoes that bite a single human on a single day assuming non immunity and 100% 
efficiency in transmission (Garrett-Jones 1964). It is mathematically denoted as 
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𝐶 =
M𝑎2𝑝𝑛
−𝑙𝑛 p
, 
where 𝑀 is the density of adult mosquitoes, 𝑎 is their feeding frequency on humans, 𝑝 is their 
daily survival rate and 𝑛 is the duration of parasite development in humans. 
The malaria basic case reproduction number 𝑅0 is the expected number of hosts who would be 
infected after one generation of the parasite by a single infectious person who had been 
introduced into an otherwise naive population. It is defined as the product of vectorial capacity, 
the net efficiency of transmission and the duration of the infection (Johnston et al. 2013). The 
estimation of C from the individual components is normally difficult and prone to compounded 
error that result from the errors introduced by individual terms (Dye and Hasibeder 1986). To 
sustain transmission a minimum value ( 𝑅0 = 1 ) must be attained. Though 𝑅0 remains a gold 
standard for measuring transmission intensity, it is difficult to measure accurately in the field 
(Tusting et al. 2014). 
1.11.8 Net infectiousness of humans to mosquitoes (k)  
At the population level, k is defined as the fraction of mosquitoes that would become infected 
after blood feeding on any human. The determination of k is normally influenced by processes 
acting in both humans and mosquitoes and includes: fluctuations in gametocyte density, 
naturally acquired transmission-blocking immunity (Tusting et al. 2014), the efficiency with 
which the gametocytes are taken up by mosquitoes in a blood meal relative to their measured 
density, the effective contact of the vectors with humans and factors influencing the 
susceptibility of mosquitoes to malaria infection such as the mosquito innate immunity (Trape 
et al. 1987, Smith et al. 2004), midgut natural microbiota (Cirimotich et al. 2011) among others. 
In practice, it is impossible to directly measure this metric in a natural mosquito population. 
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However, the metric can be estimated using; (1)  direct skin feeding assays (SFAs) where 
laboratory-reared mosquitoes are directly fed on infected humans to determine the proportion 
that become infected (Killeen et al. 2006), (2) using standard membrane-feeding assays (MFA) 
(Bousema et al. 2012a) and (3) infection rates in the natural vector population (Burkot et al. 
1990). Though k has been shown to correlate well with EIR at low transmission areas, it has 
been criticized for its low precision and accuracy (Tusting et al. 2014). To measure the effect of 
sexual-stage transmission-blocking vaccine, accurate measurement of k is needed before and 
after vaccination. 
1.12 Spatial and temporal heterogeneity of malaria 
Plasmodium falciparum transmission is the process by which a malaria parasite completes its 
life cycle from human to human via a mosquito vector (Tusting et al. 2014), and the intensity of 
transmission refers to the frequency of new human infections (Smith et al. 2012). Transmission 
intensity for most infectious agents (including Plasmodium falciparum malaria parasites) is 
heterogeneous as has long been recognized empirically and explored using mathematical 
models. For many infectious diseases, ~20% of the human population account for ~80% of the 
infectious burden (Woolhouse et al. 1997b). The processes leading to malaria transmission 
depend on the ecology and biting behavior of mosquitoes which in turn is determined by climate 
(rainfall, temperature and humidity), hydrology and soil composition (Packard and Gadehla 
1997, SHILILU et al. 2003, Olson et al. 2010, Stefani et al. 2013, Weiss et al. 2014), the 
distribution of human residence and behaviors (urbanization and housing) (Hay et al. 2005, 
Omumbo et al. 2005), control interventions (Bhatt et al. 2015a) altitude (Brooker et al. 2004, 
Ernst et al. 2006, Baidjoe et al. 2016), proximity to dense vegetation (Ernst et al. 2006, Kreuels 
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et al. 2008), wind direction (Midega et al. 2012), and host genetic factors (Mackinnon et al. 
2005).  
Rainfall combined with suitable temperatures (between 25oC and 30oC) provides optimal 
breeding environment for the vector mosquitoes while humidity is associated with vector 
longevity (Dutta and Dutt 1978). High temperatures of (>34oC) are associated with high larval 
and adult mosquito mortalities (Kirby and Lindsay 2004) while temperatures below 16oC are 
unable to produce viable adults (Bayoh and Lindsay 2003, Bayoh and Lindsay 2004). Irrigation 
schemes, dams and swampy areas provide suitable breeding ground for mosquitoes to oviposit 
(Ijumba and Lindsay 2001) thus increasing mosquito abundance. On the other hand, aridity 
negatively affect the vector development and survival (Shililu et al. 2004). Limited availability 
of water bodies reduces the number of suitable sites for oviposition and also reduces the 
mosquito survival rate at all stages of development (Gray and Bradley 2005).  
Social economic status and housing characteristics are key determinants of malaria transmission 
intensity (Ernst et al. 2006, Tusting et al. 2013, Tusting et al. 2015, von Seidlein and Knudsen 
2016). Improvements to housing contributes significantly to malaria control and elimination by 
decreasing house entry by malaria infected mosquitoes and thus exposure to biting. Housing 
quality is an important risk factor for malaria infection across the spectrum of malaria 
endemicity in sub-Saharan Africa (Tusting et al. 2015, Tusting et al. 2017). Similarly, lower 
economic and/or education levels are associated with increased risk of malaria transmission 
(Baragatti et al. 2009, Tusting et al. 2013).  
Urban areas have lower malaria incidence compared to rural areas of sub-Saharan Africa, this 
is partly due to limited availability of optimum environmental conditions for the development 
of the vector mosquitoes thus resulting in low vector densities and low transmission intensity 
(Trape et al. 1987). In addition, accessibility to anti-malarial drugs and modern housing in urban 
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settings provide a plausible explanation for the spatial variation observed between rural and 
urban settings. Inequitable distribution of malaria control programs in rural settings has been 
documented (Noor et al. 2007). Malaria control programs tend to distribute control interventions 
to areas that are more accessible hence leaving out areas that need the nets most. 
 The temporal variations of malaria transmission witnessed in sub-Saharan Africa have also 
been attributed to climate change (Afrane et al. 2012) (for instance, the highlands of Kenya have 
experienced increasing malaria transmission), increased urbanization resulting from increasing 
population density, scaled up malaria control interventions, increased irrigation schemes among 
others. These factors act at various spatial scales and may explain why some households, 
villages, regions, countries and continents experience higher risk of malaria while others remain 
free or experience fewer episodes of the disease. 
 
Figure 1.9: Predicted 1 × 1 km spatial resolution Plasmodium falciparum parasite rate 
endemicity class maps of Africa prevalence in (A) 2000 and (B) 2010. 
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The dark grey, light grey, and white areas are malaria free and the limits of unstable and stable 
transmission, respectively, for each year. PfPR2–10 predictions were made to areas within the 
stable limits of transmission. PfPR2–10=community Plasmodium falciparum parasite rate 
standardised to the age group 2–10 years (Noor et al. 2014). 
Just as there are variations in the determinants of malaria transmission at various spatial scale, 
malaria heterogeneity is apparent at a global scale (Noor et al. 2014), Figure 1.8, with some 
continents (for instance Africa) experiencing high transmission while others experience very 
low to no transmission. Similarly there are variations within continents - where transmission 
ranges  from holo-endemic to meso-endemic or even no transmission (Noor et al. 2014), and 
further variations have been observed within countries, for instance, Mali (Gaudart et al. 2006), 
Ghana (Kreuels et al. 2008), Ethiopia (Yeshiwondim et al. 2009), Kenya (Brooker et al. 2004, 
Bejon et al. 2010) and Tanzania (Bousema et al. 2010a) and between homesteads within the 
same village(Bejon et al. 2014). 
1.13 Remote sensing   
Modelling malaria transmission is often challenging. The identification of all the natural factors 
(such as seasonality, rainfall, temperature, humidity, surface water and vegetation) and 
anthropogenic elements (such as agriculture, irrigation, deforestation, urbanization and 
movement of populations) that likely correlate with transmission intensity is logistically difficult 
and expensive (Stefani et al. 2013). The ultimate aim is usually to determine malaria incidences 
without clinical surveillance and thus enhance the identification of potential at risk areas at 
various spatial scales (Bannister-Tyrrell et al. 2017). Data collection techniques that monitor 
environmental changes relevant to the epidemiology of infectious diseases have gained 
popularity in the recent past (Tatem et al. 2004). For instance, remote sensing (RS) (i.e., the 
process of acquiring information about an object area or feature from a distance) (Hay 2000) 
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has been used extensively to study environmental differences such as land cover, altitude and 
climatic conditions (Kulkarni et al. 2010). The use of RS to provide new insights for malaria 
studies has been reviewed extensively (Rogers et al. 2002, Herbreteau et al. 2007). From the 
review by Herbreteau et al. (Herbreteau et al. 2007), RS is often, and increasingly, used to study 
parasitic diseases (59% of studies) including malaria (16% of studies). The distribution of 
malaria has been shown to depend on static geographical factors as well as environmental 
alterations over time (Stefani et al. 2013). Ecosystem changes resulting from natural features or 
human interventions, on a local or global scale, can alter the ecological balance and context in 
which vectors and their parasites develop and transmit disease (Patz et al. 2000). The mosquito 
population processes and malaria incubation periods in vectors have been shown to vary with 
temperature and moisture conditions (Kulkarni et al. 2010). Similarly, human interventions such 
as forest clearance and pollution have been associated with changing malaria transmission rates 
(Conn et al. 2002, Patz and Olson 2006, Olson et al. 2010). Curran et al. (Curran et al. 2000) 
propose the linking of malaria incidence with land cover (LC) and/or land use (LU) 
characteristics while Ostfeld et al. (Ostfeld et al. 2005) propose the use of more explicit 
landscape approaches to study eco-epidemiological systems that may improve the 
understanding and prediction of the malaria risk.  
1.14 Hotspots  
1.14.1 Defining a hotspot of malaria transmission 
WHO defines a focus of malaria transmission as a defined and circumscribed locality situated 
in a currently or formerly malarious area containing the continuous or intermittent 
epidemiological factors necessary for malaria transmission (WHO 2007). A hotspot of malaria 
transmission is defined as a geographical part of a focus of malaria transmission where 
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transmission intensity exceeds the average level. Therefore, several hotspots of malaria 
transmission may be present in a single focus of transmission.  
1.14.2 Importance of studying hotspots of malaria transmission 
Hotspots fuel transmission within transmission foci, whereas the foci form independent 
malarious areas with minimal or no transmission between them, and may themselves contain 
hotspots. Two main reasons why hotspots are relevant for malaria control have been proposed 
(Woolhouse et al. 1997b, Smith et al. 2007b). Firstly, on theoretical grounds, if interventions are 
untargeted, hotspots are likely to be the areas where residual malaria transmission will persist. 
This hypothesis is supported by observations made in the field (Bautista et al. 2006, Ernst et al. 
2006). Hotspots of malaria transmission can thereby form a major stumbling block in efforts to 
eliminate malaria (Moonen et al. 2010). Secondly, hotspots of malaria transmission are likely 
to play a catalyzing role in areas of stable transmission (Bousema et al. 2010a). Interventions 
targeted at transmission hotspots have the potential to reduce community-wide malaria 
transmission intensity (Bousema et al. 2010a). Thirdly, if resources are limited then they should 
be directed on those most at risk. 
1.14.3 Potential for targeted control 
Malaria hotspots maintain malaria transmission during the  low transmission seasons and thus 
may provide the parasite reservoir during the high transmission season (Bousema et al. 2012b). 
Elimination strategies may need to focus reactive screening and treatment of households in 
endemic zones (Moonen et al. 2010). The procedure can be enhanced through proactive case 
detection, where people living within hotspots are screened for parasitaemia and treated at 
regular intervals (Moonen et al. 2010). Targeted control would mean that the most diseased 
households are prioritized (Moonen et al. 2010, Stresman et al. 2010, Bousema et al. 2012b), 
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thus reducing the transmission intensity to the whole population. Detecting hotspots involves 
mapping asymptomatic carriers through cross sectional surveys, hospital surveillance for 
symptomatic parasitaemia, or using serological tools (Moonen et al. 2010). Targeting 
households within a hotspot is likely to be logistically feasible, much more efficient, and may 
allow for more complicated interventions than if hotspots were untargeted.   
1.14.4 Challenges with hotspot targeted control 
The topic of targeting hotspots of malaria transmission has gained interest in the recent past 
(Bannister-Tyrrell et al. 2017). In a cluster, randomized trials targeting hotspots in western 
Kenya, modest results were achieved inside the hotspots but no lasting results were observed 
outside the hotspots (Bousema et al. 2016). Important implementation questions remain; 1) to 
what extent are hotspots of transmission stable and generalizable? (Bejon et al. 2010) 2) at what 
level of transmission intensity should hotspots be targeted to achieve interruption? 3) are 
hotspots detected by different diagnostic tools consistent? 4) How do we define hotspots 
boundaries, and sample size? (Stresman et al. 2017) These parameters need to be well 
understood to aid the design of an effective targeted intervention programme. 
1.15 Scope 
The proposed scope of this work comprise a study of febrile malaria children admitted to the 
Kilifi county referral hospital over a 25-year period (1990 - 2014). Two cohorts of children 
within the KHDSS area followed actively for febrile malaria was used to validate the use of 
malaria positive fraction at KCH as a proxy measure of community incidence rate. Politically 
defined geographical areas (locations) linked to clinical data allowed a 25-year analyses of age, 
spatial and temporal variations of admissions with malaria from the KHDSS area, whereas the 
more comprehensive KHDSS data collection from the year 2003 allowed a more detailed 
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analysis of homestead level variations using the geographical coordinates system. From the year 
2009, yearly data collection on ITN use for all residents of the KHDSS and remote sensing data 
downloaded from the year 2000 to 2014 allowed detailed analysis of the effectiveness of 
personal and community ITN use, and the effect of soil moisture on the probability of admission 
with malaria. Work on the multicenter micro-epidemiological analyses was an important 
extension following earlier observations that heterogeneity becomes more apparent as 
transmission intensity declines. The collated datasets from studies conducted in areas 
experiencing variable transmission intensities in sub-Saharan Africa allowed for a detailed 
secondary analysis of various micro-epidemiological parameters and their association with 
overall transmission intensity. Whereas studies of febrile malaria may be less affected by the 
diagnostic tool used given the accompanying high parasite biomass, studies of asymptomatic 
parasitaemia are likely to be more sensitive to the diagnostic tools used especially in areas of 
low transmission intensity. Work on the detection of asymptomatic malaria hotspots by 
diagnostic tool (PCR, microscopy and RDT), allowed an assessment of the degree with which 
hotspots detected by microscopy and RDT overlap with those detected by PCR, and a further 
comparison of the stability of hotspots among diagnostic tools. 
1.16 Composition of the thesis 
I will introduce the specific datasets and their contextualization in the specific chapters 
describing the results. Chapter 2 will focus on the statistical methodology common to all 
chapters. Thereafter the main data chapters are: 
Chapter 3. An analysis of the age, spatial and temporal variations in admissions with malaria to 
Kilifi county hospital and the assessment of the factors predicting admissions with malaria 
parasites. 
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Chapter 4. A descriptive analysis of micro-epidemiology of malaria transmission intensity using 
multicenter datasets assembled from sub-Saharan Africa. 
Chapter 5. A comparison of malaria hotspots detected by Microscopy, RDT and Polymerase 
Chain Reaction  
Each chapter contains a brief introduction, data description, additional analysis specific to that 
chapter, results and discussion. Chapter six contains the overall discussion of the findings, 
further areas of research and conclusions. 
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Chapter Two 
2 Material and Methods 
2.1 Spatial analysis 
Identification of disease clusters is essential for public health surveillance and potential 
targeting. Spatial analyses to describe clustering have been extensively applied in malaria 
epidemiology (Pullan et al. 2012). For instance, Kulldorff’s spatial scan statistic and the 
Moran’s I statistic have been used in malaria epidemiology to describe spatial heterogeneity 
(Brooker et al. 2004, Ernst et al. 2006, Bejon et al. 2010, Bousema et al. 2010a, Bejon et al. 
2014). The K function has been applied to investigate spatial clustering of households with 
seropositive children during evaluation of targeted screening strategies to detect Trypanasoma 
cruzi infection (Levy et al. 2007) and the identification of malaria clustering and hotspots in an 
endemic area in western Kenya (Wanjala et al. 2011), among other applications. The scan 
statistic identifies hotspots that would potentially benefit from targeted intervention (Bousema 
et al. 2016), while the Moran’s I and the Variogram are used to examine spatial auto-correlation 
in certain continuous features of malaria transmission. 
Methods for local cluster detection include; the Geographical Analysis machine (GAM) also 
referred to Openshaw (Openshaw et al. 1987), Anselin’s local indicator of spatial association 
(LISA) (Anselin 1995), the Besag-Newell test (Besag and Newell 1991), the spatial scan statistic 
among others. I used the Kulldorff’s spatial scan statistic to detect local clustering because it 
adjusts for multiple testing, heterogeneous population density distributions and potential 
confounders. 
Kulldorff’s spatial scan statistic (Kulldorff 1997), estimated in SaTScanTM software 
(http://www.satscan.org), was used to detect hotspots of symptomatic malaria and 
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asymptomatic parasitaemia. SaTScan imposes a circular scanning window that moves across 
geographical space with radius varying from zero to a maximum radius enclosing at most 30% 
(pre-specified by the user) of the population in the sampling frame. For each location and size 
of the window, the number of observed cases are counted and the expected cases computed by 
assuming a uniform distribution of cases across the population. The scan statistic compared the 
count within each circle and that outside to derive a log likelihood statistic. The testing 
procedure for the null hypothesis of complete spatial randomness, is based on the Monte Carlo 
simulations where for each simulation run, the observed cases across the entire set of data 
locations are randomly permuted in space according to the data locations and population size. 
The expected log likelihood under random simulations is then computed. The observed log 
likelihood is then compared with the simulated log likelihoods to determine statistical 
significance. 
An elliptic window shape can be used as an alternative to the circular window, in which case a 
set of ellipses with different shapes and angles are used as the scanning window. This may 
provide higher power for true clusters that are elliptical in shape, but lower power for circular 
and other very compact clusters, and comes with extra computational cost. 
I restrict my analysis below to using circular windows to detect hotspots.  This may not be 
realistic in some settings, for instance where hotspots follow a river and could well be elliptical. 
Circular hotspots on the other hand are the most commonly used in practice (Bannister-Tyrrell 
et al. 2017), they are computationally efficient and it is easier to determine hotspots properties 
that are of interest (Radius, Risk Ratio and significance). 
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2.2 Spatial functions 
Several techniques for examining disease clustering have been described in literature 
(Auchincloss et al. 2012) including: the kernel intensity function (Kelsall and Diggle 1995), 
Cuzick and Edwards’ method (Cuzick and Edwards 1990), the Knox test (Kulldorff and 
Hjalmars 1999) and the K-function (Ripley 1977). A disadvantage with the kernel intensity ratio 
is the preselection of a bandwidth that can lead to variation in results depending on the selected 
bandwidth (Wheeler 2007). Similarly, Cuzick and Edwards’ method requires pre-selection of 
the number of nearest neighbours (Wheeler 2007), while the knox test requires a prior choice of 
critical distances to determine which pairs of cases are close in space and time (Kulldorff and 
Hjalmars 1999). These preselected parameter choices are mostly subjective and at best 
dependent on prior knowledge and may thus influence statistical inference. The K-function was 
preferred for the analysis of binary data because it corrects for edge effects, does not require 
prior specification of parameters that may influence statistical inference and allows for a range 
of spatial and temporal scales. Other spatial functions commonly used in spatial point pattern 
analysis for continuous data include the Variograms and Moran’s I (Pullan et al. 2012). Here, 
the Moran’s I and the K functions were used to examine global spatial dependence in malaria 
transmission.  
Ripley’s K-function for a distance d, K(d), is a second-order analysis of point patterns in two-
dimensional space and is defined as the expected number of other points of the process within 
a distance d of a typical point of the process divided by the intensity. This quantity can be 
estimated as 
?̂?(𝑑) =
1
?̂?𝑁
∑
𝜋𝑑2
𝐴𝑖𝑑
𝑁
𝑖=1 ∑ 𝑐(𝑖, 𝑗, 𝑑)
𝑁
𝑗=1,𝑖≠𝑗 , 
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Where N is the total sample size, 𝑐(𝑖, 𝑗, 𝑑) is an indicator function equal to 1 if the distance 
between points i and j is at most d, 0 otherwise. The quantity 
𝜋𝑑2
𝐴𝑖𝑑
 is Besag’s edge effect 
correction, 𝐴𝑖𝑑 is the part of the area of the circle of radius d centered on the point i located 
inside the domain. Other edge correction methods include Ripley’s correction, Ward and 
Ferrandino’s correction among others and their limitations have been discussed elsewhere 
(Marcon 2009). 
The K-function (Ripley 1977) was used to test consistency with or departure from spatial 
randomness within each site. The spatial point pattern data consisted of homesteads level 
geographical co-ordinates with slide positive cases and slide negative controls. The underlying 
heterogeneity in the population density distribution was controlled for by assessing the 
difference between the K-function summarizing the degree of clustering of 
locations/homesteads with cases and controls was calculated. Under the null hypothesis of no 
spatial dependence, the K-function for cases (Kcase(d)) and for the controls (Kcont(d)) are identical 
through the distance (d). A difference in K-function ((Kcase(d)) - (Kcont(d))) (Diggle and 
Chetwynd 1991), also referred to the D-function, greater than zero suggests spatial clustering. 
The 95% critical regions of the observed D-functions for the various spatial scales examined 
were constructed using repeated simulations. Edge effects were corrected as described 
elsewhere (Ripley 1976). The package spatstat in R was used to compute the D-function and the 
simulated envelops for statistical significance testing. 
The Moran’s I test evaluates local clustering or spatial autocorrelation. The Moran’s I statistic 
is interpreted under the null hypothesis that there is random distribution of the mean age of 
symptomatic malaria cases. The alternative hypothesis states that spatial autocorrelation exist 
and can either be positive or negative. The Moran’s I statistic range between -1 and 1. A positive 
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significant Moran’s I statistic indicates a tendency towards spatial clustering, on the other hand, 
a negative significant Moran’s I statistic indicates a tendency towards regularity (dispersion). 
The Moran’s I statistic of 0 indicates a random distribution of events. In epidemiological studies, 
the Moran’s I statistic is used to assess geographical similarity in continuous metrics of a disease 
(Pullan et al. 2012). 
Statistical inferences on the degree of clustering can be drawn from both the Moran I and the K 
functions. However, these spatial functions cannot identify the position of clusters. The scan 
statistic on the other hand, identifies the position of local clusters but cannot be used to describe 
the structure of clustering and the degree of geographical auto-correlation in the same way that 
spatial functions do.  
2.3 Statistical modelling 
Fine-scale spatio-temporal variations in malaria risk has been associated with environmental 
and human factors (Bannister-Tyrrell et al. 2017). The objective of any statistical modelling 
framework is to determine a minimal set of covariates that sufficiently describe specific features 
of a given dataset (Sauerbrei et al. 2007). Selecting few predictors from among a set predictors 
is usually a challenge and can easily become arbitrary. However, covariates should be included 
in the model if they significantly improve model fit (Sauerbrei et al. 2007). 
2.3.1 The linear regression model  
The multiple linear regression model was used to assess linear relationships between a 
dependent continuous variable and a set of independent variables. Let y be a dependent variable 
consisting of n observations (y1, …, yn) and p independent variables (X1, …, Xp). The multiple 
linear regression model is given by 
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  𝐲𝑖 = 𝛽0 + ∑ 𝛽𝑗𝐗𝑖,𝑗
𝑝
𝑗=1
+ 𝜀𝑖                                                                              
where, X - represents the p covariates in the model, the quantities 𝛽0, … 𝛽𝑝 are unknown 
regression coefficients/parameters; the random errors terms  𝜀𝑖|𝑿~𝑁 (0, 𝜎
2) . 
The above specified model makes key assumptions a priori that needs to be assessed to 
determine their conformity. 1) linearity, 2) independent and normally distributed error terms 
𝜀𝑖|𝑿~𝑁 (0, 𝜎
2) and 3) Constancy of residual variance. However, these assumptions are not 
usually realistic and in most cases violated. Variable transformation to linearize nonlinear 
relationship between the response and covariate(s) are recommended and these would include 
polynomials and the cubic splines just to mention a few.  
Coefficient of determination (R2) 
R2 is the ratio of the total empiric variance explained by the model to the total empiric variance 
of the response variable. The adjusted R-squared coefficient (𝑅𝑎
2) is defined to be: 
𝑅𝑎
2 = 1 −
𝑁−1
𝑁−𝑝−1
(1 − 𝑅2)                                                                                      
where p denotes the number of independent variable included in the model. The component 
(
𝑁−1
𝑁−𝑝−1
) penalizes for the model complexity. 
2.3.2 The logistic regression model 
The logistic regression model was used to assess the heterogeneity in trends by comparing a 
model with and without space-time interaction effects using the likelihood ratio test statistic. 
The model was formulated as follows: 
𝑙𝑜𝑔𝑖𝑡(𝑝𝑖) = ln (
𝑝𝑖
1−𝑝𝑖
) = 𝛽0 + ∑ 𝛽𝑗𝐗𝑖,𝑗
𝑚
𝑗=1
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where 𝑝𝑖 is the probability of a slide positive for patient i, 𝐗, represents the covariates (time and 
the dummy variables generated from location and location-time interaction) while 𝛽0, … , 𝛽𝑚 are 
the regression coefficients indicating the relative effect of the explanatory variable on the 
outcome (m is the number of continuous and dummy variables generated from the categorical 
covariates in the model). 
The relationship between the binary response variable and the covariates was assessed using 
multiple logistic regression model. To select a parsimonious final model, covariates were added 
to the model in a forward stepwise fashion and the Likelihood Ratio Test (LRT) used to compare 
nested models. This procedure identified a set of covariates which resulted in a significant 
reduction in −2𝐿𝑜𝑔?̂? at 5% significance level. 
The likelihood ratio test statistic was computed as follows: 
𝐿𝑖𝑘𝑒𝑙𝑖ℎ𝑜𝑜𝑑 𝑟𝑎𝑡𝑖𝑜 𝑠𝑡𝑎𝑡𝑖𝑠𝑡𝑖𝑐 (𝐷) = (−2𝑙𝑛
𝑙𝑖𝑘𝑒𝑙𝑖ℎ𝑜𝑜𝑑 𝑜𝑓 𝑡ℎ𝑒 𝑟𝑒𝑑𝑢𝑐𝑒𝑑 𝑚𝑜𝑑𝑒𝑙
𝑙𝑖𝑘𝑒𝑙𝑖ℎ𝑜𝑜𝑑 𝑜𝑓 𝑡ℎ𝑒 𝐶𝑜𝑚𝑝𝑙𝑒𝑥 𝑚𝑜𝑑𝑒𝑙
), 
The degrees of freedom are equivalent to the difference between the number of parameter 
estimates between the more complex model and the reduced model. 
Potential multicollinearity was assessed by examining correlations between continuous 
predictor variables and formally by using the variance inflation factor. The effect of collinearity 
was mitigated by selecting covariates that were most significant in the model. The variability 
accounted by the model in the logistic regression analysis was measures using the psedo-R2.  
Pseudo-R2 
In linear regression models, the coefficient of multiple determination (R2) measures the amount 
of variation in the outcome variable explained by the covariates. Generalizing R2 to logistic 
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regression models has proved difficult. Various measures have been proposed in literature and 
their limitations discussed (Mittlböck and Schemper 1996). The Pseudo-R2 also referred to the 
McFadden’s likelihood ratio index is defined as: 
𝑅𝑀𝑐𝐹𝑎𝑑𝑑𝑒𝑛 = 1 −
𝑙𝑐
𝑙𝑛𝑢𝑙𝑙
 
where 𝑙𝑐  and  𝑙𝑛𝑢𝑙𝑙 are the maximized log-likelihood of the complex model and the null model 
respectively. A criticism to McFadden’s index is that when applied to linear regression model, 
it is not equivalent to the coefficient of multiple determination thus creating an interpretation 
challenge as a measure of explained variation in logistic models. However, despite the 
drawbacks, McFadden’s index can be used to give some sense of how much variation in the 
outcome is being explained by the predictors, and is the most widely accepted measure for 
logistic regression.  
Presence of clusters within the study population should be accounted for during statistical 
analysis. Ignoring clustering may result to inflated significance, that is, smaller p-values and 
narrower confidence intervals than would be expected if clusters were absent (Altman and Bland 
1997). Robust standard errors for predictors of malaria in Kilifi County were sort when 
clustering was suspected using models accounting for clusters. Sources of clustering of malaria 
transmission could result from unmeasured predictors that could range from genetic factors at 
homestead level, quality of housing, proximity to water bodies among others.   
2.3.3 Model-based geostatistics 
Geostatistical modelling is an extension of standard regression modelling to account for 
spatial/temporal autocorrelation. Geostatistical models are frequently used in malaria 
epidemiology to generate disease maps that can subsequently be used to guide interventions 
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strategies. These models take advantage of spatial and temporal autocorrelation (“borrow 
strength” from neighboring homesteads/villages) to interpolate missing data and hence 
producing smooth maps (Giardina et al. 2012). The models are reliable when spatial 
autocorrelation is evident and covariate information do not fully account for spatial patterns in 
the dataset and thus the need to incorporate spatial dependencies in the modeling framework. 
Health monitoring and evaluation teams have utilized these models to produce malaria risk maps 
in Africa (Noor et al. 2014), Senegal (Giardina et al. 2012), Zambia (Riedel et al. 2010), 
Zimbabwe (Mabaso et al. 2006), Ghana (Kasasa et al. 2013), Kenya (Stresman et al. 2017) just 
to mention a few, and in parasitic infections (Soares Magalhaes et al. 2011, Karagiannis-Voules 
et al. 2013, Scholte et al. 2014) and other diseases (Wimberly et al. 2013). The models were 
however not applied in this thesis, because my objectives were to describe and examine hotspots 
in directly measured datasets rather than to impute data that was not directly measured.  
2.4 Multiple fractional polynomial (MFP) transformations 
The multiple fractional polynomial algorithm was used as previously described (Sauerbrei and 
Royston 1999, Sauerbrei et al. 2006). MFP model selection begins with a model of predefined 
complexity and uses a backward elimination procedure to simplify it. This procedure preserves 
the familywise error rate.  
To illustrate the procedure a model with a single continuous covariate (x) is used for simplicity. 
The linear model is defined by 𝛽0 + 𝛽1𝑥 and in some instances, provides an adequate description 
of the response-covariate relationship. However, in most instances the assumption of linearity 
if often violated and thus nonlinear models need to be investigated to improve the model fit. The 
fractional polynomial transformation is a feasible choice. The first-degree fractional polynomial 
(FP1) function is formulated as follows: 𝛽0 + 𝛽1𝑥
𝑝. The power “p” is an element of a restricted 
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set S = (−2, −1, −0.5, 0, 0.5, 1, 2, 3), where 𝑥0 denotes a log transformation. FP1 functions can 
be extended to the more complex and flexible two-term FP2 functions with powers (p1, p2) 
defined as 𝛽0 + 𝛽1𝑥
𝑝1 + 𝛽1𝑥
𝑝2 with p1 and p2 taken from the set S. If p1 = p2, the proposed 
equation is 𝛽0 + 𝛽1𝑥
𝑝1 + 𝛽1𝑥
𝑝1 ∗ log x , referred to as the repeated-powers FP2 model. Given 
the restricted set of powers for “S”, there are fundamentally 8 FP1 transformations, (8
2
) = 28 
FP2 transformations with distinct powers, and 8 FP2 transformations with equal powers (p1 = 
p2) (Sauerbrei et al. 2007).  
 To enhance parsimony and the stability of the model during function selection a sensible default 
function is required. In this case a linear function is a natural choice. It follows that unless the 
data supports a more complex FP function, a straight line is preferred. The suitable model is 
selected in 3 steps: 1) a comparison between the best FP2 model with the null model is made 
based on a likelihood ratio test, 2) If significant, FP2 model is tested against a straight-line 
model, 3) if also significant, a final step compares the best FP2 and FP1 models as described in 
detail elsewhere (Royston and Sauerbrei 2003). MFP transformations were used to allow for 
nonlinear effects of the covariates in the regression models.  
2.5 Meta-analysis 
Meta-analysis is a quantitative statistical analysis tool that combines findings from several 
similar but independent studies or trials to test statistical significance for a pooled estimate. The 
aim is to increase power and precision of the estimates (Mulrow 1994). This method, 
implemented in the Stata package metan (Harris et al. 2008), was used to pool correlations from 
multiple studies conducted within sub-Saharan Africa. Individual estimates and the pooled 
estimate were graphically presented using forest plots (Harris et al. 2008). Heterogeneity was 
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assessed by visual inspection of the forest plots to detect overlapping CI and statistically by 
using an I2 test statistic in which values circa 50% indicate moderate heterogeneity. Fixed effect 
meta-analysis was used except when the I2>50%, in which a random effect meta-analysis was 
applied. Stata’s user-written function (metaninf) (Steichen 2001) was used to conduct sensitivity 
analyses to examine the influence of each study site on the pooled correlation estimate. This 
was examined by omitting one study at a time and then assessing the influence of the omitted 
site, that is, a site was considered influential if the pooled correlation estimate without that site 
was not within the 95%CIs of the overall pooled correlation.  
Funnel plots (Sterne et al. 2001), which are plots of effect estimates against sample size were 
used to assess publication bias. The funnel plot is built on the premise that the precision of the 
effect size increases with increasing sample size. In the absence of bias, the plot resembles a 
symmetrical inverted funnel. Otherwise, skewed asymmetrical funnel plots indicates bias 
(Egger et al. 1997). Stata function metafunnel was used to graph funnel plots for assessing 
reporting bias in meta-analyses.  
2.6 Multiple imputation. 
Missing data occur in most epidemiological and clinical research and is mostly unavoidable due 
to nonresponse and subject attrition (Rubin 2004). For instance, mortality before taking 
measurement at a hospital setting or completing follow-ups introduces missing data that 
inherently reduce the power with which parameters are estimated thus potentially undermining 
the validity of research conclusions. Interest towards addressing missingness during data 
analysis has been on the increase. Multiple imputation can potentially reduce bias, increase 
efficiency (reduce standard errors) and is now available in standard statistical softwares (Horton 
and Lipsitz 2001). Unlike the classical complete case analysis, where only complete data points 
68 | P a g e  
 
are included in the analysis, multiple imputation ensures that data points that are missing are 
filled and a full dataset can be used for the final analysis.  
In the presence of missing data, the validity of multiple imputation analysis depends on the type 
of missingness and the variables included in the imputation model (Sterne et al. 2009). There 
are three types of missingness: 1) missing completely at random (MCAR)- in this case there is 
no systematic differences between the missing data and the observed ones, 2) missing at random 
(MAR) occurs when systematic differences between missing values and the observed ones can 
be explained by differences in the observed data, and 3) missing not at random (MNAR) occurs 
when systematic differences between missing values and the observed ones are not fully 
explained by differences in the observed data (White et al. 2011). Complete case analysis is 
valid if the likelihood of being a complete case given the covariates in the model, is independent 
of the outcome. Multiple imputation approaches are valid under the assumption of MAR. 
However, when factors associated with both the outcome and missingness are not included in 
the imputation model (MNAR), multiple imputation will not fully remove bias. To detect the 
mechanism of missingness, careful preliminary analysis to identify the scope for multiple 
imputation and to provide guidance for building the imputation model is required (Sterne et al. 
2009). 
In epidemiological settings, it is possible for missing values to occur in more than one variable. 
Multiple imputation with chained equations (MICE) allows a set of multiple imputation models, 
one for each variable with missing data to be applied concurrently (White et al. 2011). MICE 
can handle different variable types including; continuous, binary, ordered and unordered 
categorical variables. Three to five imputed datasets are theoretically sufficient (Allison 2000), 
however, in practice more imputed datasets are recommended (Horton and Lipsitz 2001, 
Graham et al. 2007). Analysis of each imputed dataset is done separately and the parameter 
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estimates combined using Rubin’s rules (Rubin 2004). That is, suppose 𝜃𝑗  is the regression 
coefficient of interest from a regression model obtained from the j-th imputed dataset. The 
respective post-imputation combined estimate is the average of individual estimates: 
?̅? = ∑ 𝜃𝑗/𝑘
𝑘
𝑗=1
 
where 𝜃𝑗  is the estimate of 𝜃 using the j-th imputed dataset and k is the number of imputed 
datasets. The associated standard error is a combination of the within and between-imputation 
variances (White et al. 2011) formulated as follows:   
𝑆𝐸(?̅?) = √
∑ 𝑣𝑎𝑟(𝜃𝑗)
𝑘
𝑗=1
𝑘
+ (
𝑘 + 1
𝑘
) ∗
∑ (𝜃𝑗 − ?̅?)
2𝑘
𝑗=1
𝑘 − 1
 
For a sufficiently large number of imputed datasets, the combined estimate follows an 
approximate Gaussian distribution. 
Preliminary analysis to assess the mechanism of missingness was done prior to multiple 
imputation. This involved assessing the association between missing data with covariates and 
the outcome. MICE was conducted in STATA software as indicated in chapter 3. 50 imputed 
datasets were used to impute missing data on personal ITN use. In the imputation model, the 
outcome variable and the covariates were included as previously recommended (Sterne et al. 
2009). Standard errors were calculated using Rubin’s rules accounting for variability in results 
among imputed datasets. Results from complete case analysis and multiple imputation were 
reported and compared. 
The above statistical methods were used in the analyses presented in chapter 3, 4 and 5. 
Hereafter I will mention the methods used without giving details but with reference to this 
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chapter. Any additional statistical methodology specific to any given chapter will be discussed 
in the relevant chapter.  
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Chapter Three 
3 Age, spatial and temporal variations in hospital admissions with malaria 
in Kilifi county 
3.1 Introduction 
Marked declines in malaria transmission intensity and related mortality has been witnessed in 
parts of sub-Saharan Africa (Ceesay et al. 2010, O'Meara et al. 2010, Noor et al. 2014). It is 
known that children acquire immunity to malaria following repeated exposure and there is an 
inverse relationship between the intensity of malaria transmission and age of susceptibility to 
malaria (Snow et al. 1997, Woolhouse 1998). The shift in age of susceptibility to malaria 
following implementation of malaria control interventions has been reported in both field 
conditions (Okiro et al. 2009, Trape et al. 2011, Karema et al. 2012) and predicted by simulation 
studies incorporating acquired immunity (Pemberton-Ross et al. 2015).  
3.2 Rationale 
In areas of high transmission intensity, younger children present to hospital with severe anaemia 
as the main complication of P. falciparum infection. In areas with less intense transmission, 
cerebral malaria predominates slightly older children with relatively higher mortality rate. It is 
therefore essential to monitor outcomes following initial reductions in malaria transmission.  
In this chapter, I present data from a 25-year longitudinal surveillance of hospital admission 
with malaria to Kilifi county hospital on the Kenyan coast. 
3.3 Study objectives 
1. Describe trends of malaria admissions by age group over the 25-year period 
2. Assess the spatial and temporal heterogeneity of malaria transmission in Kilifi county 
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3. Assess the effectiveness of personal and community ITN use 
4. Examine the effect of EVI on malaria transmission as a proxy for soil moisture content 
which may correlate with the presence of mosquito breeding sites. 
3.4 Methods 
3.4.1 Kilifi county and population  
Kilifi County is located along the Kenyan coast and to the north of Mombasa. The county has a 
population of approximately 1.11 million people (KNBS 2009) and covers an area of 
approximately 12,245.90 km2. The region is predominantly rural, with less than 15% of the 
population living in the urban area of Kilifi town (Scott et al. 2012). This region has been 
endemic for malaria transmission, though in the recent past declining transmission has been 
witnessed (O'Meara et al. 2008, Noor et al. 2009a). Kilifi District Hospital (KDH) recently 
renamed Kilifi County Hospital (KCH) and the Kilifi Health and Demographic Surveillance 
System (KHDSS) are part of Kilifi County (Figure 3.1) and play a major role in providing 
healthcare services. Similarly, the Kenya Medical Research Institute (KEMRI) and KEMRI-
Wellcome Trust Research Programme is based at the hospital and primarily conduct research 
on malaria and other diseases (Scott et al. 2012). The population around Kilifi mainly depends 
on subsistence farming, tourism and fishing as the major economic activities. 
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Figure 3.1: Map of Kilifi county indicating the hospital and the KHDSS area 
The main crops are maize and tree crops such as coconuts and cashew nuts. Low soil fertility 
coupled with low unreliable rainfall over the years has led to persistent poor crop yield making 
the county one of the poorest in Kenya. The long rains are expected between April and July and 
the short rains between November and December, but considerable year to year variation in the 
amount of rainfall has been witnessed.  
3.4.2 The KHDSS  
The study area and population characteristics have been described in detail elsewhere (Scott et 
al. 2012). Briefly, the KHDSS (http://www.kemri-wellcome.org/khdss) was established in the 
year 2000, to provide a platform upon which hospital and community based studies conducted 
at the site recruit and locates study participants. The area has been mapped using global 
positioning system (GPS) and digital maps produced. Field work personnel conduct re-
enumeration and vital status registration to update the population register by visiting every 
homestead three times a year. KHDSS covers an area of about 891km2 and has a residence 
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population of about 260,000 (March 2011). Mapping and census are done and recorded into a 
population register linked to inpatient records through an integrated data management system. 
The KHDSS population register is constantly updated for births, deaths and in- and out-
migration events every 4 months. Approximately 70% of the children presenting for admission 
at the Kilifi County Hospital are linked to their residence information using the system while 
the rest are mostly non DSS residents. 
3.4.3 Malaria control in the KHDSS area  
The Kilifi Health and Demographic Surveillance (KHDSS) area has seen several malaria control 
programs even before its inception in 2000. For instance, the first ITN study was conducted 
between July 1993 and July 1995 in the northern part of Kilifi and demonstrated that ITN use 
provides personal protection against malaria (Nevill et al. 1996). In 2002, Population Service 
International (PSI) launched a retail campaign for ITN distribution (Noor et al. 2006). This 
campaign was boosted by the delivery of highly subsidized ITNs through Maternal and Child 
Health (MCH) clinics towards the end of 2004 (Okiro et al. 2007). In September 2006, the 
Ministry of Health launched a campaign of free distribution of ITNs to children under the age 
of five years (Noor et al. 2007). This campaign was repeated later in 2013 with the motive of 
increasing ITN coverage. Besides the various campaigns on ITN use, other control measures 
have been rolled out that include the government policy changes on 1st line drug treatment of 
malaria in government clinics. That is, before the year 2000, chloroquine was used as the 1st line 
treatment against malaria (Shretta et al. 2000) despite reports of drug resistance and increased 
human to vector transmission (Hogh et al. 1998). It was due to the overwhelming evidence 
against chloroquine that a policy changeover to sulphadoxine-pyrimethamine (SP) was effected 
in mid-2000 lasting to around April 2006 when another policy changeover was effected to 
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artemether-lumefathrine (AL) (Shretta et al. 2000). Another control method seen in this study 
area involved training shopkeepers on treatment compliance in Chonyi area. These control 
methods may have contributed in suppressing the incidence of clinical malaria in some parts of 
the study area (Marsh et al. 1999). The trend in malaria parasite prevalence on the Kenyan coast 
and the combination of factors which may explain the changes observed between 1974 and 2014 
is summarized in Figure 3.2 below. 
 
Figure 3.2 Prevalence of malaria on the Kenyan coast and the combination of factors which 
may explain the changes since 1974. 
Extracted monthly GAM fitted median PfPR2-10 (red line) shown in relation to annual and long 
rains (March-June) percentage anomalies in precipitation (dark and light grey bars 
respectively); cumulative "effective" mid-year ITN distribution data (dark green likely 
efficacious, light green <50% efficacious); estimated day 7 anti-malarial drug failures to clear 
parasitaemia based on information provided in text (blue triangles); and malaria policy 
milestones for standard treatment guidelines and mass ITN distribution dates (FMD), including 
reported ITN use among all age groups(Snow et al. 2015). 
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3.4.4 Kilifi county hospital surveillance system 
KCH provides primary care services and acts as the only referral facility within the KHDSS 
area. Upon admission, KHDSS residents received a unique personal identifier that links them to 
their demographic details. Between 1989 and 2002, admitted patient’s residence were known to 
sublocation level after which homestead level GPS coordinates were available. Laboratory 
records and standard clinical data for all admissions were linked to demographic records for the 
residents of KHDSS area using personal identifiers. For most residents of the KHDSS, KCH is 
the nearest facility offering inpatient care, however, two more facilities offering similar inpatient 
service are the Malindi District Hospital and the Coast Provincial General Hospital that are 
within 20 kilometers to the North and South of the KHDSS respectively.  
Screening for malaria parasites at the KCH paediatric admission wards has been continuous 
since the establishment of a pediatric admission ward surveillance system in 1989. These 
assessments are conducted on all emergency admissions, irrespective of presumptive diagnosis, 
except for those admitted for elective surgery. 
3.4.5 Ethical consideration 
Approval for human participation in the hospital surveillance and the cohorts was given by the 
KEMRI Scientific Steering Committee and the Ethical Review Committee of KEMRI. The 
studies were conducted per the principles of the declaration of Helsinki. 
3.4.6 Data collection 
The study was conducted at KCH situated at the center of the KHDSS area as described above. 
Children <13 years of age were admitted to the pediatric service, where demographic details 
and clinical history were recorded and blood samples were collected and examined for malaria 
parasites by microscopy. Children with signs of severe disease such as impaired consciousness 
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or deep breathing were assigned to the high dependency unit, whilst children without such signs 
were admitted to the pediatric ward. Research clinicians provided 24-hour clinical cover of both 
the high dependency unit and the general pediatric ward.   
Thick and thin blood smears were stained with 10% Giemsa and examined at x1000 
magnification for P. falciparum malaria parasites. One hundred microscopy fields were 
examined before slides could be considered negative. Microscopy standards were monitored 
through a quality assurance scheme including training on induction and at regular intervals for 
microscopists and the use of external quality control slides. 
3.4.7 Data analysis 
The analysis included children admitted between 1990 and 2014 to KCH, aged between 3 
months and 13 years, and residing within the KHDSS area. Key metrics were the Malaria 
Positive Fraction (MPF) and the mean age of the children admitted with positive malaria slides 
(i.e. without applying a threshold parasitaemia). The MPF describes the fraction of acute 
admissions to hospital with positive blood films compared with all admissions and is also known 
as the “Slide Positive Rate” (Jensen et al. 2009). MPFs from passive surveillance at the hospital 
were compared with incidence data from active surveillance of 2 cohorts in the community, 
conducted as previously described (Mwangi et al. 2005, Bejon et al. 2007). Unpaired t-test were 
used to test the difference in means when variables were normally distributed, otherwise the 
Wilcoxon rank-sum test was used to compare average/median age between groups. Multiple 
fractional polynomials (MFPs) were used to assess nonlinear associations in regression models. 
A sensitivity analysis was carried out with a “malaria case” defined using a cut-off parasitaemia 
of >2,500 parasites per µl. 
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3.4.8 Spatio-temporal models 
The spatio-temporal heterogeneity of malaria transmission in Kilifi County was assessed using 
a multivariable logistic regression model (refer to chapter 2 for details on the methodology) with 
the presence or absence of malaria parasites by microscopy among medical admissions 
(excluding trauma and elective surgery) as the outcome variable, time (continuous variable to 
capture the secular trends), year (categorical to capture year-to-year variability), region 
(referring to North vs South of the creek), location (referring to administrative areas within 
region) and space-time interactions as the independent covariates. I used the Pseudo R2 to assess 
the contribution of the various components of the model. As a measure for the background 
community prevalence of parasitaemia, age-standardized parasite prevalence estimates among 
trauma cases were determined using standard methods (Smith et al. 2007a), but only when 
children were afebrile on admission and clinical assessment did not reveal any other acute cause 
for admission. 
3.4.9 Predictor variables 
Enhanced Vegetation Index (EVI) data between 2000 and 2014 were used as a proxy for soil 
moisture(Midekisa et al. 2012). EVI data were downloaded at a 250x250m2 pixel resolution for 
16 day intervals. I extracted the EVI bands using ArcGIS and saved them in the georeferenced 
tagged image file format (GeoTIFF). The GeoTIFF files were then processed into data using 
QGIS batch processing functionality and scaled to between 0 and 1. The EVI dataset was 
aggregated to a year.  
Data on ITN use were obtained from yearly KHDSS surveys targeting all residents between 
2009 and 2014. I used data from responses to the question “did you sleep under an ITN last 
night?” or “did your child sleep under an ITN last night?” 
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Regular geographical grids were imposed on the study area and concentric circles were 
generated around each admitted child’s residence using longitude and latitude coordinates. The 
prevalence of ITN use within each concentric circle and the mean EVI within each grid space 
was used in multivariable models. Model parsimony from the resulting sets of EVI and ITN 
covariates created was determined using a forward stepwise selection criterion and the 
likelihood ratio testing done to formally compare models. The superiority of non-linear models 
over linear models was assessed visually by plotting residuals against covariates, and 
statistically by testing the significance of multiple fractional polynomials over linear fits where 
asymmetrical distributions of residuals were identified as described in chapter 3. Observations 
with missing locations, age and slide result were excluded prior to the analysis. Multiple 
imputation with 50 imputed datasets was used to impute missing data on personal ITN use. The 
variables community ITN use, malaria positivity, EVI, and age were used in the imputation 
model. The imputed datasets were combined as per Rubin’s rules described in chapter 2. Age 
standardized parasite prevalence was computed in R (version 3.0.2) and all other analysis were 
done using Stata 12.0 (Stata Corp., College Station, TX, USA). 
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3.5 Results 
Over 25 years, there were 107,218 pediatric admissions recorded, of whom 87,909 were known 
residents of the KHDSS and 71,438 were ≥3 months or <13 years of age. Malaria slide data 
were missing for 2,334 leaving 69,104 for our analysis (Figure 3.3). The characteristic of the 
study population is presented in Table 3.1.  
 
Figure 3.3: Flow diagram of participant numbers. Participant numbers and reasons for 
exclusion at each stage are shown. 
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Table 3.1: Characteristic of the study population 
Period in which 
data was 
available 
Analysis 
Type Characteristics 
Malaria Slide 
Positive 
Malaria Slide 
Negative 
1990 to 2014 
Descriptive 
Analysis 
Admissions N(%) 26883(38.9) 42221(61.1) 
Age (months) 
median(IQR) 25.9(13.2-44.9) 19.2(9.7-42.7) 
Male, No. (%) 14,217(53.0) 23,862(56.6) 
Locations    
Chonyi          No. (%) 2,774 (10.3) 3,955 (9.4) 
Gede             No. (%) 695 (2.6) 1,856 (4.4) 
 Jaribuni         No. (%) 2,018 (7.5) 2,383 (5.7) 
  Junju              No. (%) 2,018 (7.5) 3,038 (7.2) 
  Mtwapa         No. (%) 1,182 (4.4) 3,160 (7.5) 
  Ngerenya       No. (%) 1,246 (4.6) 1,941 (4.6) 
  Roka                No. (%) 1,964 (7.3) 2,960 (7.0) 
  Sokoke            No. (%) 1,470 (5.5) 1,861 (4.4) 
  Takaungu        No. (%) 5,071 (18.9) 4,590 (10.9) 
  Tezo                 No. (%) 8,404 (31.3) 16,437 (39.0) 
2009 to 2014 
Logistic 
regression 
Model 
  
Admissions N (%) 1294 (17.2) 6,211(82.8) 
 
Age (months)  
median(IQR) 48.1 (30.1- 73.1) 24.2 (11.8-54.3) 
  Missing Personal ITN 
use N(%) 47(3.6) 103(1.7) 
 
 
Missing data on ITN 
during Community 
Surveys N(%) 190,417 (12.8%)  
 
3.5.1 Access to care 
I first tested for evidence of a bias in MPF by access to care.  In order to assess the effect of 
access to care, I examined the data for trends in MPF over the euclidean distance between 
children’s residence and the hospital (Figure 3.4A). Best-fit lines showed greater heterogeneity 
in MPF over distance than linear trend in MPF over distance (a non-significant gradient of -
0.003 per km, 95%CI -0.006 to 0.0003, p=0.08), suggesting that geographical heterogeneity had 
a greater effect than any bias that may be introduced by distance from the hospital. Furthermore, 
I found that the incidence of malaria on active case detection from 2 cohorts monitored over 10 
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years (Mwangi et al. 2005, Bejon et al. 2007) correlated closely with MPF measured at the 
hospital (r=0.84, p<0.001, Figure 3.4B). 
 
Figure 3.4: Association between MPF, distance from hospital and malaria incidence. 
Panel A shows the association of Malaria Positive Fraction with Distance from Hospital (km), 
the green line presents the predicted linear regression line, the red line presents the predicted 
line from the multiple fractional polynomial model and the blue line presents the fitted lowess 
function. Panel B shows an association between malaria incidence from active case detection 
in Junju and Ngerenya with the MPF among patients admitted in hospital from these sites. 
3.5.2 Geographical distribution and trends in malaria positive fraction  
The fraction of acute admissions that were positive for malaria (i.e. the “Malaria Positive 
Fraction” or MPF) for the full dataset was 0.389 (95%CI 0.385 to 0.393). MPF was subject to 
marked spatial and temporal heterogeneity (Figure 3.5A). There was a decline in MPF over the 
years with the lowest MPF (i.e. 0.07 (198/2858)) being recorded in 2009, and a subsequent 
increase in MPF (up to 0.24 (511/2169)) in 2014 (Figure 3.5A). I therefore refer to the 1990-
2002, 2003-2008 and 2009-2014 as “pre-decline”, “decline” and “post-decline” periods, 
respectively. 
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The average age of children admitted with malaria positive slides and acute illness increased 
gradually from 20.2 months (95%CI 18.9 to 21.6) in 1990 to 45.3 months (95%CI 42.5 to 48.3) 
in 2014 (p<0.001). During the same period the mean age for children with malaria negative 
slides and acute illness increased only slightly from 19.8 months (95%CI 18.6 to 21.1) in 1990 
to 26.1 months (95%CI 24.9 to 27.5) p<0.001 in 2014 (Figure 3.5B). Furthermore, the mean age 
of children with asymptomatic parasitaemia among trauma admissions did not increase 
significantly ranging from a geometric mean of 52.1 months (95%CI 49.5 to54.9) in the 1990-
2002 pre-decline period to 64.6 months of age, 95%CI 49.5 to 84.2 in the 2009-2014 post-
decline period, p= 0.0543 (the latter wide confidence interval reflecting the reduced prevalence 
of asymptomatic infection). 
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Figure 3.5: Temporal trends of malaria positive fraction, age of slide positive and mortality 
among acute admissions. 
Panel A shows the temporal trend of Malaria Positive Fraction (MPF). Panel B shows the trends 
of mean age over time for the slide positive and slide negative admissions. Panel C shows the 
temporal trends of absolute number of deaths and Panel D shows case fatality rates. 
The absolute number of malaria slide positive deaths recorded in the hospital surveillance fell 
over time, although the absolute number of malaria slide negative deaths did not show a clear 
trend (Figure 3.5C). The case fatality rate (i.e. the proportion of children admitted who died) 
among malaria slide positive children was static, although among slide negative children the 
case fatality rate showed a gradual decline (Figure 3.5D). 
Models accounted for variation in MPF poorly in the pre-decline period, however the decline 
period was dominated by temporal variation, and the post-decline period was dominated by 
spatial variation (Figures 3.6A, 3.6B and 3.6C, respectively). 
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Figure 3.6: Geographical distribution of malaria positive fraction and age of slide positive 
acute admissions over time. 
Panels A, B and C show spatial distributions of MPF for the Pre-decline, Decline and Post-
decline periods respectively, and their associated pie charts show the proportion of the 
variability in MPF explained by the predictors; Region (i.e. North vs South), Location, Time 
trend (i.e. as a continuous variable), an interaction between time and location, year to year 
variation (i.e. year as a stratified variable) and the unexplained variations. Panels D, E and F 
show spatial distributions of age in months for the slide positive admissions during the Pre-
decline, Decline and Post-decline periods. 
There was an inverse relationship between MPF and average age of children with positive slides 
when averaged by location: areas with higher average age of malaria tended to have lower MPF 
and vice versa (Figure 3.6A compared to 3.6D, 3.6B compared to 3.6E and 3.6C compared to 
3.6F). This was statistically significant before the decline (r= -0.36, p<0.001), but not after (r= 
-0.05, p=0.66). There was a shift in the burden of disease from younger age groups to older age 
groups after the decline (Figure 3.7). 
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Figure 3.7: Trends of malaria positive fraction by age group (years). 
The graph show the trend of malaria positive fraction in each age category <1 (less one year 
old), 1-3 (1 to 3-year-old), 3-5 (3 to 4-year-old), 5-7 (5 to 7-year-old), 7-10 (7 to 10-year-old), 
>10 (children over 10-year-old).  
3.5.3 Is the post-decline increase in malaria due to falling immunity? 
In order to disentangle the effects of loss of immunity from transmission intensity, I 
hypothesized that MPF for children <1 year old (MPF<1yr) would indicate transmission intensity 
without the offsetting of acquired immunity (as has been done previously (Snow et al. 1996, 
Bejon et al. 2014)). I examined the trends in MPF<1yr by region (i.e. using the Creek in the center 
of the County as the point of division into Northern vs Southern regions) in view of the 
significant effect of region on variability of MPF (Figure 3.6C). MPF<1yr showed a clear decline 
from the mid-1990s down to almost zero in the Northern region by 2008 and to low levels in 
the Southern region from 2008 onwards, with a very slight increase after 2009 in the North and 
a slightly more marked but variable increase in the South after 2009 (Figure 3.8A). In contrast, 
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MPF>1yr showed a greater increase in both regions in the post-decline period, which was 
particularly marked in the South (Figure 3.8B). Within geographical locations, malaria 
positivity showed substantial variability from year to year (Figure 3.8C).  
I also examined the age-corrected parasite prevalence (PfPR2-10) among the (3,971/69,104) 5.8% 
trauma admissions (excluding trauma cases with fever) as a proxy of community parasite 
prevalence (Figure 3.8D). PfPR2-10 which declined from (30/72) 43% and (35/62) 56% in the 
Northern and Southern regions, respectively in 1999, to <1% (i.e 0/151 in the North and 1/100 
in the South) in both regions in 2009, but subsequently rose, reaching (2/102) 2% and (3/83) 4% 
in the Northern and Southern regions, respectively, in 2014.  
 
Figure 3.8: Temporal trends of malaria positive fraction by age and parasite prevalence. 
Panels A and B show the temporal trends of MPF in admitted children aged<=1-year-old and 
children aged>1-year-old respectively, red line represents the Southern region while the blue 
line represents the Northern region of the hospital. Panel C shows all age MPF for randomly 
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selected locations from the Southern and Northern regions. Panel D shows the age standardized 
parasite prevalence (PfPR2-10) among the trauma cases.  
3.5.4 Factors predicting malaria positive slides among admissions 
Over the full monitoring period from 1990-2014 there was significant variation in MPF over 
space and time, and the spatial variation was most marked in the post-decline period (Figure 
3.6C). The variation accounted for by an interaction between space and time was also more 
marked during this period, suggesting substantial temporal instability of the sub-regional spatial 
pattern during this period (Figure 3.8D). The interaction between space and time was strongly 
significant (p<0.0001) but accounted for only ~1% of the variability in MPF. However, the 
regional differences (i.e. with lower MPFs North versus South of the creek) remained temporally 
consistent despite the sub-regional instability. 
The prevalence of ITN use among residents in the Northern region was estimated at 32%, 16% 
and 26% in the years 2000, 2003 and 2005, respectively (malaria indicator surveys, Table 2) 
and then 55.9% (95%CI 55.7 to 56.1) in 2009 rising to a high of 82.6% (95%CI 82.5 to 82.8) in 
2013 during the mass ITN distribution campaign (Figure 3.9).  
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Figure 3.9: Trends in ITN use by age group (years) over time for the period (2009 -2014). 
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Table 3.2: Data from Malaria indicator surveys conducted in the Northern region of 
Kilifi Demographic Surveillance Area 
Clusterid Year population size ITN use (N) 
157 2000 19 10 
159 2000 11 11 
160 2000 11 2 
161 2000 11 0 
162 2000 16 5 
163 2000 16 4 
164 2000 10 0 
165 2000 13 1 
166 2000 7 2 
167 2000 13 2 
168 2000 7 4 
170 2000 8 0 
172 2000 14 4 
173 2000 11 9 
174 2000 16 1 
177 2000 17 3 
179 2000 10 5 
180 2000 12 7 
1230 2000 12 4 
2 2003 87 39 
48 2003 118 0 
86 2003 113 3 
99 2003 54 27 
279 2003 99 5 
280 2003 129 15 
286 2003 66 22 
291 2003 43 7 
317 2003 114 21 
336 2003 112 22 
349 2003 73 31 
359 2003 99 0 
362 2003 156 11 
163 2005 33 22 
167 2005 28 7 
171 2005 53 7 
176 2005 51 14 
180 2005 68 4 
259 2005 95 16 
265 2005 81 6 
271 2005 59 29 
1418 2005 37 17 
1478 2005 29 11 
1482 2005 21 12 
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Detailed spatial data was available between 2009 and 2014 including Enhanced Vegetation 
Index data (EVI, a proxy for soil moisture) and ITN use for each of the 250,000 residents in the 
study area (Figure 3.10 and Figure 3.11).  
 
Figure 3.10: Finer-scale geographical distribution of malaria positive fraction (row I), 
insecticide-treated net use (row II) and enhanced vegetation index (row III) over time and the 
average admissions per year (row IVa) and population density (row IVb). 
Panels IVc, IVd and IVe are the legends for row I, row II and row III respectively. 
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Figure 3.11: Trends in insecticide-treated net use, enhanced vegetation index. 
Panel A shows the trends of EVI from year 2000 through to 2014. Panel B shows the trend of 
ITN use for a six-year period 2009 -2014. 
I identified four independent predictors of malaria slide positivity; a) ITN coverage in the 2km 
radius around the child’s residence, b) age of the child c) EVI in the 0.25x0.25 km square around 
the child (i.e. the finest resolution at which EVI was available) and d) time (Figure 3.12B, Table 
3.3). These predictors explained ~ 23% of the variability on the outcome variable leaving about 
77% unexplained variability in the response variable. 
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Figure 3.12: Regression model prediction and variability explained by the predictors of the 
model. 
Panel A shows the predicted probability of a positive slide result (y axis) against the prevalence 
of ITN use in a 2km radius around each admitted child’s residence. Panel B shows the pseudo 
R2 of the various variables assessed in the extended model (ITN use around a child’s residence, 
EVI, Age, Age-time interaction, Time, Region and Location).  
 Personal ITN use was a predictor in univariable analysis (OR=0.73, 95%CI 0.65 to 0.83, 
p=<0.001), but not after adjusting for ITN use in the 2km radius around the admitted children’s 
residences (Table 3.3).  
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Table 3.3: Multiple logistic regression model of malaria on personal ITN use, ITN use prevalence around the child’s residence age 
and EVI for both complete case analysis and multiple imputation. 
 Complete case analysis Imputed data analysis 
Covariates  Covariates from Multiple 
Fractional Polynomial model 
Odds 
Ratio P-value (95% CI) 
Odds 
Ratio P-value (95% CI) 
Personal ITN use Personal ITN use  0.925 0.307 (0.797   1.075)  0.937 0.37 (0.814   1.087)  
Community level 
ITN use (2km 
radius) 
ITN1=ITN_2km^2-
0.3908547648   0.159 <0.001 (0.104   0.242)  0.154 <0.001 (0.102   0.233) 
ITN2=ITN_2km^2*ln(ITN_2km) 
+0.1835882418 2.3E-4 <0.001 (1.1E-5   5.0E-3) 4.9E-4 <0.001 (3.0E-5   8.4E-3) 
Age in Years Age1=(Age/10)^0.5-
0.5888197049 3.0E+07 <0.001 (4.6E+6   1.9E+8) 1.3E+07 <0.001 (2.6E+6   6.6E+7) 
Age2=(Age/10)-0.3467086449 6.1E-06 <0.001 (1.5E-6   2.5E-5) 2.8E-05 <0.001 (8.9E-6   8.6E-5) 
EVI (0.25x0.25 km) EVI  23.43 <0.001 (4.40    124.17) 12.26 0.001 (2.73   55.00) 
Time=(year-2008) T1=ln(time)-1.142973262  2.11 <0.001 (1.77   2.43) 1.30 <0.001 (1.24   1.36) 
Age-Time 
interaction 
Age1*T1 4.2E-3 0.002 (1.3E-4  0.14) 0.32 0.01 (0.14  0.76) 
Age2*T1 120.56 <0.001 (8.3  1.8E+3) 2.44 0.003 (1.35  4.40) 
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There were no marked differences in characteristics of missing ITN data compared to non-
missing data by age, EVI, gender and location of residence (Table 3.4). Results from multiple 
imputation were not significantly different from complete case analysis (Table 3.3).  
Table 3.4: Characteristic of individuals with missing ITN data during community ITN 
use surveys. 
 Characteristics  Missing data Complete data 
Overall    No. (%) 190,411 (12.81) 1,296,346 (87.19) 
Age (years) median (iqr) 19 (8 - 31) 15 (7 - 32) 
EVI median (iqr) 0.366 (0.326-0.393) 0.370 (0.336-0.397) 
Male        No. (%) 75,823 (48.16) 501,641 (46.70) 
Missing by locations     
Chonyi                No. (%) 28,178 (14.80) 215,829 (16.65) 
Gede                   No. (%) 14,649 (7.69) 108,598 (8.38) 
Jaribuni              No.  (%) 7,904 (4.15) 70,616 (5.45) 
Junju                   No.  (%) 23,470 (12.33) 150,654 (11.62) 
Mtwapa             No.  (%) 9,870 (5.18) 63,074 (4.87) 
Ngerenya           No. (%) 9,834 (5.16) 79,737 (6.15) 
Roka                    No. (%) 11,714 (6.15) 87,215 (6.73) 
Sokoke                No. (%) 5,251 (2.76) 44,089 (3.40) 
Takaungu           No. (%) 16,751 (8.80) 137,710 (10.62) 
Tezo                    No. (%) 62,790 (32.98) 338,822 (26.14) 
 
There was strongly significant (p<0.0001) non-linear relationship between community ITN use 
in the 2km radius area around a child’s residence and a slide positive result such that MPF 
reduced substantially with increasing ITN use (Figure 3.12A). The probability of presenting for 
admission with clinical malaria increased with higher values of EVI around the child’s residence 
and with later years of admission. However, the probability of clinical malaria increased to a 
peak at ~5-years of age at admission and decreased again (Figure 3.13). Similar results were 
obtained using a model that included clustering at the 250 square meters (Table 3.5) except that 
the confidence intervals were slightly wider (Figure 3.13).  
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Table 3.5: Multiple logistic regression model of malaria on personal ITN use, ITN use 
prevalence around the child’s residence and EVI (allowing clustering at 250 square 
meters) 
Covariates  Covariates from multiple 
fractional polynomial model 
Odds 
ratio P-value (95% CI) 
Personal ITN use Personal ITN use  0.925 0.355 (0.78   1.09)  
Community level 
ITN use (2km 
radius) 
ITN1=ITN_2km^2-
0.3908547648   0.159 <0.001 (0.097   0.259) 
ITN2=ITN_2km^2*ln(ITN_2k
m) +0.1835882418 2.3E-4 <0.001 (6.6E-6   0.008) 
Age in Years Age1=(Age/10)^0.5-
0.5888197049 3.0E+07 <0.001 (4.0E+6   2.3E+8) 
Age2=(Age/10)-0.3467086449 6.1E-06 <0.001 (1.3E-6   2.9E-5) 
EVI (0.25x0.25 km) EVI  23.4 <0.003 (2.86    190.7) 
Time=(year-2008) T1=ln(time)-1.142973262  2.1 <0.001 (1.76   2.44) 
Age-Time 
interaction 
Age1*T1 4.2E-3 0.004 (1.0E-4   0.17) 
Age2*T1 120.56 0.001 (7.1    2.0E+3) 
 Pseudo R2 =0.144 
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Figure 3.13: MFP regression model prediction of all predictors. 
Row A (without accounting for clustering) and B (accounting for clustering) shows the predicted 
probability of a positive slide result (y axis) against the predictors included in the model. 
Variables assessed in the extended model are ITN use 2km radius around a child’s residence, 
the enhanced vegetation index (EVI), age in years and time (year of presentation to hospital for 
admission).  
3.5.5 Sensitivity Analysis 
It has previously been shown that applying a parasite threshold to the definition of malaria 
enhances the specificity of the endpoint, as lower parasite densities are more likely to reflect 
coincident chronic asymptomatic parasitaemia and a non-malarial clinical illness such as 
pneumonia. I therefore repeated the analysis using a cut-off >2,500 parasites per µl. The same 
patterns were seen: i.e. a post-decline increase in MPF among older children (Figure 3.14), and 
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inverse relationship between MPF and age of malaria (r=-0.63, p<0.001), and of protection by 
community-level ITN use (Figure 3.15). These patterns remained statistically significant.   
 
Figure 3.14: Trends of malaria positive fraction, over time and region using a case 
definition for malaria of >2,500 parasites/µl. 
Panels A and B show the temporal trends of MPF in admitted children aged<=1-year-old and 
children aged>1-year-old respectively, red line represents the Southern region while the blue 
line represents the Northern region of the hospital.  
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Figure 3.15: Regression model prediction using a case definition for malaria of >2,500 
parasites/µl. 
The figure shows the predicted probability of a positive slide result (y axis) against the 
prevalence of ITN use in a 2km radius around each admitted child’s residence.  
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3.6 Discussion 
The proportion of acutely unwell children admitted to hospital with malaria positive slides (i.e. 
the MPF) declined from 2002 until 2009 (as reported previously (O'Meara et al. 2008)). 
However, after 2009 there was an increase in MPF that continued through to 2014. This increase 
was mostly seen in older children: there were relatively modest increases among children less 
than 1 year of age (MPF<1yr), but much greater increases among children above 1 year of age 
(MPF>1yr). This combination of findings suggests that the increase in malaria is due to increasing 
susceptibility to disease among older children, exacerbated by a slight increase in underlying 
transmission intensity since 2009. Additional evidence for increasing transmission after 2009 
can be seen in the increasing prevalence of asymptomatic parasitaemia (PfPR) among children 
admitted for trauma, and work showing increasing parasite prevalence throughout the Kenyan 
Coast (Snow et al. 2015).  
It has been shown previously that at high transmission intensities children acquire immunity 
rapidly, and so are not susceptible to disease when they are older (Okiro et al. 2009). On the 
other hand, at low transmission intensity there is less disease among younger children, and 
consequently older children acquire less immunity and remain susceptible (Okiro et al. 2009). 
Therefore, the lowest malaria rates will likely occur just after a recent reduction in transmission: 
at this point current exposure is low, but older children are immune because of their previous 
exposure when transmission was high. As time goes by after a reduction in transmission, a 
cohort of older children will emerge who are susceptible to the disease, and the rates of malaria 
will increase again. 
Taking together these finding of a) trends of increasing age of children admitted with positive 
malaria slides in parallel with falling PfPR2-10 in the community and falling MPF<1 among 
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hospital admissions b) a geographical association where areas with high MPF have low average 
age of children admitted with malaria c) previous analyses (Reyburn et al. 2005) and 
geographical analyses (Snow et al. 1997) showing the importance of the relationship between 
prior exposure and immunity to malaria, the most likely conclusion is that reduced exposure led 
to increasing susceptibility among older children and hence the subsequent increase in MPF.   
Other potential explanations for increasing malaria admissions among older children could 
include increased prevalence of preferential ITN use among younger children rather than loss 
of immunity. However, multivariable models that accounted for personal ITN use showed that 
age, and the interaction between age and year, were independent predictors of malaria, 
indicating that the increasing MPF among older children was independent of variation in ITN 
use by age (Table 3.3 and Table 3.5). Furthermore, the difference in ITN use by age was modest 
(87% of children less than 1 year of age used ITNs compared with 78% of children between 1 
and 5 years of age). Other interventions to prevent malaria targeted at younger children that 
increased over time could produce a similar pattern, but there are no such interventions reported 
in the area. An increasing prevalence of outdoor biting might also preferentially affect older 
children. However, this would not explain the clear inverse correlations seen between MPF and 
average age over time and by geographical region, which suggests that immunity is an important 
component of the variation in MPF. In the absence of host immunity older children may be at 
higher risk than younger children since mosquito biting may be proportional to surface area 
(Smith et al. 2004). However, MPFs do not necessarily reflect incidence. For instance, the risk 
of non-malarial fever falls as children get older which would lead to an apparent increase in 
MPF. 
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The scale-up in ITN use occurred in 2006, and therefore is not related to the reductions in 
transmission seen from 2000 onwards: changing anti-malarial drug use and rainfall may be 
relevant (Snow et al. 2015). Regardless of the cause of the prior decline, I found clear evidence 
of ITN efficacy during the period in which they were used. Personal ITN use was associated 
with reduced MPF among children admitted to hospital. However, when multivariable models 
were examined it was the prevalence of ITN use in the 2km radius area around a child that 
independently reduced the probability of a malaria positive slide, regardless of personal use. 
Hence it is likely that the resurgence in malaria seen since 2009 would have been even more 
marked in the absence of ITNs.  
The WHO and Kenyan national policy recommend universal ITN coverage to control malaria. 
However, operational constraints often do not allow this and so instead many distribution 
programmes target younger children and pregnant women as high risk groups. Our data suggest 
that universal coverage should be a high priority since a) older children are increasingly in need 
of protection as transmission falls and b) the mass-protective effect would achieve substantial 
gains in malaria control above those achieved by personal ITN use.  
ITN use was lowest among adolescents and young adults (Figure 3.9). The low ITN use among 
10-15-year-old adolescent girls is a cause of concern as they transition to young mothers 
(primigravidae). Primigravidae are at a particular risk of severe malaria and are at a higher risk 
of stillbirth, miscarriage, preterm delivery low birthweight and increased infant mortality when 
exposed to malaria (Brabin 1983, Guyatt and Snow 2001, Conroy et al. 2012). First pregnancies 
(primigravidae) are at the highest risk of infection and adverse pregnancy outcomes because of 
lack immunity to 'pregnancy-specific' variants of Plasmodium falciparum that selectively 
accumulate in the placental intervillous space leading to placental and occult placental malaria 
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that may not always be associated with detectable blood-stage infection (Conroy et al. 2012). 
Community engagement and sensitization targeting this age groups should be conducted to 
enhance coverage. 
Fortunately, there was no strong evidence of an increasing case fatality rate as transmission fell 
(Figure 3.5D). The risk of mortality from severe malaria increases in older age-groups across 
the range from children to adults (Dondorp et al. 2008) but this increase may be less evident 
within the age range of children below 10 years of age (Marsh et al. 1995, von Seidlein et al. 
2012b). Furthermore, many other factors influence mortality over time, including variation in 
hospital acceptance over time, access to care (due to improved road network), better care 
(Dondorp et al. 2010, Maitland et al. 2011) and socioeconomic conditions. My data do not 
suggest that increasing mortality is an immediate concern of the post-decline period despite the 
increasing rates of malaria in older children. 
Study limitations include the use of MPF among acute admissions which may be biased by 
varying access to care. In support of the use of MPF, there was a close correlation between 
location-matched MPFs with the incidence rates from active case detection data from two cohort 
studies conducted within the same study area. Furthermore, geographic heterogeneity was larger 
than any consistent bias in MPF with distance to the hospital (Figure 3.4), agreeing with 
previous work (Bejon et al. 2014).  
The analyses were based on the proportion of children with positive malaria slides. This case 
definition includes children with chronic asymptomatic parasitaemia and coincident fever. To 
exclude a bias resulting from including these children I repeated the analysis after applying a 
threshold of >2,500 parasites per µl, which excludes the majority of children with asymptomatic 
parasitaemia (Bejon et al. 2007) (Figure 3.14 and 3.15). 
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The ITN use surveys were conducted annually and based on reported rather than observed use.  
The potential misclassification of this approach could lead to an underestimate of the protective 
effect of ITNs. During the study period, there were no other widespread interventions such as 
anti-malarial prophylaxis or presumptive treatment that were targeted at younger children. ITN 
use has not been randomly assigned and therefore confounding could be present. If present, this 
would most likely dilute the effect size (i.e. ITN use would be better taken up in areas of higher 
malaria risk). Furthermore, observational studies of ITN use have consistently shown similar 
findings to randomized controlled Trials (RCTs) suggesting that within specific communities 
confounding is not pronounced (Lim et al. 2011). 
Our data were taken from a single geographical setting. However, there is evidence that 
immunity to malaria is dependent on exposure in a wide range of geographical settings (Okiro 
et al. 2009) and therefore our findings may be relevant more widely across Africa in settings 
where transmission is falling (O'Meara et al. 2010).  
In conclusion, I show that despite substantial reductions in malaria transmission in Kilifi, 
residual malaria transmission has continued and older children are increasingly vulnerable to 
disease. As countries and regions make progress in malaria control (Noor et al. 2014), 
maintaining control measures will be essential: in fact, further progress will be required to offset 
the increasing rates of malaria in older children. Achieving ITN coverage close to 100% shows 
promise as a strategy, but will require novel strategies, particularly among groups that seem less 
keen to use ITNs such as adolescent males and young adults (Noor et al. 2009b). 
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Chapter Four 
4 Effect of transmission intensity on hotspots and micro-epidemiology of 
malaria in sub-Saharan Africa 
4.1 Introduction 
In chapter 3 above I demonstrated that heterogeneity of malaria transmission increases with 
decreasing transmission intensity. This concept has been previously derived using mathematical 
models but little empirical evidence is available.  
Here I sought to provide further empirical evidence on the trends in micro-heterogeneity of 
malaria transmission using a large assembled set of data from studies conducted in sub-Saharan 
Africa on a) acute symptomatic malaria (detected through active and/or passive case detection 
or cross-sectional surveys) and b) prevalence of parasitaemia detected through cross-sectional 
surveys (Mogeni et al. 2017a).  
4.2 Objectives 
I used data drawn from 19 different study sites across 7 sub-Saharan African countries, 
representing a range of transmission intensities from intense transmission in Burkina Faso 
(Tiono et al. 2013) to low transmission in The Gambia and the Northern part of Kilifi, Kenya 
(Mogeni et al. 2016) to :-  
1. Describe trends in parameters describing local clustering (or hotspots) and in global 
measures of spatial autocorrelation of malaria cases at varying transmission intensities. 
2. Compare temporal stability of malaria hotspots 
3. Examine the association between micro-variations in mean age of symptomatic malaria 
(as a proxy for exposure/acquired immunity) and the MPF across the sites. 
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4.3 Methods 
4.3.1 Multisite data collation from centers in sub-Saharan Africa 
A group of researchers interested in malaria hotspots work were approached to participate in 
forming a group (The Hotspot Group) and make available homestead level geocoded datasets 
with the aim of assessing the properties of malaria hotspots in sub-Saharan Africa. An email 
invitation was sent to the Hotspots Group members inviting them to make available data on 
asymptomatic parasitaemia or febrile malaria surveillance or both and including age of study 
participants and homestead level GPS co-ordinates for any length of monitoring. All the 
investigators contributing data were assured of being listed in any resulting manuscript(s) and 
their contribution acknowledged. 
 To identify studies assessing microepidemiology of malaria transmission, a search was 
conducted in PubMed on the geographical heterogeneity of malaria transmission, variability of 
malaria risk by age and stability of hotspots using MeSH terms “Childhood” “Malaria” 
(“Heterogeneity” OR “Heterogeneous” OR “Variability” OR “Variation” OR “Hotspots”) and 
“Age”. Several previous studies assessed the properties of hotspots of malaria transmission in 
single sites. Few studies examined stability of hotspots and only one study investigated the 
efficacy of targeting control interventions on hotspots of malaria transmission. There were no 
previous studies examining the properties of hotspots across multiple sites. 
Studies that used microscopy for detection of malaria parasites, performed clinical assessments 
for presence or absence of fever, reported homestead level geospatial coordinates and age of 
study participants were included in the analyses. For cluster-randomised or individual-
randomised controlled trials, data from intervention and control arms were analysed separately. 
Datasets were then further subdivided by year before analysis for spatial clustering. Only studies 
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where Ethical approval and consent for human participation had been granted by authorities of 
the participating countries were reported. In the Kilifi sites, approval for human participation in 
cross-sectional surveys, cohorts and hospital surveillance was given by the Kenya Medical 
Research Institute Ethics Research Committee. Prior to any study procedure, written informed 
consent was obtained from all individuals participating in the surveys or, where appropriate, 
their parents or guardians. The studies were conducted per the principles of the declaration of 
Helsinki. 
 
4.3.2 Data  
Data were assembled from studies conducted in sub-Saharan Africa (Figure 4.1, Table 4.1) with 
homestead-level geospatial records linked to malaria surveillance at sites with varying 
transmission intensities. Data were shared with no personal identifiers except geospatial 
coordinates. 
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Figure 4.1: Map of sub-Saharan Africa showing countries and their respective number of 
studies included in the analysis 
4.3.3 Malaria case definition 
Symptomatic malaria and asymptomatic parasitaemia were classified per the definitions shown 
in Table 4.1. The key metrics were P. falciparum parasite prevalence (i.e. the proportion of 
asymptomatic parasite carriage from community cross-sectional surveys), malaria positive 
fraction (MPF; defined as the fraction of symptomatic malaria) and mean age of children 
presenting with symptomatic malaria.  
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Table 4.1: Study characteristics 
 
 
Location Study description 
 
 
Sample 
size (N) 
 
Malaria case definition 
(symptomatic malaria) 
 
 
MPF 
 
Asymptomatic 
parasitaemia 
assessed? 
 
Parasite 
Prevalence 
(%) 
Kilifi Kenya 
(Bejon et al. 
2014) 
Ngerenya Dispensary Surveillance; 
monitoring was conducted from 1st April 
2014 to 31st December 2015 
 
1998 
Any presentation with 
parasitaemia 
 
0.048 No 
 
 
Not applicable 
Kilifi Kenya 
(Bejon et al. 
2010) 
Junju cohort, monitored between 1st January 
2005 and 31st December 2015 
 
4534 Temperature >37.5 oC 
and parasitaemia 
>2500/µL 
0.376 No 
 
 
Not applicable 
Kilifi Kenya 
(Bejon et al. 
2010) 
Ngerenya cohort, monitored between 1st 
January 2003 and 31st December 2015 
 
3659 Temperature >37.5 oC 
and parasitaemia 
>2500/µL 
0.043 No 
 
 
Not applicable 
Kilifi Kenya 
(Kangoye et 
al. 2016) 
Ganze RTSS cross-sectional surveys of 
asymptomatic parasitaemia and a study 
cohort monitored for clinical episodes in 
2012 and 2013 
 
2532 
1518* 
 
Temperature >37.5 oC 
and parasitaemia 
>2500/µL 
 
0.053 Yes 
 
 
 
1.25 
Kilifi Kenya 
(Bejon et al. 
2014) 
Pingilikani Dispensary Surveillance; 
monitoring was conducted from 1st January 
2009 to 31st December 2014. Each year’s 
data were analysed separately to capture 
temporal trend in transmission intensity 
 
 
22595 
 
Temperature >37.5 oC 
and parasitaemia 
>2500/µL 
 
0.243 
 
No 
 
 
 
 
Not applicable 
Kilifi Kenya 
(Mogeni et 
al. 2016) 
Kilifi County Hospital Surveillance; 
monitoring conducted from 1st January 
2009 to 31st December 2014. Each year’s 
data were analysed separately to capture 
temporal trends in transmission intensity 
 
 
8707 
 
 
Any slide positive test 
result among acute 
admissions 
 
 
0.171 
No 
 
 
 
 
 
Not applicable 
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Kilifi, 
Kenya 
(Bejon et al. 
2007) 
Junju cross-sectional bleeds between 2011 
and 2015, each year’s data were analysed 
separately to capture temporal trends in 
transmission intensity 
 
1925 
 
Not applicable 
 
_ Yes 
 
 
 
16.05 
Nandi, 
Western 
Kenya 
(Brooker et 
al. 2004) 
10-week active case surveillance study 
undertaken in three schools in Nandi 
District, Western Kenya during a malaria 
outbreak May to July 2002 
 
520 
 
Temperature >37.5 oC 
and parasitaemia 
>2500/µL 
 
0.242 
No 
 
 
 
Not applicable 
Western 
Kenya 
(Ernst et al. 
2006) 
Hospital surveillance study conducted 
between 2001 - 2004.  
 
599 Temperature >37.5 oC 
and parasitaemia 
>2500/µL 
0.084 
No 
 
 
Not applicable 
Asembo, 
Western 
Kenya 
(Lindblade 
et al. 2004) 
 
 
In late 1996, villages in Asembo were 
randomized into intervention and control 
villages. Cross-sectional surveys were 
conducted between 1996 and 2001. Data 
from symptomatic and asymptomatic 
individuals were analysed separately and by 
year of enrollment.  
 
3614 
3047* 
 
Measured axillary 
temperature >37.5 oC 
and parasitaemia 
>2500/µL 
 
0.659 Yes 
 
 
 
 
 
 
61.9 
Rural 
Afigya-
Sekyere, 
Ghana 
(Kreuels et 
al. 2008) 
Cohort of infants monitored by monthly 
active case detection and passive case 
detection. Enrolled at 3 months (±4 weeks) 
of age between January 2003 and 
September 2005. Treatment and placebo 
arms were analyzed separately.  
 
 
2721 
 
 
Temperature >37.5 oC 
and parasitaemia 
>500/µL 
 
 
0.413 
 
 
No 
 
 
 
 
 
 
Not applicable 
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Mulanda, 
Eastern 
Uganda 
(Pullan et 
al. 2010) 
Cross -sectional study conducted in four 
contiguous villages in Mulanda, sub-county 
in Tororo, Eastern Uganda between July 
and December 2008. age 
985 Not applicable _ 
 
Yes 
 
 
53.7 
Uganda 
(Kamya et 
al. 2015) 
Cohort study of three Uganda sub-counties 
(Nagongera, Walukuba and Kihihi) 
between 2011 and 2014 
3239 Temperature >37.5 oC 
and parasitaemia 
>2500/µL 
0.331 No 
 
 
Not applicable 
The Gambia 
(Hennig et 
al. 2015) 
Cohort study of four Gambian villages 
(Keneba, Manduar, Jali and Kantong 
Kunda) between 2009 and 2012 
 
3117 
Temperature >37.5 oC 
and parasitaemia 
>2500/µL 
0.024 No 
 
 
Not applicable 
Mali 
(Sissoko et 
al. 2015) 
Cross-sectional surveys were conducted 
during the wet and dry seasons and passive 
case detection in two villages in Mali were 
conducted between May (Kolle) or July 
(Sotuba) and December 2009 
 
1867 
1128* 
 
Temperature >37.5 oC 
and parasitaemia 
>2500/µL 
 
0.424 Yes 
 
 
 
 
15.61 
Mali 
(Crompton 
et al. 2008) 
Longitudinal study conducted between May 
and December 2006. Analysis was 
restricted to children aged 2-15 years 
 
 
695 
695* 
Temperature >37.5 oC 
and parasitaemia 
>2500/µL 
0.51 
Yes 
 
 
 
 21.75 
Tanzania 
(Mosha et 
al. 2013) 
Cross sectional survey conducted between 
August and November 2010 in northern 
Tanzania. Analysis was restricted to 
children <15 years 
 
328 
 
Not applicable 
 
- Yes 
 
 
 
52.23 
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Northern 
Tanzania 
(Gosling et 
al. 2009) 
The study was conducted between July 
2004 and July 2007. Infants aged 2-4 
months randomized to treatment regimens. 
Treatment and placebo arms were analyzed 
separately. 
 
2300 
Temperature >37.5oC 
and parasitaemia 
>2500/µL 
 
0.161 No 
 
 
 
 
Not applicable 
Saponé 
district, 
Burkina 
Faso (Tiono 
et al. 2013) 
Cluster-randomized study with treatment 
and control arms. Four cross-sectional 
surveys were conducted between January 
2011 and January 2012: a) before 
randomization, b) 1 month, c) 2 months and 
d) 12 months. Monitoring for symptomatic 
malaria was conducted passively at local 
health care facilities during the same study 
Period. Treatment and placebo arms were 
analyzed separately. 
 
4045  
11932* 
 
 
Temperature >37.5 oC 
and parasitaemia 
>2500/µL 
 
0.707 Yes 
 
 
 
 
 
 
 
 
 
31.32 
* Shows sample size for asymptomatic parasitaemia studies when both symptomatic and asymptomatic datasets were available 
for analysis 
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4.3.4 Statistical methods 
Data from each site were used to quantify spatial clustering of malaria (described in detail 
above). The various metrics from each site were pooled together to examine systematic variation 
in metrics of spatial clustering over transmission intensity using site as the unit of analysis. 
Observations with missing geo-coordinates, age and malaria slide results in any of the requested 
datasets were excluded prior to the analysis. No data imputation was done at any analysis stage. 
4.3.5 Local cluster detection 
The spatial scan statistic (details are discussed in chapter 2) was used to detect local spatial 
clusters of asymptomatic carriers and/or symptomatic malaria cases using a Bernoulli model. 
Cases were individuals with malaria and controls were individuals without malaria. I assessed 
variation in the number of hotspots per study site, the risk ratio (RR) of the most likely (primary) 
hotspot (i.e. the ratio of the risk of malaria within the hotspot divided by the risk outside the 
hotspot) and the p-value of the primary hotspot over transmission intensity.  
4.3.6 Global spatial pattern analysis 
Ripley’s K-function was used to analyse binary data and Moran’s I for the analysis of the age 
of children with clinical malaria as a measure of acquired clinical immunity. The K-function 
and the Moran’s I methodology have been described in detail in chapter 2. Key parameters of 
interest from this analysis were the estimate of the D-function, the spatial autocorrelation 
coefficients and measures of significance. Sensitivity analysis was conducted at various 
predefined distances. 
Symptomatic malaria cases and asymptomatic parasitaemia were examined separately. For each 
dataset, parameters from the local cluster detection and from the D-function analyses were 
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assessed against the overall transmission intensity measured by the MPF for datasets on 
symptomatic malaria or parasite prevalence for datasets on asymptomatic parasitaemia. 
Multiple fractional polynomials to assess nonlinear fits of MPF or parasite prevalence on the 
hotspots parameters (i.e. number of hotspots, risk ratios, and p-values) in the regression models 
adjusted for potential confounders (i.e. study design, sample size and overall mean age of study 
participants included in each study).  
4.3.7 Temporal stability of hotspots analysis 
There were few datasets with repeated sampling of overlapping homesteads, and therefore 
stability of spatial heterogeneity could only be tested in 4 datasets from western Kenya (Hawley 
et al. 2003), Ghana (Kreuels et al. 2008), Burkina Faso (Tiono et al. 2013) and Uganda (Kamya 
et al. 2015). MPFs and/or parasite prevalence were computed by grids (2x2km square) and by 
year (or time points for cross-sectional surveys). I assessed stability of the spatial heterogeneity 
by examining correlation between MPFs or parasite prevalence within grids separated in time. 
4.3.8 Correlation between age of clinical malaria and transmission intensity 
The average age of children with malaria was computed as the geometric mean age of children 
presenting with symptomatic malaria. The correlation between the average age of symptomatic 
malaria and MPF at predefined square grid sizes (i.e. 1km2, 2km2 and 4km2) were calculated 
using the Spearman’s rank correlation coefficient. Variable grid sizes were used for sensitivity 
analysis and were calculated using longitude and latitude coordinates. Pooled correlations for 
the predefined grid size were estimated in a fixed effect meta-analysis, however if heterogeneity 
(I2) between studies was large (>50%), a random-effect meta-analysis was conducted (details 
on meta-analyses are discussed in chapter 2). Global spatial autocorrelation for age of 
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symptomatic malaria at homestead level within sites was assessed using Moran’s I statistic and 
the significance determined using Monte Carlo simulations. 
SaTscan was executed from R using rsatscan package which allows SaTscan to be executed in 
the background from R’s command line. The K-function and the Moran’s I statistics were 
executed in R version 3.3.1, and graphs, meta-analyses, multiple fractional polynomial 
procedure and other analyses were conducted in Stata version 12 (StataCorp, Texas). 
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4.4 Results 
4.4.1 Malaria morbidity in the study sites 
Nineteen studies conducted between 1996 and 2015 in seven countries were examined (Figure 
4.1). The characteristics of each study population are presented in Table 4.1 with references to 
previously published work. 
4.4.2 Hotspots of malaria cases 
Data from cross-sectional surveys in Asembo western Kenya, were analysed from 79 villages 
randomized to receive insecticide-treated bednets. In this high transmission site (overall, 
MPF=0.66 and parasite prevalence=61.9%), hotspots of malaria transmission were identified in 
both asymptomatic and symptomatic datasets, but the significance was borderline and the risk 
ratio slightly higher than 1. Figure 4.2 and Figure 4.3 illustrates hotspots of febrile malaria and 
hotspots of asymptomatic parasitaemia respectively for homesteads in the control group. 
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Figure 4.2: Hotspots of asymptomatic parasitaemia cases (control arm) in Asembo western 
Kenya. 
Black and green circle represent statistically significant primary and secondary hotspots 
respectively with their relative risk (RR) and p value displayed beside the circles. 
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Figure 4.3: Hotspots of clinical malaria cases (control arm) in Asembo western Kenya. 
Black and green circles represent statistically significant primary and secondary hotspots 
respectively with their relative risk (RR) and p value displayed beside the circles. 
Data from Sapone, Burkina Faso were analyzed from 1550 homesteads in 18 villages. Overall 
there were 6,848 (56.8%) episodes of febrile malaria recorded during the 12-month passive 
surveillance and 8,346 (25.7%) episodes of microscopically confirmed asymptomatic infections 
recorded during the four survey time points over the 12-month period. Hotspots of malaria 
transmission were identified in both asymptomatic and symptomatic datasets for both the 
treatment and control group. However, the significance (as illustrated by the p-values) ranged 
between borderline to no significance and the risk ratio were close to 1. Figure 4.4 below 
illustrates hotspots of febrile malaria during the months coinciding with the 4-asymptomatic 
malaria survey time points. 
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Figure 4.4: Hotspots of clinical malaria cases (control arm) in Burkina Faso. 
Each black circle represents a statistically significant hotspot with its relative risk (RR) and p 
value displayed beside the circle. 
In the low transmission settings in Kilifi and The Gambia, significant hotspots were observed 
in Ganze Kilifi county (overall MPF=0.05) but not in The Gambian villages (overall 
MPF=0.024). In contrast with the high transmission settings in Asembo and Burkina Faso 
(Figure 4.2 - Figure 4.4), the risk ratios were markedly different from 1 (Figure 4.5 and Figure 
4.6). 
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Figure 4.5: Hotspots of clinical malaria cases by village in The Gambia. 
 Each black circle represents a statistically significant hotspot with its relative risk (RR) and p 
value displayed beside the circle. 
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Figure 4.6: Hotspots of clinical malaria cases in Ganze Kilifi County. 
Each blue circle represents a statistically significant hotspot with its relative risk (RR) and p 
value displayed beside the circle (Kangoye et al. 2016). 
4.4.3 Trends in parameters describing hotspots and clustering of malaria cases 
The median number of significant hotspots for the datasets was 1 and there was no clear trend 
over transmission intensity (Figure 4.7A). However, the risk ratios for primary hotspots were 
highest at low MPFs (Figure 4.7B) and decreased with increasing MPF. The statistical 
significance of hotspots was lower at very low MPFs, then increased with increasing MPF to a 
peak at an MPF of ~0.3, and then gradually decreased with increasing MPF after MPF >0.3 
(Figure 4.7C).  
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Figure 4.7: Hotspots of symptomatic parasitaemia. 
Panel A displays a scatter plot of the number of significant hotspots per study area against 
malaria positive fraction, panel B shows the Log risk ratios of malaria within the primary 
hotspot against the malaria positive fraction and panel C shows the –Log (P-values) of the 
primary hotspots against malaria positive fraction. The blue line in A, B and C show the fitted 
multiple fractional polynomial model predictions after adjusting for study design and the overall 
age of study participants. Shaded areas in panels A, B and C represent 95% CIs. 
Although the average age of children in the dataset was significantly associated with the RR and 
p-values (Figure 4.8), analyses adjusted for average age of children in the dataset (Figure 4.7A, 
4.7B and 4.7C) and analyses stratified by study design (i.e. passive vs active case detection) 
showed a similar trend in variation of RR over transmission intensity (Figure 4.9).  
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Figure 4.8: Trends in parameters of primary hotspots over mean age of study participants. 
Panel A shows a scatter plot of log transformed risk ratios against overall mean age. Panel B 
shows a scatter plot of log transformed P-values against overall mean age. The green line 
presents multiple fractional polynomial fits of age on MPF adjusted for the study design. Shaded 
areas in panels A, B and C represent 95% CIs. 
 
Figure 4.9: Summary of malaria hotspots from symptomatic parasitemia among passive 
(blue) and active (red) surveillance studies. 
Panel A shows a scatter plot of the no of significant hotspots against malaria positive fraction, 
panel B presents the Log risk ratios of malaria within the primary hotspot against the malaria 
positive fraction and panel C presents the –log P-values of the primary hotspots against malaria 
positive fraction. The blue and red lines in panels A, B and C show the fitted multiple fractional 
polynomial model predictions for passive and active case detection studies respectively. Shaded 
areas in panels A, B and C represent 95% CIs. 
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While there were fewer studies that included data on asymptomatic parasitaemia, a similar trend 
for risk ratios with increasing parasite prevalence was observed, but without a clear trend for p-
values (Figure 4.10). Fractional polynomial transformations significantly improved model fits 
(Table 4.2). 
Table 4.2 : Comparison between linear and the multiple fractional polynomial model fit. 
The P-value shown are derived from the log-likelihood ratio test for a nested model with a 
fractional polynomial over the linear fit model. 
Hotspots 
Parameter Figure 
Best fit fractional polynomial 
transformations 
Deviance 
difference 
P-
value Adjusted R2 
Number of 
hotspots Fig 2A MPF__1 = MPF^3 - 0.02058 9.181 0.04 0.1589 
Log risk Ratio Fig 2B 
MPF__1 = MPF - 0.27406 
MPF__2 = MPF^2 - 0.07511 17.486 0.001 0.7382 
- log P-value Fig 2C 
MPF__1 =MPF^0.5 - 0.5235 
MPF__2 = MPF- 0.27406 11.667 0.015 0.2792 
*MPF refers to Malaria Positive Fraction and MPF__1 and MPF__2 are the fractional polynomial 
transformations for MPF. 
 
 
Figure 4.10: Hotspots of asymptomatic parasitaemia. 
Panel A displays a scatter plot of the number of significant hotspots in each study dataset against 
parasite prevalence, panel B presents the Log risk ratios of malaria within the primary hotspot 
against the parasite prevalence and panel C displays the –Log (P-values) of the primary 
hotspots against parasite prevalence. The blue lines in panels A, B and C show the fitted multiple 
fractional polynomial model predictions. Shaded areas in panels A, B and C represent 95% CIs. 
 
 
125 | P a g e  
 
Using the modelled relationship between PfPR and the reproduction number (R0) reported by 
Smith et al (Smith et al. 2006), I determined the ratios of R0 inside and outside hotspots, and 
plotted these against PfPR (Figure 4.11). The ratio of R0 inside to R0 outside rose steeply below 
a parasite prevalence of 10%.  
 
Figure 4.11: Scatter plot of the ratio of log transformed R0 inside to outside the hotspot plotted 
against parasite prevalence. 
The blue line shows the fitted multiple fractional polynomial model predictions and the shaded 
areas represents 95% CIs. 
4.4.4 Spatial autocorrelation 
Ripley’s difference in k-function (i.e. the D-function) indicated significant spatial structure in 
many but not all sites (Figure 4.12). As seen with hotspots, the proportion of sites that had 
significant spatial structure increased from the lowest MPFs to a peak at MPFs of 0.15 - 0.45, 
and then declined at higher MPFs. This trend was consistent at the various spatial scales 
examined (Figure 4.12). The magnitude of the D function decreased with increasing MPF and 
was consistent at various spatial scales (Figure 4.13). 
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Figure 4.12: Clustering of malaria transmission. 
Panels A, B, C, D, E, F, G, and H shows the proportion of datasets with significant clustering 
at homestead level, 0·5, 1, 1·5, 2, 3, 4, and 5-kilometer level respectively, against malaria 
positive fraction. 
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Figure 4.13: Difference in K-functions for cases and controls (D-function) against malaria 
positive fraction. 
Panels A, B, C, D, E, F, G, and H show the D-function at homestead level, 0·5, 1, 1·5, 2, 3, 4 
and 5 kilometer distances for each dataset. The blue dots represent symptomatic parasitaemia 
datasets while red represents asymptomatic parasitaemia datasets.  
4.4.5 Temporal trends 
Overall, the spatial distribution of asymptomatic parasitaemia showed modest temporal stability 
in the Asembo and Burkina Faso sites (Table 4.3). On the other hand, the spatial distribution of 
febrile malaria was predictive of febrile malaria over one and two years in Uganda, but not in 
the other sites.  
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Table 4.3: Association between distribution of MPF within grids (size= 2x2 km2) over time 
interval  
 (Asembo Bay, Kenya (Hawley et al. 2003), sub-counties of Uganda (Kamya et al. 2015) and 
Afigya-Sekyere Ghana (Kreuels et al. 2008)) in years and over consecutive cross-sectional 
surveys conducted over a span of one year (Saponé district, Burkina Faso (Tiono et al. 2013)). 
 
Study 
Site 
Interval between 
cluster (year) 
Febrile Malaria  Asymptomatic Parasitaemia 
Correlation 
(95%CI) P-value 
Correlation 
(95%CI) P-value 
Asembo 
Bay 
  
1 -0.09 (-0.26 - 0.09) 0.3072 0.23 (0.08 - 0.36) 0.003 
2 0.14 (-0.04 - 0.31) 0.1245 0.16 (0.01 - 0.31) 0.0433 
3 0.16 (-0.08 - 0.38) 0.1873 0.02(-0.18 - 0.22) 0.8512 
4 0.45 (0.11 - 0.70) 0.0124 0.21 (-0.12 - 0.49) 0.2041 
5 0.06 (-0.32 - 0.43) 0.7726 0.45 (-0.13 - 0.80) 0.1226 
  
Burkina 
Faso 
  
Interval between 
cluster (Survey)         
1 -0.07 (-0.21 - 0.08) 0.3667 0.24 (0.10 - 0.36) <0.001 
2 0.06 (-0.13 - 0.24) 0.5359 -0.09 (-0.25 - 0.08) 0.293 
3 0.27 (0.01 - 0.50) 0.0457 0.34 (0.11 - 0.53) 0.0043 
 
Uganda 
 
Interval between 
cluster (year)         
1 0.39 (0.27 - 0.50) <0.001 _ _ 
2 0.29 (0.13 - 0.44) 0.001 _ _ 
3 0.19 (-0.06 - 0.41) 0.1332 _ _ 
Ghana  
 
Interval between 
cluster (year)         
1 0.26 (-0.03 - 0.51) 0.0756 _ _ 
2 0.30 (-0.14 - 0.64) 0.1757 _ _ 
      
 
4.4.6 Average age of symptomatic malaria episodes and correlations with MPF 
Spearman’s rank correlation coefficients of MPF against average age of symptomatic children 
with malaria at various spatial scales (i.e. 1km2, 2km2 and 4km2 grids) were negative in most 
study datasets. This suggests that patches of greater exposure to malaria (i.e. high MPF) were 
associated with younger children presenting with malaria parasites in their blood and vice versa 
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(Figure 4.14, Figure 4.15 and Figure 4.16). The pooled estimates increased with increasing grid 
size agreeing with previous findings (Bejon et al. 2014). 
 
Figure 4.14: Forest plot showing the correlation (Rho) between MPF and age of symptomatic 
malaria at a 1x1 km grid size. 
The pooled estimate from the random-effects meta-analysis is labeled “Overall”. 
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Figure 4.15: Forest plot showing the correlation (Rho) between MPF and age of symptomatic 
malaria at a 2x2 km grid size. 
The pooled estimate from the random-effects meta-analysis is labeled “Overall”. 
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Figure 4.16: Forest plot showing the correlation (Rho) between MPF and age of symptomatic 
malaria at a 4x4 km grid size. 
The pooled estimate from the random-effects meta-analysis is labeled “Overall”. 
Significant moderate heterogeneity was observed between studies at the 1x1 and 2x2 Km square 
spatial grid but not at a 4x4 grid size. The funnel plot resembled a symmetric funnel for the 1x1 
km grid (Figure 4.17 A) but not for the 2x2 and 4x4 km grid sizes (Figure 4.17 B and C). 
However, it should be noted that some datasets included in Figure 4.17 A, could not be included 
in Figure 4.17 B and C due to the size of the study area not permitting >10 grid sizes that could 
enable the computation of correlations when lager grids were used. 
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Figure 4.17: Funnel plot with pseudo 95% confidence limits. 
Panels A, B and C show the funnel plots of individual study standard errors plotted against the 
correlation between the mean age of clinical malaria and MPF at prespecified spatial grids. 
 
These negative associations tended to be more marked where the average MPF at the site was 
low, and this trend was statistically significant when the correlations were measured using 2km2 
grids (i.e. p=0.04) but not at 1km2 or 4km2 grids (Figure 4.18 A, B and C). The pooled 
correlation between MPF and slide positive age for 1x1, 2x2 and 4x4 kilometer spatial resolution 
was -0.07 (95% CI -0.14 to 0.00), -0.21 (95% CI -0.31 to -0.11) and -0.27 (95% CI -0.37 to -
0.18) respectively and were in the same direction. The test of heterogeneity between studies was 
I2=55.9%, p=0.002; I2=53.5%, p=0.005; and I2=31.6%, p=0.104 respectively. 
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Figure 4.18: Fine-scale geographical correlation of mean age (months) against malaria 
positive fraction (MPF) for each study dataset plotted against overall study MPFs (as a proxy 
for transmission intensity). 
Panels A, B and C show 1x1, 2x2, and 4x4 km2 grid respectively. The test of heterogeneity 
between studies was I2=55·9%, p=0·002; I2=53·5%, p=0·005 and I2=31·6%, p=0·104 
respectively. 
Furthermore, I observed significant spatial autocorrelation for the age of symptomatic malaria 
episodes at most sites (Figure 4.19), suggesting that there are focal areas where older individuals 
tend to be seen with symptomatic malaria, and conversely focal areas where younger individuals 
tend to be seen with symptomatic malaria. 
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Figure 4.19: Homestead level spatial autocorrelation of age in months for symptomatic 
individuals for the various studies. 
Red dots show significant autocorrelation while blue dots show non-significant spatial 
autocorrelation. 
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4.5 Discussion 
This chapter describes fine-scale spatial heterogeneity of P. falciparum malaria cases from 
studies conducted at 19 different sites experiencing varying transmission intensities in seven 
sub-Saharan African countries (Figure 4.1). The RR of the primary hotspots increased with 
falling MPF. The strength of evidence (as measured by p-values) increased from low MPFs to 
moderate MPFs and then declined towards high MPFs. Taking these findings on variation in 
degree of heterogeneity and on statistical significance of heterogeneity together, I conclude that 
spatial heterogeneity becomes gradually more marked as transmission intensity falls, albeit with 
statistical significance becoming weaker at very low transmission intensity because of reduced 
power due to small numbers of malaria cases. It may therefore be appropriate for malaria control 
programmes to target hotspots at low transmission intensity despite apparently modest statistical 
significance. The decline in the degree of spatial heterogeneity towards high MPF may be due 
to either more even distribution of transmission intensity per se, or to saturation in the metric 
used to quantify malaria exposure (i.e. the MPF). 
Similar findings were seen for generalized measures of spatial autocorrelation where the degree 
of spatial autocorrelation (D-functions) is shown to increase as MPF falls (Figure 4.13) with 
significance testing showing a peak when MPF is within 0.15-0.45 range (Figure 4.12). 
Hotspots of stable asymptomatic parasitaemia have previously been described in Kilifi, Kenya 
(Bejon et al. 2010). I could quantify the temporal stability of the spatial distribution in 4 datasets 
outside Kilifi (where these studies have previously been conducted (Hawley et al. 2003, Kreuels 
et al. 2008, Tiono et al. 2013)). This showed temporal instability, however, with 4 datasets I 
was unable to examine trends in stability across sites. An indirect approach to examining 
temporal stability is to look for evidence of spatial variation in clinical immunity. Micro-
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variation of malaria transmission is likely to lead to variations in the rate and degree of 
acquisition of clinical immunity if the micro-variation is sufficiently stable. Children acquire 
immunity against symptomatic malaria following repeated exposure. At high transmission 
intensity, children acquire immunity rapidly due to intense exposure when they are young and 
hence do not present with symptomatic malaria when they are older. On the other hand, at low 
transmission, children acquire immunity slowly and are more likely to present with symptomatic 
malaria when they are older (Snow et al. 1997). As might therefore be predicted, I observed a 
negative correlation between MPF and age of symptomatic malaria keeping with previously 
reported findings (Bejon et al. 2014, Mogeni et al. 2016), and is taken to imply that immunity 
is acquired more rapidly with greater exposure to malaria, leading to a lower average age of 
symptomatic malaria episodes. Furthermore, there were positive autocorrelations (i.e. 
significant values of Moran’s I) in the age of children with symptomatic malaria, again 
suggesting that micro-variation of transmission intensity may have led to variation in the degree 
of acquisition of clinical immunity. 
In the 4 datasets with longitudinal data, the temporal stability of the distribution of clinical 
malaria was lower than that seen in previous analyses in Kilifi and the highlands of Western 
Kenya (Ernst et al. 2006, Bejon et al. 2010). Furthermore, I identified substantial heterogeneity 
in the correlations between MPF and age of symptomatic malaria. Taking these findings 
together, I conclude that temporal stability of hotspots is not a reproducible feature of malaria 
transmission. I did not identify a strong trend of greater spatial stability at any range of MPF 
(Figure 4.18). 
Mathematical models suggest that targeting control interventions on hotspots results in a more 
marked decline in malaria compared to untargeted interventions with an equal amount of 
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resources (Bousema et al. 2012b). To implement such a strategy requires the accurate 
identification of hotspots and our data suggest that hotspots may not be temporally stable, and 
may be more difficult to accurately identify at high transmission. A previous attempt at targeting 
hotspots of malaria transmission in Rachuonyo – an area of moderate transmission intensity in 
western Kenya - achieved modest reductions in transmission inside the targeted hotspots, but no 
lasting reductions outside the targeted hotspots in a cluster-randomized control trial (Bousema 
et al. 2016). The authors suggested that the limited impact was at least partly explained by 
challenges in defining the geographical boundaries of transmission hotspots (Bousema et al. 
2016); our findings on temporal instability of hotspots would confirm difficulties in defining 
hotspots. 
Study limitations include the use of data collected using microscopy which is of limited 
sensitivity for parasitaemia. PCR has been shown to be more sensitive for parasitaemia, 
particularly in low transmission regions (Okell et al. 2012). This is unlikely to bias studies based 
on febrile malaria episodes since symptomatic malaria individuals usually have parasite 
densities well above the detection threshold for microscopy. However, submicroscopic 
infections among studies of asymptomatic parasitaemia may influence the stability of hotspots. 
Most studies included applied a threshold parasitaemia to define febrile malaria. The threshold 
reduces the likelihood that cases of asymptomatic parasitaemia with co-incident fever are non-
specifically included in febrile malaria cases (Mwangi et al. 2005, Bejon et al. 2007).  
The modifiable areal unit problem may lead to bias when an arbitrary grid size is used to 
aggregate data. I mitigated this problem by conducting a sensitivity analysis using grids with 
varying sizes (i.e. 1km, 2km and 4km squares). A further limitation is that detection of febrile 
malaria is influenced by study design, sample size and targeted age group, which was not 
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standardized across studies. However, I observed similar results even after adjusting for these 
potential confounders, and identified similar results for studies of febrile malaria and of 
asymptomatic parasitaemia.   
Most of the studies included were conducted in relatively high to moderate transmission settings 
or in low transmission settings following recent reductions in transmission. Areas that have 
historically experienced low transmission may be under-represented, and furthermore study 
sites were clustered within West and East Africa without representation of Central and Southern 
Africa. Only researchers interested in malaria hotspots were targeted to contribute data used in 
this study thus presenting a potential source of bias.    
 
4.6 Conclusions 
I found geographical micro-variation in malaria transmission within sites from across sub-
Saharan Africa at a variety of transmission intensities. Micro-variation was greater in low 
transmission settings, albeit with less statistical power to detect it where cases of malaria are 
few. The temporal instability of hotspots and the difficulties in defining hotspots (especially in 
higher transmission settings) will be a challenge to targeted control. However, given the 
predictability with which hotspots occur when transmission intensity is low (e.g. PfPR<10%), 
malaria control programmes should have a low threshold for responding to apparent clustering 
of cases. The ratio of R0 inside to R0 outside rose steeply below a parasite prevalence of 10%, 
suggesting that the potential to interrupt transmission by targeting hotspots increases below this 
prevalence. Many sub-Saharan African countries currently contend with high malaria 
transmission and based on recent evidence (Bousema et al. 2016), are unlikely to benefit 
 
 
139 | P a g e  
 
significantly from targeted control. However, some countries have witnessed substantial 
declines (such as, Zanzibar (Bhattarai et al. 2007), Swaziland (Kunene et al. 2011) among 
others) that warrant the implementation of targeted control to achieve elimination. Our data 
predicts that hotspots will be a marked feature of transmission in such settings. 
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Chapter Five 
5 Detecting malaria hotspots: a comparison of RDT, microscopy and 
polymerase chain reaction 
5.1 Introduction 
The efficacy of targeting hotspots of malaria transmission is likely to be higher if hotspots are 
detected accurately and their stability determined. I have shown in chapter 4 that the stability of 
hotspots may not be a generalizable property of malaria transmission. However, this potentially 
varies according to the diagnostic tools used to assess parasitaemia.  For instance, the lower 
densities detectable by PCR could lead to greater temporal stability of the heterogeneity 
detected. 
5.2 Objectives 
• To quantify the extent to which hotspots of malaria transmission detected by RDT and 
microscopy overlap geographically with those detected by PCR.  
• To examine the variability in temporal stability of hotspots identified by the three 
diagnostic tools.  
5.3 Method 
5.3.1 Ethics statement 
Approval for human participation in cross-sectional surveys was given by the Kenya Medical 
Research Institute Ethics Research Committee. Prior to any study procedure, written informed 
consent was obtained from all individuals participating in the surveys or, where appropriate, 
guardian/ parental consent was sought for children. The studies were conducted per the 
principles of the declaration of Helsinki. 
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5.3.2 Study sites 
I analysed data from annual cross-sectional surveys conducted within three separate cohort 
studies in Kilifi County on the Kenyan coast. The Junju cohort is located within the southern 
part of the Kilifi Health and Demographic Surveillance System (KHDSS) area (Figure 5.1) 
(Scott et al. 2012) and experiences perennially higher malaria transmission intensity (Mogeni et 
al. 2016) compared to the Ngerenya and Ganze cohorts which are located to the north.  
 
Figure 5.1: Map of Kilifi county showing the KHDSS area (shaded grey), and the homesteads 
where the studies were conducted. 
Annual surveillance of asymptomatic malaria in these cohorts has been described in detail 
elsewhere (Bejon et al. 2010, Kangoye et al. 2016). Briefly, in the Junju and Ngerenya cohorts, 
cross-sectional surveys were undertaken annually between 2007 and 2016 in Junju, and between 
2007 and 2014 in Ngerenya (Bejon et al. 2010). Surveys took place in April and May of each 
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year, just before the rainy season and all individuals recruited to the study cohorts were invited 
to participate by providing a blood sample for malaria diagnosis. In Ganze, two cross-sectional 
surveys were conducted, first, between July and September 2012, and second, between May and 
July 2013 (Kangoye et al. 2016). Global positioning system coordinates were linked to every 
homestead in each cohort.  
5.3.3 Laboratory procedures 
Presence of malaria parasites was examined using RDTs, microscopy and PCR by trained 
laboratory technicians and standardized across the sites. Blood samples were obtained from all 
children under 15 years of age whose consent to participate in the study had been obtained 
(Bejon et al. 2010, Kangoye et al. 2016). Children with fever (that is, axillary temperature 
>37.5oC) were referred for immediate assessment and treatment and not included in the survey 
data. Each sample collected was assessed for parasitaemia using RDT, microscopy and PCR in 
all sites. 
RDT analysis - The RDT used for the study is CareStart Malaria test manufactured by 
AccessBio Inc. RDTs detect the presence of P. falciparum histidine-rich protein 2 (HRP2) and 
P. falciparum lactate dehydrogenase (PLDH) in the blood. RDT stocks were stored in an air-
conditioned room with monitored temperature and humidity. Quality assurance for the stored 
test kits was conducted regularly before use by trained laboratory technicians. 
Microscopy analysis - Thick and thin blood smears were Giemsa stained and examined using 
light microscopy at 1,000x magnification for malaria parasites and malaria species respectively. 
Malaria infection and parasite counts by microscopy were determined independently by two 
readers and discordant readings resolved by a third reader. The number of parasites/200 white 
blood cells (WBCs) was counted and parasite density per microliter of blood calculated using 
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an average count of 8000 WBCs/µl of blood as described elsewhere (Mwangi et al. 2005) and 
reported by species (that is; P. falciparum, P. malariae and P. ovale).  
 PCR analysis - DNA was first extracted from 30 µl of whole blood using QIAxtractor machine 
(QIAGEN, Hilden, Germany). The DNA was eluted in 100 µl from which 5 µl of DNA was 
amplified by quantitative PCR. This was done using a TaqMan® assay for the P. falciparum 
multicopy 18S ribosomal RNA genes as described elsewhere (Hermsen et al. 2001), except that  
a modified probe (5′-FAM-AACAATTGGAGGGCAAG-NFQ-MGB-3′) as described 
elsewhere (Sheehy et al. 2012) was used. An Applied Biosystems 7500 Real-Time PCR System 
with quantification by Applied Biosystems 7500 software v2.0.6 was used. Samples were 
analysed in singlet wells. Three negative control wells and 7 serial dilutions of DNA extracted 
from in vitro parasite cultures were included as standards on each plate in triplicate (Ogwang et 
al. 2015). Plates failing quality control standards were repeated. The lower limit of accurate 
quantification of this method is 10 parasites/mL within the PCR elute, and by assessing 1/20th 
of 30 µl with a gene target present on 3 chromosomes have a theoretical limitation of 4.5 parasite 
per µl of whole blood, compared with a sensitivity of 50 parasites per µl for thick blood films.  
Laboratory technologists assessing malaria using each given diagnostic tool were blinded to the 
results of the other diagnostic tools. RDT, microscopy and PCR standards were monitored 
through a quality assurance scheme that included comprehensive training during induction and 
at regular intervals during the study period. Microscopy quality assurance was evaluated using 
external quality control slides. 
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5.3.4 Geographical cluster analysis 
Individuals who had complete data on RDT, PCR and microscopy were included in the analysis. 
Hotspots are defined as geographical areas experiencing significantly higher prevalence of 
asymptomatic parasitaemia than would be expected by chance. In this study, I assess chance 
using the spatial scan statistic (Kulldorff 1997) through the Bernoulli model in SaTScanTM 
software v9.4.1 as described in the methods section. Local clusters of RDT, PCR and 
microscopy data were assessed separately and the differences in parameters (i.e. risk ratios (RR), 
hotspots radius and P-values) compared.  
5.3.5 Temporal variation in malaria transmission 
Parasite prevalence was computed by imposing spatial grids on the data and collapsing to the 
mean prevalence within each cell of the grid. This was done with grids of variable sizes 
0.5x0.5km, 1x1km and 2x2km grid squares, selected a priori to allow for a sensitivity analysis 
that would examine the potential bias resulting from the modifiable areal unit problem, and 
repeated by year. The association between parasite prevalence by PCR and by microscopy or 
RDT was assessed for the various grid sizes. Furthermore, the stability of spatial heterogeneity 
for RDT, PCR and microscopy datasets was assessed by examining parasite prevalence within 
grids separated in time using the Spearman’s rank correlation coefficient.  
The degree to which hotspots overlap was defined as the fraction of homesteads within the 
intersection of hotspots detected by PCR and microscopy or RDT divided by the total number 
of homesteads within the hotspots. Only homesteads within primary hotspots (most likely 
cluster regardless of significance) and any other statistically significant secondary clusters were 
included in the computations. 
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Hotspots of malaria transmission were mapped on Google Map extracts in R version 3.3.1 
(Team 2016). Graphs were generated, Cohens’ Kappa statistic was computed and correlation 
analyses using Stata version 12 (StataCorp, Texas). 
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5.4 Results  
A total of 8581 study participants were surveyed in the three study sites. There was a positive 
correlation between P. falciparum parasite density measured by PCR and by microscopy among 
those testing positive (Figure 5.2a) (r=0.72, p<0.001, and a strong association between detection 
by PCR and detection by microscopy (Table 5.1, kappa=0.6159, p<0.001).  
 
Figure 5.2: Distribution of parasite densities. 
Panel A shows a scatter plot of Log-transformed parasite/µl densities detected by microscopy 
and PCR (PCR negative test results were assigned an arbitrary value of 0.05 parasite/µl, while 
microscopy negative test results were assigned an arbitrary value of 1 parasites/µl before log 
transformation to allow complete data presentation for samples that were either positive by 
PCR or microscopy). Panels B and C show histograms of log-transformed PCR and microscopy 
parasites/µl densities respectively, against normal distribution functions. 
 
Table 5.1: Number of samples that were malaria parasite positive by microscopy and PCR 
Site N 
Malaria test result  
Both PCR and 
Microscopy n(%) 
PCR only 
n(%) 
Microscopy 
only n(%) 
Negative by PCR and 
microscopy n(%) 
Junju 4910 790 (16.1) 688 (14.0) 22 (0.45) 3410 (69.45) 
Ngerenya 2406 5 (0.21) 44 (1.83) 0 (0) 2357(97.96) 
Ganze 1265 12 (0.95) 62 (4.90) 1(0.08) 1190(94.07) 
Total 8581 807 (9.40) 794 (9.25) 23 (0.26) 6957(81.07) 
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Parasite densities by PCR and microscopy were log-normally distributed (Figure 5.2b and 5.2c). 
The geometric mean PCR densities (of positive samples) were lowest in Ngerenya 11.79 
parasites/µl (95%CI 3.68-37.76 parasites/µl) and highest in Junju 220.02 parasites/µl (95%CI 
184.17-262.85 parasites/µl). 
5.4.1 Hotspots of malaria transmission 
Malaria species were only examined by microscopy. Overall, the prevalence of malaria by 
species in the three sites were 9.67% (830/8581 films), 0.16% (13/8004 films), 0.60% (48/8014 
films) and 0% (0/8014 films) for P. falciparum, P. ovale, P. malariae and P. vivax respectively. 
P. ovale and P. malariae were only detected in the moderate transmission site (Junju) and not 
in either of the low transmission sites. No P. vivax case was reported in any of the sites.  
In pooled data analysis from Junju, I identified 2 statistically significant hotspots of P. 
falciparum (radius=1.75 km, RR=2.69, p<0.001) and (radius=1.07 km, RR=2.87, p<0.001). I 
identified one significant primary hotspot of P. malariae (radius=0.053 km, RR=10.41, 
p=0.003) and a borderline significant secondary hotspot (radius=0 km, RR=9.33, p=0.065) and 
a non-significant hotspots of P. ovale (radius=1.76 km, RR=6.3, p=0.439). The hotspots of P. 
falciparum, P. malariae and P. ovale overlapped geographically (Figure 5.3). Further analysis 
is restricted to P. falciparum. 
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Figure 5.3: Hotspots of malaria transmission by species. 
Green (significant primary and secondary hotspots), blue (primary non-significant hotspot) and 
the black (significant primary and secondary hotspots) circles represent hotspots of P. 
falciparum, P. ovale and P. malariae respectively as detected by microscopy. 
P. falciparum was detected by PCR, RDT and microscopy. Significant hotspots of malaria 
transmission by the three diagnostic tools were observed in the Junju and Ganze sites. However, 
hotspots of malaria transmission in Ngerenya were statistically significant only when measured 
by PCR and RDT, and not statistically significant when measured by microscopy (Table 5.2). 
Overall (pooled data analysis across all years of monitoring), the degree of overlap between 
hotspots detected by PCR and those detected by microscopy was 100% in Junju, but less overlap 
was noted when hotspots were examined by year (Table 5.2 and Figure 5.4). 
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Figure 5.4: Hotspots of malaria transmission by diagnostic tool. 
Panels A and B show the Junju (moderate transmission) and Ganze (low transmission) cohorts 
respectively. In Junju, there was complete overlap between PCR (black circles) and microscopy 
(green circles) but partially by RDT (blue) for the primary hotspot (I). However, for the three 
diagnostic tools used, there was complete overlap in the significant secondary hotspots (II). In 
Ganze, the hotspot detected by microscopy (green circle) was within the hotspots detected by 
PCR (black circle) and at the border with RDT (blue circle). 
However, in the Junju site, there was partial overlap of PCR and RDTs’ primary hotspots 
(45.9%), but complete overlap for the significant secondary hotspots (Table 5.2). Overall, 
overlap in hotspots detected in Ganze and Ngerenya sites were inconsistent. The risk ratios for 
microscopy hotspots were consistently larger than those measured by PCR. 
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Table 5.2: Properties of malaria hotspots and degree of homestead overlap between hotspots detected by PCR, microscopy and RDT. 
    PCR Microscopy RDT Degree of Overlap (%) 
Study Period Radius RR P-value Radius RR P-value Radius RR P-value 
PCR vs 
Microscopy  
PCR vs 
RDT 
RDT vs 
Microscopy  
Junju 
Overall 1.75 1.85 <0.001 1.75 2.69 <0.001 0.81 1.91 <0.001 100 45.9 45.9 
Overall* 1.07 2.23 <0.001 1.07 2.87 <0.001 1.07 2.61 <0.001 100 100 100 
2007 0.9 2.17 0.003 2.11 4.57 <0.001 2.38 4.99 <0.001 42.02 39.32 82.22 
2008 1.67 2.2 <0.001 1.76 2.22 0.002 1.58 3.92 <0.001 71.54 72.5 85.71 
2009 2.38 2.34 <0.001 1.54 3.4 <0.001 1.71 7.88 <0.001 68.79 55.84 73.64 
2010 1.77 2.01 <0.001 1.78 2.65 <0.001 1.97 3.76 <0.001 79.2 73.13 63.19 
2011 1.44 2.71 <0.001 1.72 6.28 <0.001 0.64 5.5 0.009 76.42 20.18 23.68 
2012 2.08 2.02 <0.001 1.29 2.7 <0.001 1.78 2.08 0.001 57.63 61.81 57.76 
2013 0.36 3.31 0.002 0.19 9.07 0.133 1.98 2.69 0.001 8.33 8.53 2.33 
2014 0 3.37 0.089 0.94 4.11 0.096 0.19 2.11 0.018 0 0 0 
2015 0.74 2.25 <0.001 0.63 3.31 <0.001 0.52 2.44 <0.001 25.42 48.65 22.64 
2015* 0.33 2.68 0.02 0.14 3.56 0.015 0.33 2.49 0.025 25.42 100 0 
2016 0 3.74 0.208 0.64 3.19 0.122 0.02 3.61 0.017 0 0 0 
Ganze Overall  12.12 4.14 <0.001 0.76 31 0.003 10.08 67.4 <0.001 2.75 75.61 2.8 
Ngerenya 
Overall 1.04 5.35 0.005 0 36.6 0.122 0 33.8 0.017 50 50 100 
2007-2010 0 8.96 0.213 1.65 8.11 0.758 0 60.69 0.059 0 100 0 
2010-2014 0.56 5.2 0.016 - - - 0.83 14.28 0.34 - 25 - 
                 * includes significant secondary clusters 
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5.4.2 Association between parasite prevalence by PCR, microscopy and RDT 
In all sites, and across all three grid sizes examined, there was a strong positive correlation 
between prevalence of parasitaemia measured by PCR and microscopy or RDT (i.e. 
geographical areas experiencing high malaria prevalence as measured by PCR were also more 
likely to be high when measured by microscopy or RDT). However, the associations were 
weaker in low transmission settings (Table 5.3 and Table 5.4).  
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Table 5.3: Association between parasite prevalence by PCR and microscopy at various grid sizes. 
Site Year 
Parasite Prevalence  0.5x0.5 km2 Grid  1x1 km2 Grid  2x2 km2 Grid  
PCR 
(%) 
Microscopy 
(%) 
Correlation (CI) P-value Correlation (CI) P-value Correlation (CI) P-value 
Junju Cohort 
Overall  30.10 16.54 0.73 (0.70 - 0.76) <0.001 0.81 (0.77 - 0.84) <0.001 0.86 (0.82-0.89) <0.001 
2007 29.82 16.27 0.70 (0.50 - 0.83) <0.001 0.70 (0.37 - 0.88) <0.001 0.83 (0.38-0.96) 0.005 
2008 47.51 29.33 0.79 (0.63 - 0.89) <0.001 0.83 (0.62 - 0.94) <0.001 0.93 (0.71-0.99) <0.001 
2009 31.45 21.36 0.58 (0.32 - 0.76) <0.001 0.82(0.58 - 0.93) <0.001 0.90 (0.58-0.98) <0.001 
2010 39.32 21.98 0.78 (0.71 - 0.84) <0.001 0.76 (0.63 - 0.85) <0.001 0.83 (0.65-0.92) <0.001 
2011 26.93 15.48 0.69 (0.58 - 0.77) <0.001 0.80 (0.69 - 0.87) <0.001 0.88 (0.75-0.95) <0.001 
2012 27.68 15.40 0.72 (0.62 - 0.79) <0.001 0.79 (0.67 - 0.87) <0.001 0.80 (0.59-0.91) <0.001 
2013 19.42 7.89 0.69 (0.59 - 0.77) <0.001 0.79 (0.67 -0.87) <0.001 0.85 (0.68-0.93) <0.001 
2014 30.32 14.76 0.73 (0.64 - 0.81) <0.001 0.83 (0.73 - 0.89) <0.001 0.91 (0.81-0.96) <0.001 
2015 30.75 17.65 0.77 (0.61- 0.88) <0.001 0.76 (0.49 - 0.90) <0.001 0.81 (0.37-0.95) 0.005 
2016 23.51 11.26 0.46 (0.17 - 0.69) 0.004 0.48 (0.04 - 0.77) 0.036 0.47 (-0.22-0.85) 0.167 
Ngerenya 
Cohort 
Overall  2.04 0.21 0.37 (0.27-0.46) <0.001 0.38 (0.26-0.48) <0.001 0.40 (0.22-0.56 <0.001 
                    
Ganze 
Cohort 
Overall 5.85 1.03 0.45 (0.34 - 0.55) <0.001 0.45 (0.30 - 0.58) <0.001 0.48 (0.28 - 0.63) <0.001 
2012 7.73 1.81 0.51 (0.37 - 0.63) <0.001 0.53 (0.35 - 0.68) <0.001 0.60 (0.34 - 0.77) <0.001 
2013 4.11 0.30 0.35 (0.17 - 0.51) <0.001 0.30 (0.05 - 0.52) 0.0195 0.23 (-0.11 - 0.53) 0.1852 
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Table 5.4: Association between parasite prevalence by PCR and parasite prevalence by RDT at various grid sizes 
Site Year 
Parasite 
Prevalence  
0.5x0.5 km2 Grid  1x1 km2 Grid  2x2 km2 Grid  
PCR 
(%) 
RDT 
(%) 
Correlation (CI) 
P-
value 
Correlation (CI) 
P-
value 
Correlation (CI) 
P-
value 
Junju  
Overall  30.1 20.2 0.58 (0.53 - 0.63) <0.001 0.66 (0.60 - 0.71) <0.001 0.67 (0.60-0.76) <0.001 
2007 29.82 15.7 0.68 (0.46 - 0.82) <0.001 0.69 (0.35 - 0.87) <0.001 0.89 (0.54-0.98) 0.002 
2008 47.51 21.5 0.65 (0.42 - 0.81) <0.001 0.53 (0.09 - 0.79) 0.021 0.93 (0.69-0.99) <0.001 
2009 31.45 15.8 0.56 (0.30 - 0.75) <0.001 0.69 (0.34 - 0.87) 0.001 0.87 (0.49-0.97) 0.002 
2010 39.32 13.9 0.52 (0.36 - 0.64) <0.001 0.49 (0.25 - 0.67) <0.001 0.35 (-0.08-0.66) 0.1045 
2011 26.93 5.3 0.56 (0.43 - 0.67) <0.001 0.73 (0.59 - 0.83) <0.001 0.77 (0.55-0.89) <0.001 
2012 27.68 22.4 0.58 (0.45 - 0.69) <0.001 0.66 (0.50 - 0.78) <0.001 0.79 (0.57-0.90) <0.001 
2013 19.42 14.6 0.63 (0.51 - 0.73) <0.001 0.79 (0.67 - 0.87) <0.001 0.89 (0.77-0.95) <0.001 
2014 30.32 37.1 0.71 (0.61 - 0.79) <0.001 0.88 (0.81 - 0.93) <0.001 0.89 (0.77-0.95) <0.001 
2015 30.75 32.8 0.55 (0.29 - 0.74) <0.001 0.53 (0.13 - 0.78) 0.0135 0.86 (0.49-0.97) 0.002 
2016 23.51 28.9 0.54 (0.26 - 0.73) <0.001 0.62 (0.23 - 0.84) 0.005 0.91 (0.66 - 0.98) <0.001 
 Overall 5.98 1.67 0.44 (0.33 - 0.54) <0.001 0.47 (0.32 - 0.59) <0.001 0.52 (0.33 - 0.67) <0.001 
Ganze 2012 8.18 2.99 0.56 (0.42 - 0.67) <0.001 0.48 (0.28 - 0.64) <0.001 0.59 (0.34 - 0.77) <0.001 
 2013 3.94 0.44 0.23 (0.04 - 0.41) 0.0170 0.44 (0.21 - 0.62) <0.001 0.37 (0.03 - 0.63) 0.0327 
Ngerenya Overall  2.04 0.38 0.40 (0.22 - 0.56) <0.001 0.85 (0.78 - 0.90) <0.001 0.37 (0.18 - 0.53) <0.001 
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5.4.3 Temporal stability of malaria transmission in the study sites 
In the Junju site, the prevalences of parasitaemia within grids were predictive of the prevalence 
in the following year. The stability appeared to be greater for PCR and microscopy, which 
remained significant for intervals below 5 years, and less stable for RDT prevalences, which 
were significantly predictive of the prevalence in the following year and only up to 2 year 
intervals in this site.  
In contrast, the prevalences of parasitaemia within grids in Ganze were not predictive for the 
following year by any measure (Table 5.5, Table 5.6 and Table 5.7) and such an analysis was 
not possible in Ngerenya due to low power resulting from limited number of malaria cases in 
the area. The findings on temporal stability were consistent across the 3 spatial scales used 
(0.5x0.5 km2, 1x1 km2 and 2x2 km2). 
 
 
 
 
 
155 | P a g e  
 
Table 5.5: Association between distribution of malaria parasite prevalence detected by microscopy, PCR and RDT within 0.5x0.5 km2 
grid size over time intervals. 
    0.5x0.5 km2 Grid 
Study 
Site 
Interval between 
cluster (year) 
Microscopy Analysis PCR Analysis RDT Analysis 
Correlation 
(95%CI) 
P-
value 
Correlation (95%CI) P-value Correlation (95%CI) P-value 
Junju 
1 0.46 (0.40 - 0.52) <0.001 0.40 (0.33-0.46) <0.001 0.32 (0.25-0.39) <0.001 
2 0.46 (0.40 - 0.53) <0.001 0.34 (0.27-0.42) <0.001 0.34 (0.26-0.41) <0.001 
3 0.31 (0.22 - 0.39) <0.001 0.28 (0.19-0.37) <0.001 0.11 (0.02-0.21) 0.0233 
4 0.30 (0.20 - 0.40) <0.001 0.30 (0.19-0.40) <0.001 0.07 (-0.05-0.18) 0.2465 
5 0.31 (0.17 - 0.43) <0.001 0.19 (0.05-0.33) 0.009 0.05 (-0.09-0.19) 0.4637 
6 0.25 (0.09 - 0.40) 0.0022 0.18 (0.02-0.34) 0.0313 0.11 (-0.06-0.27) 0.2092 
7 0.19 (0.001 - 0.37) 0.0494 0.17 (-0.02-0.35) 0.0748 0.18 (-0.02-0.35) 0.0719 
8 0.28 (0.05 - 0.49) 0.0207 0.11 (-0.13-0.34) 0.3554 0.16 (-0.09-0.38) 0.2038 
9 0.27 (-0.08 - 0.57) 0.122 -0.04 (-0.38 - 0.30) 0.8105 -0.04 (-0.30 - 0.38) 0.8253 
Ganze 1 -0.05 (-0.40-0.31) 0.798 0.39 (0.04-0.65) 0.0308 - - 
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Table 5.6: Association between distribution of malaria parasite prevalence detected by microscopy, PCR and RDT within 1x1 km2 grid 
size over time intervals. 
    1x1 km2 Grid 
Study 
Site 
Interval between 
cluster (year) 
Microscopy Analysis PCR Analysis RDT Analysis 
Correlation (95%CI) P-value Correlation (95%CI) P-value 
Correlation 
(95%CI) 
P-
value 
Junju 
1 0.46 (0.37 - 0.54) <0.001 0.41 (0.32-0.49) <0.001 0.44 (0.35-0.52) <0.001 
2 0.49 (0.40 - 0.58) <0.001 0.40 (0.29-0.49) <0.001 0.44 (0.34-0.53) <0.001 
3 0.33 (0.21 - 0.45) <0.001 0.34 (0.22-0.45) <0.001 0.16 (0.03-0.29) 0.0175 
4 0.35 (0.21 - 0.48) <0.001 0.38 (0.23-0.50) <0.001 0.12 (-0.04-0.28) 0.1394 
5 0.27 (0.08 - 0.45) 0.006 0.15 (-0.05-0.34) 0.1403 0.03 (-0.17-0.22) 0.794 
6 0.29 (0.07 - 0.48) 0.01 0.19 (-0.03-0.39) 0.094 0.08 (-0.14-0.30) 0.4575 
7 0.20 (-0.05- 0.44) 0.1142 0.19 (-0.07-0.42) 0.1525 0.05 (-0.21-0.30) 0.7078 
8 0.23 (-0.09- 0.51) 0.1616 0.07 (-0.25-0.38) 0.6712 0.03 (-0.29-0.34) 0.871 
9 0.34 (-0.14- 0.69) 0.1574 0.04 (-0.42-0.48) 0.8789 -0.20 (-0.60-0.28) 0.4059 
Ganze 1 -0.05 (-0.40-0.31) 0.798 0.39 (0.04-0.65) 0.0308 - - 
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Table 5.7: Association between distribution of malaria parasite prevalence detected by microscopy, PCR and RDT within 2x2 km2 grid 
size over time intervals. 
    2x2 km2 Grid 
Study 
Site 
Interval 
between cluster 
(year) 
Microscopy Analysis PCR Analysis RDT Analysis 
Correlation (95%CI) P-value 
Correlation 
(95%CI) 
P-value 
Correlation 
(95%CI) 
P-value 
Junju 
cohort 
1 0.46 (0.32-0.58) <0.001 0.41 (0.26-0.53) <0.001 0.43 (0.29-0.56) <0.001 
2 0.55 (0.41-0.66) <0.001 0.44 (0.29-0.58) <0.001 0.50 (0.35-0.62) <0.001 
3 0.44 (0.26-0.59) <0.001 0.34 (0.15-0.51) <0.001 0.18 (-0.02-0.37) 0.0843 
4 0.46 (0.25-0.63) <0.001 0.48 (0.28-0.64) <0.001 0.08 (-0.16-0.31) 0.532 
5 0.53 (0.29-0.71) <0.001 0.34 (0.06-0.57) 0.0188 0.11 (-0.19-0.38) 0.4836 
6 0.47 (0.18-0.69) 0.003 0.32 (-0.01-0.59) 0.0505 0.27 (-0.07-0.55) 0.1179 
7 0.48 (0.12-0.73) 0.0111 0.65 (0.35-0.82) <0.001 0.22 (-0.17-0.56) 0.2651 
8 0.33 (-0.16-0.69) 0.1788 0.27 (-0.22-0.66) 0.2732 0.34 (-0.15-0.70) 0.1659 
9 0.54 (-0.19-0.89) 0.1318 0.74 (0.14-0.94) 0.024 0.34 (-0.42-0.82) 0.3721 
Ganze 
cohort 
1 0.35 (-0.08- 0.67) 0.1075 0.30 (-0.14-0.64) 0.1712 - - 
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5.5 Discussion 
P. falciparum parasite prevalence has frequently been used as a marker of transmission intensity 
and is widely used in detection of hotspots of asymptomatic parasitaemia. However, the 
estimated prevalence of parasitaemia has been shown to vary substantially with the diagnostic 
tool used. PCR and other molecular techniques are significantly more sensitive than microscopy 
and RDT for detection of malaria parasites, especially at lower transmission intensities where 
parasite densities are lower (Okell et al. 2009, Okell et al. 2012). This study examines the micro-
epidemiology of malaria transmission in three sites on the Kenyan coast experiencing varying 
transmission intensities.  
There was substantial heterogeneity of malaria transmission in the three sites, as has been 
previously described (Bejon et al. 2010). Hotspots were detected by PCR, RDT and microscopy, 
and were statistically significant for all sites except by microscopy in the Ngerenya site. When 
all years from the Junju site were pooled for spatial analysis, hotspots by PCR completely 
overlapped with hotspots by microscopy and partially overlapped with RDT. However, an 
analysis of individual year by year data showed some variation in the degree of overlap (Table 
5.1). Overlap became less marked in later years, coinciding with reductions in transmission 
intensity (O'Meara et al. 2008), and little overlap was noted in Ganze, where transmission is 
lower (Kangoye et al. 2016). It is unsurprising that hotspots of the different malaria species 
overlapped geographically since they are transmitted by similar vectors. 
There were significant correlations between PCR and microscopy, and between PCR and RDT 
parasite prevalences within grid cells imposed on the data at three different spatial scales. The 
correlations were stronger in Junju than in Ngerenya and Ganze (Table 5.2). The prevalence of 
infection was below 2% in Ngerenya and Ganze. Taking the findings on degree of overlap of 
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hotspots in the different transmission settings and the correlation between parasite prevalence 
together, I conclude that hotspots detected by PCR are likely to occur in the same geographical 
areas as those detected by microscopy at moderate transmission intensities. However, the degree 
to which they overlap is lessened when transmission is less intense. 
As would be expected, PCR densities were lower than microscopy densities (Bejon et al. 2006), 
and the average densities by PCR were lower in low transmission settings (Ngerenya and Ganze) 
compared to the moderate transmission setting (Junju). Moreover, the proportion of PCR 
positive cases that were positive by microscopy were highest in Junju, followed by Ganze and 
Ngerenya in that order (Table 5.1). My findings suggest that microscopy and RDT misses a 
larger proportion of infections in low transmission areas (Ngerenya and Ganze) compared to the 
one moderate transmission setting in Junju, and may explain why PCR becomes more important 
in detecting hotspots at lower transmission intensities.   
I observed stable hotspots of asymptomatic parasitaemia in the Junju cohort but not in Ganze, 
and I was not sufficiently powered to assess stability of hotspots in Ngerenya. Hotspots were 
similarly stable when detected by PCR or microscopy but not RDT (Table 5.3). The advent of 
HRP2 dependent RDTs greatly expanded access to malaria diagnostics tools because of low 
cost and ease of applicability in the field, but the sensitivity of this technique is lower than that 
of PCR and may be comparable to the sensitivity of routine microscopy (WHO 2012b). In 
addition, HRP2 antigen can circulate in blood for weeks after treatment leading to false 
positives,  and recent studies show that some P. falciparum parasites do not express the HRP2 
protein leading to false negatives (Cheng et al. 2014). These factors potentially result in poorer 
discrimination for the location of hotspots, explaining the lack of long-term stability of hotspots 
detected by RDT. Furthermore, hotspots defined by RDT did not consistently overlap the PCR 
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or microscopy hotspots. I conclude that although RDTs have a firmly established place in 
diagnosis of acute fever and malaria indicator surveys  (Murray et al. 2008, WHO 2012b), their 
utility for fine-scale mapping of hotspots is less clear. 
The main limitation of this study is that data were collected from geographical areas of close 
proximity on the Kenyan coast. However, these geographical areas captured a range of 
transmission intensities and during a period when transmission was falling (Mogeni et al. 2016). 
Although the Ngerenya dataset (i.e. a site with low transmission intensity) was large (n=2286), 
there were few positive cases (Table 5.1) and hence limited power to describe and compare 
hotspots. Microscopy has low sensitivity in detecting minority species in mixed infections. In 
this study only P. falciparum specific PCR was used and this could have led to non-falciparum 
infections being missed and therefore underestimated the prevalence of the minority species and 
the position, size and significance of the hotspots. 
Clinical malaria case monitoring has also been used to identify hotspots of malaria transmission 
(Kangoye et al. 2016). However, this may be less sensitive in identifying stable hotspots of 
malaria where substantial immunity in the population offsets the risk of clinical malaria (Bejon 
et al. 2010) and even at low transmission intensity, hotspots determined by PCR do not overlap 
with microscopy hotspots (Kangoye et al. 2016). Hence, PCR monitoring of asymptomatic 
infection may identify hotspots that would not be detected by monitoring clinical cases and may 
be useful for pre-elimination surveillance. 
5.6 Implications of the findings 
Malaria control programs increasingly need to adopt targeted malaria control at low 
transmission intensities. My findings suggest that PCR, RDT and microscopy can potentially 
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determine hotspots at moderate transmission intensities, but PCR testing has a diagnostic 
advantage as transmission intensity falls. Therefore, Malaria control programs should consider 
PCR testing when the prevalence of infection is low. 
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Chapter Six 
6 Concluding remarks and recommendations 
6.1 Summary of findings 
Parts of sub-Saharan Africa have witnessed declines in malaria transmission intensity over the 
past two decades. Spatial heterogeneity is expected to be more marked as transmission intensity 
declines and therefore presents an opportunity for targeted control. However, this should be 
accompanied by an understanding of the factors predicting malaria heterogeneity. Furthermore, 
it is predicted that declining transmission intensity may result to a shift in age of susceptibility 
to malaria with important consequences in case fatality rates. The analyses presented in chapter 
3 of this thesis examines some of these features using a detailed 25-year longitudinal hospital 
surveillance dataset with the aim of describing the spatial-temporal patterns of malaria 
transmission in Kilifi County. I conducted further analysis of trends of malaria positive fraction 
by age group and the effect of environmental factors, personal and community ITN use, and age 
on malaria heterogeneity. The key findings were: - 
• Malaria transmission intensity in Kilifi County is spatially and temporally 
heterogeneous. Hospital presentation with malaria parasites declined from around the 
year 2000 to 2009 and increased through to 2014. The decline in transmission intensity 
occurred before the mass distribution of ITN and the practical implementation of the 
government policy change over from chloroquine to ACT as the first line mode of 
treatment against uncomplicated malaria. Geographical heterogeneity was greater after 
the decline keeping with previous observations. Furthermore, the stability of malaria 
transmission at the locational level declined with declining transmission intensity such 
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that the negative association between MPF and age of susceptibility at the post decline 
period was non-significant. 
• During the high transmission period, young children predominantly presented to hospital 
for admission with malaria parasites in their blood. However, as transmission intensity 
declined, largely older children presented with malaria for admission. Fortunately, there 
was no clear trend towards increasing mortality as would be predicted. This result may 
not be definitive given several unmeasured potential confounders that likely mask the 
true trend in mortality over time. For instance, a) increasing hospital accessibility over 
time leading to more timely presentation for treatment and b) improved malaria case 
management over time because of implemented research findings. 
• The prevalence of ITN use among the whole population within a 2-kilometre radius of 
the admitted child’s residence was strongly predictive of protection. High community 
ITN coverages were associated with lower malaria cases. 
• The enhanced vegetation index (EVI) was predictive of malaria but explained a small 
fraction of the variability in the outcome variable. Overall, the variability explained by 
the model was ~23%. 
Geographically defined clusters (hotspots) are a consistent feature of malaria transmission in 
sub-Saharan Africa. The utility of hotspots to malaria control programmes is at moderate to low 
transmission intensity where hotspots are more marked and predicted to complicate elimination 
efforts. Although hotspots have been detected in most epidemiological studies, the potential of 
targeting them through cluster randomised controlled studies has not been assessed 
comprehensively to determine their utility in the field. This is partly because rational design of 
cluster randomised control interventions need detailed descriptions of the properties of hotspots 
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and the methods used to detect them. These properties of hotspots and the effects of diagnostic 
tools on hotspots are not well understood and compared over a variety of transmission settings 
to assess their reproducibility. The analyses presented in chapter 4 and chapter 5 of this thesis 
addressed some of these issues.  
Key findings: - 
•  The risk ratio of malaria within the hotspots was higher at low MPF suggesting that 
spatial heterogeneity becomes gradually marked at low transmission intensities, keeping 
with results from chapter 3. However, the strength of evidence (p-values) increased from 
low MPFs to moderate MPFs and then declined towards high MPFs further suggesting 
that although spatial heterogeneity becomes more apparent at low transmission 
intensities, the power to detect hotspots during low transmission becomes low as cases 
become more sparse. 
• Previous analysis of hotspots in Kilifi County on the Kenyan coast identified two types 
of hotspots; a) stable hotspots of asymptomatic malaria and b) unstable hotspots of 
febrile malaria. I examined the stability of hotspots using 4 longitudinal studies 
conducted outside Kilifi county to assess generalizability. Both hotspots of 
asymptomatic parasitaemia and hotspots of febrile malaria were unstable suggesting that 
stability of hotspots of asymptomatic malaria is not a reproducible feature in all 
transmission settings. 
•  Micro-variation of malaria transmission was negatively associated with age of 
susceptibility in most datasets, suggesting that, during high transmission intensity, 
children acquire immunity rapidly due to intense exposure when they are younger and 
hence do not present with symptomatic malaria when they are older and vice versa. I 
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assessed the association between micro-variation of symptomatic malaria with age of 
susceptibility for each dataset and combined the estimates in a meta-analysis at three 
spatial scales determined a priori. Heterogeneity between studies (I2) declined with 
increasing spatial scale while the pooled correlation estimate became larger at relatively 
coarse spatial scales keeping with previous studies (Bejon et al. 2014). In addition, there 
were significant positive spatial autocorrelations in age of susceptibility to febrile 
malaria in most datasets of febrile malaria, thus providing further evidence that micro-
variation of transmission intensity may have led to variation in the degree of acquisition 
of clinical immunity. 
The prevalence of asymptomatic parasitaemia varies considerably between diagnostic tools 
(Okell et al. 2009, Okell et al. 2012).  The aim of the analysis presented in chapter 5 (Mogeni et 
al. 2017b) was to assess the degree with which hotspots detected by RDT, PCR and microscopy 
analysis overlap geographically.  
Key findings: - 
• Substantial heterogeneity of malaria transmission was observed in the three sites, as 
previously reported (Bejon et al. 2010). P. falciparum was detected in the three sites 
examined (Junju, Ngerenya and Ganze cohorts), however, P. ovale and P. malariae were 
only detected in the Junju site. Hotspots of P. falciparum examined by microscopy 
overlapped with hotspots of P. ovale and P. malariae but there was no reported case of 
P. vivax in any of the three sites examined. 
• The degree of overlap between diagnostic tools decreased with decreasing transmission 
intensity. Hotspots detected by PCR and microscopy remained stable for over five years, 
however, hotspots detected by RDTs were significantly stable for up to 2 years.  
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The studies presented in this thesis provides important empirical evidence on the likely outcome 
following declined malaria transmission intensity and the importance of universal coverage with 
ITNs. This information emphasizes the need for continued investment on malaria control 
interventions even when transmission intensity is very low. The studies contribute to the limited 
empirical evidence of increased heterogeneity as transmission intensity decline. Furthermore, 
important recommendations for the malaria control programs are deduced; 1) PCR testing is 
needed for detection of asymptomatic malaria during low transmission intensities 2) Targeting 
of hotspots of malaria transmission may achieve greater impact when transmission intensity is 
low (i.e. when the PfPR is below 10%). 
Alternative definitions of hotspots 
A malaria hotspot can also be defined as an area where the malaria risk is highly likely to exceed 
a threshold considered to be relevant to policy. A key challenge with policy thresholds is in the 
determination of a universally acceptable cutoff that cuts across the spectrum of malaria 
transmission intensities. The definition could alternatively be based on prior theoretical 
assumptions. For instance, a threshold that includes 20% of the analysed population in the 
hotspot (Stresman et al. 2017) is based on the theoretical 80–20 assumption where 20% of the 
population has been shown to experience 80% of the disease episodes (Woolhouse et al. 1997a). 
Although this threshold may be applicable in some settings, site specific variations in 
distributions of infection may exist and the most appropriate proportion of the population to 
include in a hotspot may vary (Stresman et al. 2017). 
A hotspot of malaria transmission can also be defined as an area where the difference between 
the local sum of positive malaria cases for a given location and its neighbours is larger than the 
expected as calculated using the Getis Ord Gi* statistic. The Getis Ord Gi* statistic yields 
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standardised Z-scores and is defined as the ratios of the local sum of the values in the vicinity 
of a given distance to the sum of all values. When the local sum is different than the expected 
local sum, and the difference is too large to be the result of random chance, a statistically 
significant Z-score results. The positive Z-scores indicate high cases of malaria (hotspots) while 
negative Z-scores indicate low malaria cases (cold spots) (Getis and Ord 1992). The 
significance of a hotspot can be obtained from an optimized hotspot analysis function in ArcGIS 
(Ver.10.2, ESRI Inc., CA, USA) using threshold Z-scores (Izumi et al. 2015). For instance, 
Gwitira et al used a Z-score ≥1.96 as a cut-off to define a hotspot based on the critical Z-score 
values from 95% confidence level (Gwitira et al. 2018). Although Getis-Ord Gi* statistic has 
been used in literature to detect hotspots, it suffers from the problem of multiple testing (Gwitira 
et al. 2018), a longstanding difficulty in determining hotspots in the absence of non-arbitrary 
geographical “bins” for data, as recognized by Openshaw (Openshaw et al. 1987). 
6.2 Recommendations for future studies 
Although there was no clear trend towards increasing mortality in Kilifi following initial 
reductions in transmission intensity (chapter 3), parallel factors may contribute to the observed 
outcome. For instance, increased accessibility or hospital acceptance and improved case 
management may mask the true trend in mortality over time, if all factors were kept constant. 
Further analysis of malaria phenotypes over time may be required to give insight on the impact 
of the age-shifting burden of disease to older children on the severity of malaria. 
The rate of ITNs loss within the KHDSS area following the mass distribution of nets is a cause 
of concern. This work can be extended to assess reasons for ITN loss/ non ITN use in the 
community through focused group discussions and community engagement to improve ITN 
uptake. 
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Further analysis on the stability of hotspots during the dry and rainy seasons will likely provide 
useful information on the contribution of seasonality. Previous analysis shows that hotspots are 
maintained during dry seasons and rainy seasons (Bejon et al. 2010, Bousema et al. 2012b), 
however, there is little empirical evidence on the degree with which such hotspots overlap. The 
analysis of year to year variations presented in chapter 4 and 5 masks the potential role of 
seasonality. A more temporally fine-grained analysis to examine seasonal signals would have 
been a useful addition to this work, however, sample size constraints made it difficult to carry 
out monthly analysis for the limited longitudinal datasets that were available.  
Hotspots of malaria transmission could be predicted using remote sensing data extracted from 
NASA satellite (aqua and terra) (Bejon et al. 2010). Data from these satellites senses various 
environmental signals reflecting vegetation density, water/moisture and temperature. I 
identified that EVI (enhanced vegetation index) weakly predicted malaria cases in Kilifi County 
in Chapter 3.  A further extension to chapter 4 would entail an analysis of the correlation between 
the satellite data and malaria prevalence or MPF using regression models. The estimates can 
then be pooled to obtain overall effect sizes and a measure of heterogeneity between studies. A 
further assessment of trend in study specific effect size (for the various environmental 
covariates) over transmission intensity will be a valuable addition to the current literature 
assessing the effect environmental covariates at varying transmission intensities.  
Significant hotspots of malaria transmission can be detected within larger hotspots up to the 
homestead level (Bejon et al. 2014). This suggest that, the size of a hotspot will largely depend 
on the size of the area that is being examined. These feature of hotspots makes it difficult to 
determine the size of a hotspot that could be targeted if the whole foci of transmission were to 
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be studied. I recommend genomic studies to assess the degree of parasite mixing in space and 
time to determine the distances beyond which parasite mixing is unlikely. 
An important extension to chapter 5 will entail an analysis of the correlation between overlap 
of hotspots by diagnostic tools and temporal stability. This would require large assembled 
longitudinal datasets from which parameters describing both the degree of overlap and stability 
of hotspots could be computed and the correlations between these parameters assessed. 
6.3 Recommendations for malaria control programmes 
In conclusion, I recommend continued monitoring of malaria cases and related outcomes 
following declining malaria transmission intensity. Malaria control programmes should 
continue investing in malaria control interventions even when malaria transmission intensity 
appears to be low to prevent a likely “rebound” in malaria among older children as a population 
emerges with less immunity than was previously the case. ITN use remains an effective malaria 
control tool and achieving universal coverage should be prioritized. Key groups to target to 
achieve universal coverage are older children and adolescents.  
Heterogeneity of malaria transmission becomes more apparent as transmission intensity 
declines and is particularly marked at transmission intensities <10%. I propose that malaria 
transmission hotspots should be targeted when the overall parasite prevalence is low (<~10%), 
as my data suggest slight more modest clustering of malaria cases in hotspots at high 
transmission intensity. Many sub-Saharan Africa countries experience transmission intensities 
considerably above this threshold and may not benefit from hotspots targeted interventions. 
However, some countries in sub-Saharan Africa are already in the elimination stage and may 
benefit from targeted interventions. Mathematical modelling studies could guide on the most 
cost effective combination of interventions and coverage levels to achieve elimination. The 
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stability of hotspots may not be a reproducible property of malaria transmission hotspots in sub-
Saharan Africa and should therefore be assessed prior to rollout of interventions, and 
surveillance should therefore be continuously done to guide malaria control. Given the evidence 
on hotspots properties discussed, there is a need to design field trials to assess the impact of 
hotspot targeted interventions and the cost implication in areas experiencing low transmission 
intensities. Finally, I recommend Polymerase Chain Reaction for the identification and targeting 
of asymptomatic hotspots of malaria transmission when cross-sectional surveys are used in areas 
of very low transmission intensity, since RDT or microscopy seem to identify very similar 
hotspots at low to moderate transmission intensity. 
At the pre-elimination (Cohen et al. 2010) stage of malaria control, hotspots of malaria 
transmission are likely to be less stable and to lead to mainly symptomatic malaria cases due to 
reduced immunity among the population resulting from reduced exposure. At this stage malaria 
control programmes may consider using health-care based surveillance systems for targeting 
intervention. For instance, a symptomatic case presenting to hospital may be used to map out 
areas requiring targeted mass drug administration (MDA) in which case close contacts, 
households or villages of the index case are targeted (Hsiang et al. 2013). Alternatively, whole 
population MDA could be considered to clear residual transmission in areas of very low 
transmission intensity (von Seidlein and Greenwood 2003, Cotter et al. 2013). However, this 
approach will likely require an organized effort by neighboring countries and would be more 
feasible at a regional level as opposed to individual countries due to cross border human mobility 
and border vector dispersal. At low transmission intensity, MDA will likely result in treatment 
of many uninfected individuals, and this could be avoided by using a screening test to target 
treatment (i.e. mass screen and treat or MSAT). Countrywide MSAT will be hampered by the 
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apparent detection limitations of the available diagnostic tools and the amount of resources set 
aside for malaria interventions. 
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